Vasodilators and regional blood flow by Bolt, G.R. (Gert Roelf)
VASODILATORS AND 
REGIONAL BLOOD FLOW 
DRUKKERU ELINKWIJK BV 

VASODILATORS AND 
REGIONAL BLOOD FLOW 
Vaatverwijders en regionale doorbloeding 
PROEFSCHRIFT 
ter verkrijging van de graad van doctor in de 
GENEESKUNDE 
aan de Erasmus Universiteit Rotterdant 
op gezag van de Rector Magnificus 
Prof. Dr. M.W. Van Hof 
en volgens besluit van het College van Dekanen. 
De openbare verdediging zai plaatsvinden op 
woensdag, 3 april 1985 te 15.45 uur 
door 
GERT ROELF BOLT 
geboren te Opperdoes 
Begeleidingscommissie 
Promotor Prof. Dr. P.R. Saxena 
Overige !eden: Prof. Dr. W.H. Birkenhiiger 
Prof. Dr. M.A.D.H. Schalekamp 
Prof. Dr. P.A. van Zwieten 
Financial support by the Netherlands Heart Foundation for the publication of 
this thesis is gratefully acknowledged. 
VASODILATORS AND REGIONAL BLOOD FLOW 
Gert Roelf Bolt 
Aan mijn ouders; 
voor Taos, Paul en Eva 

CONTENTS 
Chapter 1: INTRODUCTION 
Chapter 2: APPLICATION OF THE RADIOACTIVE MICROSPHERE TECHNIQUE 
FOR STUDIES OF THE CIRCULATION IN CONSCIOUS RABBITS 
Chapter 3: SYSTEMIC AND REGIOWU. EmEMODYNAMIC CHARACTERISTICS OF 
BILATERAL CELLOPHANE PERINEPHRITIS HYPER!'ENSION rN 
CON$CIOUS RABBITS 
Chapter 4: EmEMOOYNAMIC PROFILE OF CAP'l'OPRIL IN CONSCIOUS 
ElYPERrENSIVE RABBITS 
Chapter 5: INTERACTION OF ATENOLOL WITH THE 'EIAEM)DYNAM!C PROFILE 
OF HYDRALAZINE IN CONSCIOUS HYPERI'ENSIVE RABBITS 
Chapter 6: HAEMOOYNP.MIC PROFILE OF FELODIPINE, A NEW CAI.CIOM 
ANTAGONIST, IN CONSCIOUS HYPERl'ENSIVE RABBITS 
Chapter 7: HAEMOOYNAMIC PROFILE OF PRAZOSIN IN CONSCIOUS 
HYPER!'ENSIVE RABBITS 
Chapter 8: EiAEMOOYNAMIC PROFILE 1\ND HYPOTENSIVE MECEmNISM OF 
KETANSERIN IN CONSCIOUS HYPERI'ENSIVE RABBITS 
Chapter 9: VASODILATORS AND REGIONAL BLOOD FLOW 
summary/5amenvatting 
List of pUblications 
Dankwoord 
Curriculum vitae 
page 
' 
15 
26 
41 
54 
75 
BB 
>00 
B7 
>45 
>46 
147 

CHAPTER l' 
INTRODUCTION 
Nowadays many different antihypertensive drugs are available which lower 
the blood pressure through various mechanisms of action. Accordingly, the hae-
~c changes that accompany the fall in blood pressure vary considerably 
depending upon the respective site of action of the drug and the more or less 
pronounced contribution of cardiovascular reflex mechaniSmS in the overall hae-
~c response. 
The ~ of the studies described in the present thesis is to characterize 
and compare the haemodynam.ic profiles of various types of antihypertensive drugs 
with special emphasis on the drug i.nduced changes in regional blood flows. For 
this purpose we have used the radioactive microsphere technique to study the 
systeroi.c and regional haemodynamic effects of a series of .. direct" and "indi-
rect" vasodilators in conscious hypertensive rabbits. 
DETERMINANTS OF BLOOD PRESSURE 
The perfusion pressure is defined by the pressure differen-
tial across the circulation (arterial pressure - central venous 
pressure). Because of the relatively low value and small fluctua-
tions in the central venous pressure, the latter value may be 
disregarded. A distinction is made between the systolic pressure, 
provided by the contracting ventricle, and the diastolic pressure, 
measured in the period prior to ventricular contraction. The mean 
blood pressure is obtained by integrating the arterial pulse wave 
or, alternatively, by adding one-third of the pulse pressure to 
the diastolic pressure. 
In symplified terms the arterial blood pressure is dependent 
upon two fundamental variables: the total systemic blood flow 
(cardiac output) and the resistance offered by the blood vessels 
to this forward flow (total peripheral resistance) (Bowman and 
Rand, l980a; Tarazi, 1983). The relation between arterial pres-
sure, blood flow and resistance to this flow is derived from Pois-
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seuille's formula which describes the rate of laminar flow (Q) 
through a cylindric tube as 
" Q = (P -P >-2._ k 
1 2 l.v 
(1) 
where (P1-P2 ) is the pressure differential at the two ends of the 
tube, r and 1 are radius and length of the tube, respectively, v 
is the viscosity of the fluid and k is a constant factor. When 
applied to the circulation, assuming unchanging vascular length, 
CO = MBP or MBP = CO X TPR 
TPR 
(Z) 
where cardiac output (CO) is equivalent to Q, mean arterial blood 
pressure (MBP) is equivalent to the pressure differential (P1-P2 ) 
and total peripheral resistance (TPR) is determined by the viscos-
ity of the blood and the radius of the blood vessels. For the 
whole circulation total peripheral resistance is equal to the sum 
of all vascular resistances in the various organs and tissues ar-
ranged in a parallel circuit: 
1 
TPR 
1 1 1 
+- + ..... +-
R~ R2 Rn 
(3) 
Because the radius is magnified to the fourth power in 
tion (1), resistance may be markedly affected by relatively 
egua-
small 
changes in vessel diameter. On the other hand, it will be clear 
from equation (3) that changes in vessel diameter in one vascular 
bed can be counteracted by opposing changes in other beds and, 
thus, may not necessarily affect total peripheral resistance. In 
each vascular bed about 70 % of the resistance offered to the ar-
terial blood flow is accounted for by the arterioles. In con-
trast, postcapillary vessels serve primarily as capacitance ves-
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sels. Approximately 70 % of the total blood volume is fqund on 
the venous side of the circulation. Thus, variations in diameter 
of the venous capacitance vessels cause large shifts in the circu-
lating blood volume and may acutely alter the venous return of 
blood to the hea~t (Bowman and Rand, l980a; Mille~ et al., 1982). 
CONTROL OF BLOOD PRESSURE 
The basic goal of the circulation is to provide blood flow to 
each tissue as needed to meet its requirements (Guyton, 1981). 
This is achieved by a combination of local reactions of the blood 
vessels in the tissues as well as simultaneous gross adjustments 
of large portions of the circulation. The overall system for cir-
culatory control can be divided into two parts; i) those 
that are intrinsic to the haemodynamic complex itself 
controls 
and ii) 
those controls that are extrinsic to the haemodynamic components 
(Guyton, 1976). Examples of intrinsic controls are autoregulatory 
mechanisms for acute and long term adjustments of local blood 
flows in response to changes in metabolic demands of the tissues, 
regulation of cardiac output by venous return according to the 
Frank-Starling law and long term control of pressure and blood vo-
lume by the kidney (pressure diuresis). The extrinsic controls 
include the nervous reflexes, which are especially important for 
acute modifications of the circulatory function, and hormonal sys-
tems such as the renin-angiotensin aldosteron system (figure 1). 
The purpose of pressure control is to keep the pressure high 
enough to ensure adequate blood flow to all tissues, even during 
acute stresses (Guyton, 1981). The autonomic nervous system plays 
a dominant role in the acute regulation of the arterial blood 
pressure (figure 1). Afferent information is obtained by the cen-
tral nervous system via several receptor systems of which the ar-
terial baroreceptors, located in the aortic arch and carotid bi-
furcation, are best described. Additional information is received 
from other receptor systems such as the cardiopu~onary "low pres-
sor receptors", primarily situated in the atria and puLmonary ar-
teries, chemoreceptors in aorta, carotid arteries, heart and lungs 
and receptors in the central nervous system that react upon acute 
falls in cerebral blood flow. The afferent receptor systems 
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t~ansmit seve~al stimuli to the medulla~y vasomotor centers in the 
brain which are also influenced by higher integrative centers lo-
cated in the hypothalamus, the limbic system and cortex (Shephard, 
1982; Kuchel, 1983; Struyker-Boudier, 1984). 
The integration of all influences results in a continuous re-
adjustment of the circulation by way of autonomic efferents having 
a sympathetic and parasympathetic component (figure 1). Although 
changes in vagal activity play an important role in the regulation 
of the heart rate, the sympathetic system predominantly determines 
cardiovascular control via efferent nerves to the heart and to all 
vascular beds. In addition, sympathetic fibers are responsible 
for the secretion of catecholamines from the adrenal medulla. An 
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TABLE J.. Classification and some examples of antihypertensive drugs. 
Site of action class Examples 
Autonomic nervous system 
veratrum alkaloids ( 1) 
Protoveratrine 
centrally acting drugs ( 2) 
clon:id:ine 
ex-methyldopa 
Ganglion blocking drugs ( 3) 
Hexamethonium 
Postgangl-ionic 
J3-adrenoceptor 
a-adrenoceptor 
adrenergic depressants ( 4) 
Reserpine 
Guanethidine 
antagonists ( 5 ) 
!:;~~~l~~J.l J3 , (3 ) 
Pindolol (~1 , b2 , lSA) 
antagonists ( 6 ) 
Renin-angiotensin system 
Prazosin ~ a1 ) Phentolam.J..ne ( a
1
, a 2 ) 
Kidney tubulus 
vascular smooth muscle 
COnverting-enzyme inhibitors ( 7) 
capt:opril 
Angiotensin II antagonists (a ) 
sara.J.asin 
Loop diuretics ( 9 ) 
Furosem:i.de 
Thiazide diuretics ( 9 ) 
Chlorothiazide 
Potassium sparing diuretics ( 9) 
Spironolactone 
calcium antagonists (10) 
others ( 10) 
Nifedipine 
Felodipine 
Bydralazine 
Mi.noxidil 
Diazoxide 
Nitroprusside 
Numbers refer to site of action of the drugs as represented in figure J.. 
Information, given within brackets, refers to pr~ pharmacological ac-
tions. ISA, intrinsic sympathomimetic activity. 
increase in sympathetic activity causes cardiac stimulation via 
s 1-adrenoceptors resulting in an enhanced cardiac output and con-
striction of the arterioles via a-adrenoceptors causing an incre-
ase in total peripheral resistance (figure 1). In addition, con-
striction of venous capacitance vessels, also mediated via 
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a-adrenoceptors, enhances venous return to the heart thereby in-
creasing the cardiac output as a resu~t of an increased filling 
pressure. Activation of vascular e2 -adrenoceptors causes vasodi-
latation particularly in the blood vessels to the voluntary mus-
cles (Bowman and Rand, 1980a; Miller et al., 1982). 
The autonomic nervous system and hormonal systems are inter-
related to each other (figure 1)- Sympathetic nervous activity is 
one of the most important factors in the regulation of renin re-
lease, while, on the other hand, an augmented release of noradre-
naline from synaptic nerve terminals contributes to the vasocon-
strictor action of angiotensin II- Sodium balance is another im-
portant factor modifying both sympathetic and renin-angiotensin 
responses. 
lease and 
Other substances interfering with catecholamine re-
action 
kallikrein-bradykinin 
are prostaglandines, 
system, histamine and 
products of the 
5-hydroxytryptamine. 
In addition, noradrenaline regulates its own release from nerve 
terminals by a negative feedback system mediated via presynaptic 
a 2 -receptors (Kuchel, 1983; Shephard, 1982)- Finally, the recent 
discovery of the atrial natriuretic factor, a vasoactive peptide 
that counteracts the effects of noradrenaline and angiotensin II 
and causes natriuresis, illustrates that our knowledge of the var-
ious factors involved in blood pressure regulation is probably 
still far from complete (Kleinert et aL, 1984) _ 
ANTIHYPERTENSIVE TREATMENT 
Arterial pressure is controlled at a fixed average by several 
reflex mechanisms that assure a relatively constant pressure. In 
hypertensive individuals the set point for the arterial pressure 
is abnormally high. Hypertension is a prime risk factor predis-
posing to cardiovascular disorders which may lead to cerebral ac-
cidents, myocardial infarction, congestive heart failure and reno-
vascular sclerosis terminating in renal failure. Control of hy-
pertension has been shown to have a great potential for reducing 
morbidity and mortality (Staessen et al., 1983). 
The treatment of hypextension is mainly based upon the ad-
ministration of drugs although non-specific forms of treatment, 
such as loss of weight, restriction of salt intake, psychotherapy 
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and elimination of additional risk factors and, in special cases, 
surgery, may lead to normalization of the blood pressure. The 
multifactorial nature of blood pressure control has permitted the 
development of drugs 
control (figure 1). 
affecting various aspects of the circulatory 
Antihypertensive drugs are generally classi-
fied, in accordance with their main site of action, into four gro-
ups (table 1): i) drugs that interfere with the autonomic nervous 
system, ii) inhibitors of the renin-angiotensin system, iii) diur-
etic agents and, iv) ~direct" vasodilators (Gerber and Nies, 1983; 
Van Zwieten, 1984a). 
Interference with the autonomic nervous 
various levels. Veratrum alkaloids lower 
system is 
the blood 
possible at 
pressure by 
increasing the excitability of chemoreceptors in heart, lungs and 
great vessels. Stimulation of these receptors leads to bradycar-
dia and dilatation of resistance vessels due to an increase in 
vagal tone and a reduction in sympathetic tone. Because of seri-
ous side-effects, these drugs are no longer used in hypertensive 
therapy (Bowman and Rand, 1980). Clonidine and a-methyldopa are 
examples of centrally acting antihypertensive drugs which owe 
their activity to the stimulation of a 2 -adrenoceptors in the pon-
tomedullary region of the brain. These compounds lower the arter-
ial blood pressure by reducing, both, the cardiac output and total 
peripheral resistance due to a decrease in peripheral sympathetic 
tone (Gerber and Nies, 1983; Timmermans, 1984). Ganglion block-
ing agents inhibit the transmission across the autonomic ganglia 
thereby reducing sympathetic as well as parasympathetic tone. 
Side-effects, caused by the combined blockade of both branches of 
the autonomic nervous system, are widespread and severe, for which 
reason these drugs are no longer used for chronic therapy (Gerber 
and Nies, 1983). Postganglionic adrenergic depressants, such as 
reserpine and guanethidine, inhibit sympathetic nerve activity by 
interference with the uptake, storage and/or release of noradrena-
line at the adrenergic nerve endings. The blood pressure is 
lowered due to an inhibition of the sympathetic tone in the heart 
and blood vessels (Gerber and Nies, 1983; Boura and Green, 1984). 
£-Adrenoceptor antagonists have become some of the most com-
monly used drugs in the treatment of hypertension. Due to block-
ade of cardiac s 1-adrenoceptors, these compounds reduce the heart 
rate and cardiac output. In addition £-blockers inhibit the renin 
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release. Due to partial agonism, a vasodilator response mediated 
via s 2-adrenoceptors may be produced by drugs with intrinsic sym-
pathomimetic activity (ISA) such as pindolol. The exact mechanism 
by which £-adrenoceptor antagonists exert their antihypertensive 
action is unknown. After acute administration the fall in cardiac 
output is counteracted by a reflex-mediated increase in total per-
ipheral resistance. Only after a few hours or days the blood 
pressure begins to decrease in parallel with a return of total 
peripheral resistance to pretreatment levels. Nowadays, many dif-
ferent 8-adrenoceptor antagonists are available which vary with 
respect to their kinetic characteristics, their selectivity for 
8 1-receptors, the presence or absence of 
activity, membrane selectivity and lipid 
Nies, 1983; Fitzgerald, 1984). 
intrinsic sympathomimetic 
solubility (Gerber and 
a-Adrenoceptor antagonists decrease total peripheral resis-
tance by antagonizing a-adrenoceptor-mediated contraction of vas-
cular smooth muscles. The application of aselective a-blockers, 
like phentolamine, is limited because of lack of sustained effica-
cy and unwanted side-effects such as palpitations. Selective 
blockade of a 1-adrenoceptors for instance with prazosin , which 
leaves the negative feedback on noradrenaline release mediated via 
presynaptic a 2 -receptors intact thereby causing a less pronounced 
reflex activation of the heart, has proven to be more successful 
(Cavero and Roach, 1980; Gerber and Nies, 1983; Timmermans and 
Van Zwieten, 1984). 
Drugs that interfere with the renin-angiotensin system reduce 
the blood pressure by inhibiting the formation (converting-enzyme 
inhibitors) or by antagonizing the action (angiotensin II antagon-
ists) of the pressor hormone angiotensin II. Apart from a direct 
action on vascular smooth muscle, angiotensin II also has an exci-
tatory influence on sympathetic nervous activity. Captopril, 
which inhibits the converting enzyme responsible fox the foimation 
of angiotensin II is already successfully used in the treatment of 
hypertension (Ondetti and Cushman, 1980; Sweet and Blain, 1984). 
Diuretic agents, besides £-adrenoceptor antagonists, are also 
regarded as dxugs of first choice although they have a modest 
blood pressure lowering effect that may not be sufficient in sev-
ere hypertension. The exact mechanism by which these agents lower 
the blood pressure is not cextain. The compounds act primaxily on 
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the kidney tubulus to increase salt and water excretion. The ini-
tial haemodynamic response is volume retraction and a decrease in 
cardiac output. However, over a period of days or weeks, cardiac 
output and plasma volume return close to pretreatment levels and 
the hypotensive effect is maintained by a decrease in peripheral 
vasculaz resistance. A wide variety of mechanisms has been sug-
gested to be involved in the long-term hypotensive action of diur-
etics including the inhibitory effects of sodium depletion on 
pressor responses induced by the sympathetic nervous system and 
angiotensin II (Gerber and Nies, 1983; Struyker-Boudier, 1983; 
Greven and Heidenreich, 1984). 
The last group consists of compounds with a "direct" action 
on vascular smooth muscle. To this group belong the calcium anta-
gonists which share the common ability to relax vascular smooth 
muscle, impair pacemaker activity in the heart and reduce cardiac 
contractility by decreasing the availability of calcium in the 
cells (Fleckenstein, 1977). Because their hypotensive efficacy is 
based upon the reduction in total peripheral resistance, compounds 
have been developed which show selectivity towards vascular smooth 
muscle. (Van Zwieten, l984b). other vascular smooth muscle re-
laxants used in antihypertensive therapy are hydralazine, minoxi-
dil, diazoxide and nitroprusside (Gerber and Nies, 1983; Van Zwi-
cten, 1984c). The exact mechanism by which these agents cause re-
laxation of the vascular smooth muscles is unknown. vasodilator 
drugs can be differentiated with respect to their arteriolar and 
venous sites of attack. For antihypertensive drugs the therapeu-
tic effect is predominantly based upon a reduction in total peri-
pheral resistance due to a relaxation of precapillary arterioles. 
Hydralazine and minoxidil selectively dilate arterial resistance 
vessels. Diazoxide, calcium antagonists, and also the "indirect• 
vasodilators, captopril and prazosin, affect predominantly the ar-
terial side of the circulation whereas nitroprusside dilates both 
arteriolar and venous vessels (Van Zwieten, 1980). 
The classification of antihypertensive drugs (table 1) is 
rather arbitrary and may change in the future. This is for in-
stance illustrated by the fact that prazosin, in the first edition 
of "Hypertension" (Goldberg et al., 1977) listed as a direct vaso-
dilator, is now recognized as a postsynaptic a 1-adrenoceptor anta-
gonist and is classified as such in the second edition of "Hyper-
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tension• (Gerber and Nies, 1983). However, in addition to postsy-
naptic a 1 -adrenoceptor blockade, a central action causing a reduc-
tion in sympathetic outflow has also been suggested to contribute 
to the hypotensive action of prazosin (McCall and Humphrey, 1981). 
Similarly, the action of the "direct" vasodi~ator hydralazine ap-
pears, at least in part, to be dependent upon an intact endotheli-
um suggesting that an "indirect" action (the release of an, as yet 
unknown, natural vasodilator substance from the endothelium) con-
tributes to the blood pressure lowering effects of the drug (Spo-
kas et al., 1984). In addition, new compounds have been developed 
with multiple sites of action such as labetolol which antagonizes 
both, a- and P-adrenoceptors (Fitzgerald, 1984) and ketanserin 
with 5HT2-receptor and a 1 -adrenoceptor blocking properties (Van 
Nueten et al., 1981). 
DRUG-INDUCED INHIBITION AND ACTIVATION OF 
CARDIOVASCULAR REFLEX MECHANISMS 
An important implication of the multifactorial nature of 
blood pressure regulation is that, in response to the fall in 
blood presure produced by antihypertensive drugs, cardiovascular 
reflex mechanisms become activated which oppose the initial hypo-
tensive action (Reid, 1981; Struyker-Boudier, 1984). For in-
stance, the use of direct vasodilators as a sole agent in hyper-
tensive therapy is rather limited because of the reflex-mediated 
increase in heart rate and cardiac output due to the 
hypotension-induced activation of the baroreceptor reflex. The 
consequent enhancement in myocardial oxygen requirements are par-
ticularly undesirable in patients with inadequate coronary perfu-
sion. In addition, both, the fall in renal perfusion pressure and 
the reflex-mediated increased sympathetic tone activate the 
renin-angiotensin system leading to angiotensin II formation and 
salt and water retention. These disadvantages can be largely 
overcome by using vasodilator drugs in combination with 
£-adrenoceptor antagonists, to attenuate the sympathetic nervous 
tone, and, when fluid retention is significant, diuretics. On the 
other hand, due to pharmacological interference with cardiovascu-
lar reflex mechanisms, blood pressure control may become greatly 
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impaired leading to undesirable side-effects. Thus, symptoms such 
as postural and exercise hypotension are common side-effects of 
drugs that cause an aselectve inhibition of the sympathetic vaso-
motor tone (Gerber and Nies, 1983). 
AIM OF THE THESIS 
At present many antihypertensive drugs are available with 
various mechanisms of action. Consequently, the changes in haemo-
dynamic variables that accompany the fall in blood pressure differ 
accordingly. Although the systemic haemodynamic effects of an-
tihypertensive drugs are rather well studied, less is known about 
the regional haemodynamic changes during antihypertensive treat-
ment. The studies described in the present thesis were designed 
to investigate and compare the haemodynamic profiles of a series 
of "direct" and "indirect" vasodilators with special emphasis on 
the drug-induced changes in regional blood flows. Direct vasodi-
lator drugs have gained renewed interest now that the most common 
problems experienced with these drugs, reflex-mediated cardiac 
stimulation and salt and water retention, can be counteracted by 
the concomitant administration of $-adrenoceptor antagonists and 
diuretic agents (Gerber and Nies, 1983). The development of new 
compounds in this group, such as calcium antagonists, have contri-
buted to the revival of interest in vasodilator drugs. In addi-
tion, vasodilators with an indirect action, such as 
converting-enzyme inhibitors (Ondetti and Cushman, 1980) and se-
lective a 1-adrenoceptor antagonists (Cavero and Roach, 1980), ap-
pear to cause a less pronounced activation of cardiovascular re-
flex mechanisms. Finally, because the dominant haemodynamic dis-
turbance in hypertension is an increase in total peripheral resis-
tance, vasodilator drugs are a rational approach to treatment 
(Reid, 1980; Van Zwieten, 1984c). 
According to Lund-Johansen (1982), "The vast majority of phy-
sicians treating hypertensive patients rarely think about the hae-
modynamic mechanisms underlying the increased blood pressure nor 
do they care much about how the blood pressure is reduced as long 
as it is brought near to "normal" during rest and side-effects are 
acceptable". A better understanding of the haemodynamic profiles 
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of antihype~tensive d~ugs may contribute to a more ~ational choice 
of a ce~tain d~ug tailored to the possible needs of a patient. 
METHODOLOGY 
studies have been pe~formed on conscious hype~tensive rab-
bits. By using hypertensive animals, the obtained data have a 
higher clinical relevance. Moreover, the hypotensive potency of 
drugs can be determined more easily when the blood pressure is in-
creased (Zandberg, 1984). 
Systemic and regional haemodynamic va~iables were measured 
with the radioactive microsphere technique (Heymann et al., 1977). 
Although only a restricted number of measurements can be made in 
one animal, the method has the advantage that cardiac output and 
its complete distribution can be determined in one animal. 
MOreover, by using chronic catheters for the microsphere adminis-
trations, studies can be performed on conscious animals. Apart 
from a di~ect effect on haemodynamic variables, anaesthetic agents 
also inhibit autonomic nervous activity and thus interfere with 
cardiovascular reflex mechanisms (Bowman and Rand, 1980b). The 
use of conscious animals guarantees a normal function of the re-
flex mechanisms which play an important role in the haemodynamic 
profiles of antihypertensive drugs. The application of the radi-
oactive microsphere technique in conscious rabbits is the subject 
of the second chapter of this thesis. 
Due to their docile nature and size, rabbits are very suit-
able for studies of the circulation in conscious animals using the 
radioactive microsphere technique. Hypertension can be produced 
in these animals rather easily and with relatively low costs by 
wrapping both kidneys with cellophane to induce cellophane perine-
phritis hypertension (Page, 1939). A characterization of the 
changes in systemic and regional haemodynamic variables involved 
in this experimental form of hypertension is included in the stu-
dies (chapter 3). 
The drugs used to study the haemodynamic profiles are the 
converting-enzyme inhibitor captopril (chapter 4), the arterial 
vasodilator hydralazine, alone and in combination with the 
£-adrenoceptor antagonists atenolol (chapter 5), the calcium anta-
12 
gonist felodipine (chapter 6), the a 1-adrenoceptor antagonist pra-
zosin (chapter 7) and the 5HT2 receptor antagonist ketanserin 
(chapter 8). A comparison of the haemodynamic profiles of the 
various drugs used is given in chapter 9. 
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CHAPTER 2: 
APPLICATION OF THE RADIOACTIVE MICROSPHERE TECHNIQUE FOR STUDIES 
OF THE CIRCULATION IN CONSCIOUS RABBITS 
In order to test the suitability of the radioactive microsphere technique 
for successive measurements of systemic and regional haemodynamj..c variables in 
conscious animalS, the technique was applied to determine baseline values of 
cardiac output and regional blood flows and the changes in these variables ob-
served J.5 minutes after three successive injections of physiological saline ( 0.1 
ml/kg each, i.. v. ) administered at 20 minutes intervalS in conscious New Zealand 
White rabbits (n=S). The four batches of microspheres, with a diameter of 1.5 .um 
and labeled with different isotopes, were injected directly into the left atrium 
via a catheter 1mplanted about 10 days before the experiment. cardiac output 
was determined using an arterial reference blood sample withdrawn during m.i.cros-
phere infusions from a catheter inserted into the left carotid artery at least ~ 
days prior to the experiment. 
The arterial blood pressure, heart rate, cardiac output and total peripher-
al resistance were not significantly altered by the 3 saline injections. Also 
no consistent changes were observed in blood flows to any of the regional vascu-
lar beds studied. 
A close correlation (rs-=0.9'3, p < 0.001) was found between blood flows to 
the left and right kidney which suggests that the microspheres were adequately 
nri..xed with the arterial blood. In addition, the blood flows to the left and 
right cerebral hemisphere were also significantly correlated (rs=0.68, p < 
0.001) and not significantly different from each other indicating that, despite 
ligation of the left carotid artery, collateral circulation was sufficient to 
permit even distribution of cerebral blood flow. 
In conclusion, the radioactive microsphere technique is a suitable method 
for the study of systemic and regional haemodynamics in conscious rabbits. At 
least four different measurements can be made in a period of one hour. 
The principle of the radioactive microsphere tec~~ique is 
that when microspheres, labeled with a radioactive isotope, are 
injected into the left side of the heart, they mix with the arter-
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ial blood and are distributed to the tissues in the same propor-
tion as the blood. However, in contrast to the blood cells, the 
spheres, being rigid and having a larger diameter (15 ~), become 
trapped in the capillary beds. The numbers of microspheres im-
pacted in the various tissues are assessed by counting the radi-
oactivity present. The fraction of the cardiac output distributed 
to a tissue can be derived by dividing the tissue radioactivity by 
the sum of radioactivity in all body tissues. If one imposes an 
artificial organ of which the flow is already known (e.g. a pump 
withdrawing blood), the radioactivity of this "organ" can be util-
ized to calculate cardiac output and the absolute tissue blood 
flows. Several measurements can be made by injecting various 
batches of microspheres labeled with different isotopes. 
The radioactive microsphere technique can be applied to study 
cardiac output and its distribution in animals (Hales, 1974; 
Heymann et al., 1977). Using a chronic catheter, implanted in the 
left atrium several days before the experiment, it is possible to 
perform measurements in conscious animals (Warren and Ledingham, 
1972). Thus the technique appears to be useful for investigating 
the haemodynamic profiles of vasoactive drugs, the aim of the pre-
sent thesis. 
The various applications and the limitations of the radioac-
tive microsphere technique has been the subject of many articles 
(Neutze et al., 1968; Hales, 1974; Warren and Ledingham, 1974; 
Heymann et al., 1977; Hof and Hof, 1981). However, information 
on the possible changes in haemodynamic variables when several 
batches of microspheres are administered in conscious animals is 
still limited. Therefore, it was decided to perform a control 
study with radioactive microspheres to ascertain the magnitude of 
the effects of three successive injections of physiological saline 
on systemic and regional haemodynamic variables in consc.ious male 
New Zealand White rabbits. Some of the results obtained in this 
study have been published elsewhere (Bolt and Saxena, 1984). 
METHODS 
Animals and surgical procedures 
Experiments were performed on eight male New Zealand White 
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rabbits (body weight, 3.0 ± 0.1 kg). Nine to fourteen days before 
the experiment a left-sided thoracotomy was performed under ana-
esthesia, initiated with Hypnorm, 0.5 ml, i.m. (equivalent to 15 
mg fluonison and 0.3 mg fentanyl) and maintained with a mixture of 
N20-halothane, in order to cannulate the left atrial appendage 
with a nylon catheter (0.75 mm i.d.), constructed as described by 
Warren and Ledingham (1972), for the administration of micros-
pheres. Subsequently, four to eight days before the experiment 
the left carotid artery was cannulated under light Hypnorm ana-
esthesia for the measurement of blood pressure and heart rate and 
for withdrawing arterial blood samples. The catheter was passed 
along the carotid artery until the tip of the catheter was situat-
ed in the aortic arch. Atrial and carotid catheters were tunneled 
subcutaneously and exteriorized at the dorsal side of the neck. 
The catheters were flushed with a heparin solution (Thromboli-
quine, 5000 I.U./ml) every two or three days to prevent blood 
clotting. The operations were performed under sterile conditions 
and the animals were injected with a long-acting penicillin pre-
paration post-operatively. 
Measurements of haemodynamic variables 
On the day of the experiment the animals were placed in a 
rabbit restrainer box. A Statham P23Dc pressure transducer was 
connected to the carotid catheter to record the arterial blood 
pressure and heart rate on a Grass model 7 polygraph. Mean arter-
ial blood pressure was obtained by electronically damping the 
pressure signals. 
Cardiac output and regional blood flows were measured with 
the radioactive microsphere technique using the reference blood 
sample method (Hales, 1974; Heymann et al., 1977). About 100,000 
microspheres (Nen-Trac) with a nominal diameter of 15 ~ and la-
beled with either 141ce, 113sn, 103Ru, 95Nb or 46sc were suspended 
in 0.5 ml saline containing a Lrace of Tween 80. At each measure-
ment the suspension was shaken vigourously using a Vortex mixer 
and injected (flushed with 1.5 ml saline) into the left atrial 
catheter over a 20 seconds period. A reference arterial blood 
sample was withdrawn from the carotid catheter at a rate of 1.85 
ml/min, beginning about 5 seconds before and continuing for about 
60 seconds after the injection of microspheres. The amount of 
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withd~awn blood was replaced with one-thi~d volume of human serum 
albumen (Albumen merieux 20%)-
At the end of the experiment, the animals we~e killed with an 
ove~dose of sodium pentobarbital. All organs and tissues were re-
moved, weighed, cut into small pieces and placed into plastic 
vials. The radioactivity (cpm) in the vials was counted with a 
~-scintillation counte~ (Packard, model 5986), attached to a mul-
tichannel analyser (Conrac) to discriminate isotope energies. 
With the exception of the skin, skeletal muscles and bones, for 
which an aliquot of at least 30% was taken, all organs were count-
ed in their entirety. 
Experimental protocol 
The marginal ear vein was cannulated under local anaesthesia 
(Lidocaine, 2 %) for the administration of physiological saline. 
After a stabilization period of at least 30 minutes, 4 different 
batches of microspheres, with a nominal diameter of 15 ~, were 
injected at 20 minutes intervals. Fifteen minutes before the 2nd, 
3rd and 4th microsphere administration an injection of saline (0.1 
ml/kg, i.v.) was given. Just before each microsphere injection an 
arterial blood sample (0.3 ml) was obtained to measure pH, P0 and 
Pco using an ABL-2 (Radiometer, Copenhagen). 2 
2 
Calculations and statistical evaluation 
Data were analysed on a PDP-11/70 computer, using a set of 
computer programs especially designed for the radioactive micros-
phere technique (Saxena et al., 1980). The fraction of cardiac 
output, received by the tissues, was calculated as the ratio of 
tissue radioactivity (Itis) and total body radioactivity (Itot); 
the latter was determined by adding together the radioactivity in 
all body parts and in the withdrawn blood sample (Iart). Cardiac 
output (CO) was calculated as: 
CO (m1/m.i.n) 
where Qart is the rate of withdrawal of the arterial blood sample 
(1.85 ml/min). Blood flows to individual organs and tissues 
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(Qtis) were calculated in a similar manner: 
All data have been expressed as mean (±SEM) in the text. Due 
to skewed distribution and lack of homogeneity of variances in 
some variables, non-parametric tests (Siegel, 1956) were used for 
the statistical evaluation. Initially, the Friedman"s two way an-
alysis of variance was applied to establish whether the samples 
represented different populations. The Wilcoxon matched-pairs 
signed ranks test was used to test the significance of the changes 
in haemodynamic variables from baseline values and for the compar-
ison of blood flow values in different organs. Differences were 
considered significant for p < 0.05 (2-tailed). Correlations were 
determined using the Spearman Rank test. 
RESULTS 
Blood gases 
The pH-, PCO - and P0 -values at baseline and after the three 
saline injections2were: p~, 7.39 ± 0.01, 7.41 ± 0.02, 7.43 ± 0.01 
and 7.41 ± 0.02; Pea , 39 ± 3, 39 ± 2, 39 ± 3 and 38 ± 3 rnmHg; 
and P0 , 85 ± 2, 91 ± 3, 87 ± 3 and 87 ± 3 mmHg, respectively. 
The valfies after saline administration Were not significantly dif-
ferent from those at baseline period. 
Systemic haemodynarnic variables 
Table 1 shows the changes in systolic, diastolic and mean ar-
terial blood pressure, heart rate, cardiac output, stroke volume 
and total peripheral resistance before and after the three subse-
quent saline injections in the conscious rabbits. Blood pressure 
and heart rate, recorded directly from the pulse signals in the 
aortic arch, were not significantly altered by the successive ad-
ministrations of saline. Also no consistent changes were observed 
in the cardiac output, measured with the radioactive microsphere 
technique, nor in the derived variables, stroke volume and total 
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Table 1. Effects of 3 successive injections of saline (0.1 ml.jkg) on 
systemic haemodynam.ic variables in normotensive :rabbits (n=-8). 
Baseline saline 
0.1 ml/kg 0.1 ml/kg 0.1 ml/kg 
ARl'ERIAL BI.OOD PRESSURE (mmHg) 
Systolic 91 ± 4 93 ± 4 94 ± 4 9>+ 5 
Diastolic 73 ± 4 71 ± 4 73 ± 4 71 ± 4 
Mean 81 ± 4 91 ± 4 83 ± 5 81 ± 4 
!iEAl<r RATE (beats/min) 210 ± 7 220 ±11 216 ± 10 217 ± 13 
CARDIAC OOTPOT ( ml/min) 513 ± 35 483 ± 35 480 ± 3S 490 ± 3S 
STROKE VOLUME (ml) 2.4 ± 0.2 2.2 ± 0.1 2.3 ± 0.2 2.3 ± 0.2 
TOTAL PERI:PHER.P.L 
-1 RESisrANCE ( mmBg/1. mi.n ) 163 ± 13 172 ± 10 179 ± 14 170 + 12 
pe~iphe~al ~esistance. 
Regional haemodynamic variables 
Figure 1 shows the changes in ~egional blood flows after the 
subsequent saline injections in the conscious animals. No consis-
tent changes could be noticed in any of the vascula~ beds. 
Because 15 ftiD mic~osphe~es reach the lungs via, both, peripheral 
arteriovenous anastomoses and bronchial a~teries, the values de-
noted tor the lungs ~ep~esent the combination of arte~iovenous an-
astomotic and b~onchial flows. 
A close correlation was found between the blood flows to the 
left and right kidney (rs = 0.99; p < 0.001, figure 2A). The 
mean blood flow values before and after the subsequent saline in-
jections were for the left kidney, 41 X 6, 39 ± 6, 40 ± 5 and 39 ± 
5 ml/min, respectively, and for the right kidney, 41 x 6, 39 ± 6, 
40 i 5 and 39 ± 5 ml/min, respectively. The deviation between 
blood flows to the left and right cerebral haemisphere was larger, 
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Fi-gure 1. Effec-ts of 3 su.ccesst:ve tnjec-tions of physi,otogtca'L saL'Lne {0.1 
mtjkg, t.v.) on regionaL ~tood f'Lo~s (m'L/min) in conscious rabbtt:.s (n=B). 
Do-t-ted bars, basettne vaLues; open bars, 15 min af-ter successi-ve saLine 
t.n,jec-tions. 
but still a higly significant correlation was found (r5 = 0.68; 
p < 0.001, figure 2B). The blood flow values, before and after 
the three administrations of saline, for the left cerebral hemis-
phere (2.7 ± 0.3, 2.2 ± 0.3, 2.2 ± 0.3 and 2.1 ± 0.3 ml/min, res-
pectively) were not significantly different from those for the 
right cerebral haemisphere (2.3 ± 0.3, 2.1 ± 0.3, 2.1 ± 0.3 and 
2.1 ± 0.2 ml/min, respectively). The saline injections did not 
significantly affect the blood flows. 
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DISCUSSION 
The radioactive microsphere technique was used to study the ef-
fects of three successive administrations of 0.1 ml of saline on 
systemic 
zealand 
and regional haemodynamic variables in conscious male New 
White rabbits. The baseline values of the various vari-
ables obtained in the present study agreed reasonably well with 
those previously reported for conscious rabbits (Neutze et al., 
1968; Warren and Ledingham, 1974; Van Boom and Saxena, 1980; 
Hof and Hof, 1981, table 2). In addition, because no consistent 
changes in systemic variables as well as regional blood flows were 
produced by the successive saline injections, the method can be 
succesfully employed to monitor drug-induced changes in these var-
iables on at least four different points in time. This is also 
compatible with the reported total amount of microspheres with a 
diameter of 15 ~ that can be administered before haemodynamic di-
sorders are observed (> 6xl05 , Warren and Ledingham, 1974; Hales, 
1974, Heymann et al., 1977). 
An important implication of the radioactive microsphere tech-
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Table 2. cardiac output and percentage of cardiac output distributed to 
various organs and tissues measured with the radioactive microsphere 
technique in conscious noDmetensive rabbits. 
Reference: Bo.lta van Boom.b Bofc warrend Neutzee 
Diameter of 
mi.crospheres 15 15 15 l5 25 so 50 
cardiac output 
(ml(lnin.kg) 172 183 215 
ffeart 3.0 3.3 2.4 3.3 3.7 3.8 3.1 
Brain 1.5 1.2 1.7 1.1 l.O 1.2 
Kidneys 15.4 ~3.2 ~6.6 13.6 13.9 14.9 16.2 
GIT 23.3 ~4.5 25.3 17.3 ~9.3 20.1 24.2 
MUScles 20.5 20.1 17.2 
Bones 6.4 9.2 
• Skin 4.7 7.3 5.7 5.5 7.4 7.4 
• Lungs 3.7 7.6 12.6 13.4 3.2 2.6 
a, present study; b, Van Boom and Saxena, 1.980, cardiac output measured 
with electromagnetic flow probes; c, Bof and Hof, 1981; d, warren and 
Ledingham, 1974; e, Neutze et al., 1968, cardiac output determined with dye 
dilution. ~, value significantly different from respective values obtained 
with 25 ,um spheres; -, not measured; GIT, gastro-intestinal tract. 
niques is that after left atrial injection some of the 15 ~ 
spheres bypass the peripheral vascular beds via arteriovenous an-
astomoses (AVAs) with a diameter larger than that of the spheres. 
Because AVAs are not present in the lungs (Hof and Hof, 1981), the 
shunted spheres are recovered in these organs. After the simul-
taneous injection 
left atr iurn of 
of microspheres of two different sizes into the 
conscious rabbits, Warren and Ledingham (1974) 
found that the proportion of microspheres lodged in the lungs de-
creased from 12.9 ± 1.8 % for 25 ~ spheres to 3.2 ± 3.2 % for 50 
urn spheres (table 2). Although the measured values for 25 #ID 
spheres were rather high when compared with the values obtained in 
the present study, these investigators clearly demonstrated that 
arteriovenous shunting can play an important role in the deposi-
tion of microspheres in the lungs. In contrast to the lungs, the 
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amount of microspheres trapped in the skin increased when larger 
spheres were used (table 2), indicating the presence of AVAs in 
the cutaneous circulation (Saxena and Verdouw, 1985). Even when 
50 ~ spheres were used, recovery of microspheres in the lungs 
could not be fully ascribed to bronchial artery flow since signi-
ficant shunting of these spheres was still demonstrated in the ear 
and hindleg of rabbits. This is in agreement with histological 
observations showing that AVAs have a diameter up to 150 ~ (Hey-
mann et al., 1977). The exact contribution of bronchial artery 
flow remains to be established, but it has been estimated to be 
less than 2% of cardiac output (Baille et al., 1982; Saxena and 
Verdouw, 1982). 
A comparison of blood flows to paired organs is generally 
considered as a check on streaming effects of microspheres 
(Neutze, 1968). The correlations between the blood flows to the 
left and right kidney and to the left and right cerebral hemis-
phere were highly significant which indicated an adequate disper-
sion of microspheres throughout the blood stream. Ligation of the 
left carotid artery for insertion of a catheter for blood pressure 
measurements and the withdrawal of blood samples, could possibly 
affect the cerebral circulation. A comparison of the blood flows 
to the left and right cerebral hemispheres showed no consistent 
difference between the blood flows to these areas, that on the 
left side sometimes being higher and sometimes being lower than 
that of the opposite site. Thus, collateral circulation appears 
to be ~ufficient to permit an even distribution of the cerebral 
blood flow (Neutze et al., 1968). 
In conclusion, the radioactive microsphere technique appears 
to be suitable to measure cardiac output and regional blood flows 
in conscious rabbits. By using various batches of microspheres, 
labeled with different isotopes, at least four successive measure· 
ments can be made reliably in a period of one hour. 
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CHAPTER 3: 
SYSTEMIC l\ND REGIONAL HAEMODYNAMIC CHARACTERISTICS OF BILATERAL 
CELLOPHANE PERINEPHRITIS HYPERTENSION IN CONSCIOUS RABBITS 
Using the radioactive microsphere technique, systemic and regional 
haemodyna;m:ic variables were measured in normotensive rabbits and in rabbits with 
bilateral cellophane perinephritis hypertension about 6 weeks after 
encapsulation of the kidneys. An average decrease in cardiac output of 18 
percent was measured in the hypertensive rabbits as a result of a reduction in 
stroke volume; heart rate remained unchanged. Thus, in the establ.ished phase 
hypertension was maintained by the elevated total peripheral resistance. A 
redistribution of cardiac output was observed in the hypertensive rabbits; a 
significantly higher fraction was received by the brain, small intestine and 
heart. The weight normal'ized blood flow to the kidneys, spleen, skeletal 
muscles, bones and fat was significantly decreased whereas an increase in 
vascular resistance was noticed in the hypertensive rabbits in all the organs 
investigated. A negative correlation e~ted between the weight of the left 
ventricle and the blood flow to the left ventricle in hypertensive rabbits, 
suggesting inadequate coronary perfusion as myocardial hypertrophy becomes more 
pronounced. 
Experimental forms of hypertension serve as a model for human 
hypertension and by investigating these models relevant 
information may be obtained concerning haemodynamic changes 
involved in human hypertension (Zandberg, 1984). Recent studies 
in our laboratory have shown that hypertension induced by 
unilateral cellophane wrapping of one kidney with contralateral 
nephrectomy in rabbits is characterized by a rather generalized 
increase in regional vascular resistances except for some 
splanchnic organs (Van Boom and Saxena, 1980). The enormous 
increase in total peripheral resistance in these animals is 
accompanied by a decrease in heart rate and stroke volume, 
resulting in a large reduction (> 35%) in cardiac output (Ichikawa 
et al., 1977; Van Boom and Saxena,l980). 
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The severe impairment of the performance of the heart in 
unilateral cellophane perinephritis and the reduction in renal 
mass due to nephrectomy are rather exceptional phenomena. 
Bilateral cellophane perinephritis hypertension, on the other 
hand, might be a more relevant model for human hypertension. 
Indeed, a less severe reduction in cardiac output has been 
observed in rabbits with bilateral cellophane perinephritis 
(Fletcher et al., 1976) and the more moderate increases in blood 
pressure and total peripheral resistance (Campbell et al., 1973; 
Fletcher et al., 1976) indicate that regional haemodynamics are 
affected in a different way, qualitatively and/or quantitatively. 
Therefore, we have investigated systemic and regional 
haemodynamics in rabbits with bilateral cellophane perinephritis 
to characterize the cardiovascular changes involved in this 
experimental form of hypertension. The results obtained in this 
study have been published elsewhere (Bolt and Saxena, 1983). 
METHODS 
Animals and surgical procedures 
Experiments were performed on 8 normotensive and 16 
hypertensive male New Zealand White rabbits. Hypertension was 
induced by bilateral cellophane wrapping of the kidneys, according 
to the method of Page (Page, 1939; ~age et al., 1955). Under 
Hypnorm anaesthesia (0.5 ml/kg, i.m.; equivalent to 15 mg 
fluonison and 0.3 mg fentanyl per kg) both kidneys were exposed 
through flank incisions and wrapped in cellophane. Experiments 
were performed 6 to 7 weeks later. Nine to fourteen days before 
the experiment, a left sided thoracotomy was performed in order to 
cannulate the left atrial appendage with a nylon catheter for the 
injection of microspheres (Warren and Ledingham, 1972). 
Subsequently, 4 to 8 days before the experiment the left carotid 
artery was cannulated under light Hypnorm anaesthesia for the 
measurement of arterial blood pressure and heart rate and for the 
withdrawal of arterial blood samples during the experiments. The 
various 
elsewhere 
surgical 
(Bolt and 
2 of this thesis). 
procedures have been described in detail 
Saxena, 1983; Bolt and Saxena, 1984; chapter 
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Measurement of haemodynamic variables 
On the day of the experiment the rabbits were p~aced in a 
rabbit restrainer box. A Statham P23Dc pressure transducer was 
connected to the carotid catheter to measure the systolic and 
diastolic arterial blood pressure. These variables were recorded 
continuously on a Grass model 7 polygraph. Mean arterial blood 
pressure was obtained by electronically damping the above signal, 
while heart rate was counted from the pulsatile blood pressure 
signa~- After a stabilization period of about 40 min an arterial 
blood sample (0.4 ml) was obtained for the analyses of blood gases 
using an ABL-2 (Radiometer). Cardiac output and regional 
haemodynamic variables were measured with the radioactive 
microsphere technique 
(Hales, 1974; Heymann 
a nominal diameter of 
103Ru or 95Nb were 
normotensive animals 
using the reference blood sample method 
et al., 1977)- Nen Trac microspheres with 
15 #ffi and labeled with either 141ce, 113sn, 
used. After measuring baseline values 
received three subsequent injections of 
microspheres at 20 min interfalls, 15 min after an i.v. injection 
of saline. No significant changes could be detected between the 
values of haemodynamic variables, obtained with the four different 
microsphere injections (see chapter 2). Subsequent injections of 
microspheres were also administered in hypertensive rabbits after 
treatment with antihypertensive drugs. Details of the microsphere 
technique and the formulae used for the calculation of cardiac 
output (ml.mLn- 1 .kg-1), its distribution to the various organs and 
output) and regional blood flows tissues (% of cardiac 
(rnl.min-1 .lOOg-l) are given in chapter 2 (Saxena et al., 1980). 
Peripheral vascular resistances were calculated by dividing mean 
arterial blood pressure (mmHg) by respective tissue blood flows 
-1 -1 (ml.rnin .lOOg )-
Statistica~ eva~uation 
For normotensive rabbits the mean values of the variables 
measured during the first and second microsphere injection were 
used for comparison with the values of the baseline variables in 
hypertensive rabbits. Due to skewed distribution and lack of 
homogeneity of variances 
Mann-Whitney U test was 
and hypertensive groups 
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in some variables 
used to compare the 
(Siegel, 1956). 
the non-parametric 
data in normotensive 
Differences were 
considered significant for p < 0.05 (2-tailed). Correlations were 
determined using the Spearman Rank test. 
expressed as mean (± S.E.M.) in the text. 
RESULTS 
Blood gases, body- and organ weights 
All data have been 
Blood gases, measured in normotensive and hypertensive 
rabbits, did not differ significantly (table 1). Also shown in 
table l are body- and organ- (kidneys, heart and left ventricle) 
weights measured in the two groups of animals. Total kidney mass 
was somewhat higher in hypertensive animals but the difference did 
not achieve significance. The weights of heart and left ventricle 
were increased significantly in the hypertensive group. There was 
no significant difference in the weight of other tissues in the 
two groups. 
Table 1. Blood gases, body- and organ weights measured 
normotensive and 16 hypertensive rabbits. 
(mml!g) 
(mml!g) 
Body- and organ weights: 
Body weight (kg) 
Kidneys (g) 
( % body weight) 
aeart (g) 
(%body weight) 
Left ventricle (g) 
(%body weight) 
Normotensive 
7.38 ± 0.02 
35.0 ± 1.54 
87.8 ± 1.95 
3.0 ± O.l 
19.7 ± 0.8 
0.66± 0.029 
6.2 ± 0.4 
0.21± 0.006 
2.6 ± 0.3 
0.09± 0.006 
Hypertensive 
7.36 ± 0.02 
40.6 ± 3.10 
90.0 ± 1.60 
3.0 ± 0., 
21.4 ± 0.7 
0.72± 0.018 
• 8.0 ± 0.3 
0.27± 0.006 
• 3.3 :t 0.2 
0.11± 0.005 
in 
• 
. 
8 
-----
~, significantly different (p < 0.05) 
@, n~14 in hypertensive rabbits. 
from the values in normotensive rabbits. 
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Systemic haemodynamics 
Table 2 shows the values of the systemic haemodynamic 
vaLiables measuLed in the noLmotensive and hypeLtensive Labbits. 
Systolic, diastolic and mean aLterial blood pressure were 
significantly increased in rabbits with bilateral cellophane 
perinephritis. The pulse pressure in the hypertensive rabbits, 
calculated as the difference between systolic and diastolic 
pressure, was significantly higher than in the normotensive 
rabbits, indicating an increased aortic compliance in the 
hypertensive group. Cardiac index was decreased in hypertensive 
rabbits due to a decrease in stroke volume as heart Late did not 
differ significantly in the two groups. The calculated total 
peripheral resistance was substantially higher in hypertensive 
-rabbits. 
Table 2. Systemic haemodynamic 
normotensive and 16 hypertensive rabbits. 
Arterial blood pressure 
systolic (mmBg) 
diastolic ( mmHg) 
mean (mmHg) 
Pulse pressure 
Heart rate 
stroke volume 
cardiac index 
Total peripheral 
resistance 
(mmHg) 
-l (beats.min ) 
(ml) 
-1 -1 (ml.min .kg } 
variables 
Normotensive 
97 ± 3 
76 ± 3 
86 ± 3 
21 ±l 
226 ± 9 
2.43 ± 0.19 
182 ± 10 
495 ± 39 
measured in 
Hypertensive 
. 
148 ± 4.,.. 
117 + 3 
- . 
131 ± 3 
• 31 ± 2 
242 ± 8 
1.86 ± 0.07 
. 
150 ± 5 
• 689 ± 42 
• 
~, significantly different (p < 0.05) from the values in normotensive rabbits. 
Regional haemodynamics 
8 
Table 3 shows the values of the regional haemodynamic 
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w 
~ 
Table 3. Distribution of cardiac output, regional blood flows and vascular resistances in 8 normo-
tensive and 16 hypartensive rabbits. 
cardiac output distribution Blood flow Resistance 
(%) -1 -1 ( ml. min . 100g ) -1 -1 ( mmHg/ml. min , 100g ) 
-- ~ ---~----------------------------------------------------- ------------------------- -- _,__ 
Nonnotenaive Hy~rtensive Nonnotensive Hypertensive Nonnotensive Hypertensive 
- ----------------------------------------------------------------------------------------------------
• * Heart 3,0± 0.20 3.9± 0,18* 272± 26 215± 11 0.35± 0.04 0,63± 0,03* 
Brain 1.5± 0,11 1.9± 0.12 82± 5 84± 5 * 1.10± 0.10 1.64± 0,10* 
Kidneys 15,4..!:: 1.38 13.5± 0.62 463± 63 284± 14 0.22± 0.02 0.48± 0.03* 
Stomach 4,2_± 0.59 4.9± 0.42 70± B 70± 7 1.42± 0.23 2.11± 0.20 
small 
* * intestine 7.6± 0.59 10.1± 0.60 104± a 103± 6 0.88± 0.09 1.32± o.oa 
Large 
* intestine 11.5± 1.11 12.0± 0.53 70± 7 60± 3 * 1.23± 0.10 2.32± 0.17* 
Spleen 1.6± 0,28 1.3± 0.15 684± 137 372± 44 0.17± 0.03 0,45± 0.07 
Mesentery 
• and pancreas 1.8± 0.13 2.0± 0.15 56± 6 44± 4 1.66± 0.17 3.40± 0.34 
Liver 1.5± 0.47 1.0± 0,1.3 8± .3 4± 1 24,80.± 7,3.3 42.17± 4.74* 
Skin 4.7± 0.76 4.3± 0.37 9.± 1 7± 1 10.95± 1.37 21.10± 1. 48 
skeletal 
• * muscle 20,5± 1..32 19.3± 1.13 10± 0,4 8± 1* 8.93± 0,41 18 ,62± 1..39* 
Bones 6,4± 0.55 5.9± 0.33* 16± 2 12± 1* 5.71± 0.45 11.62± 0,79* 
Fat 2,8± 0,50 1.2± 0.20 44± 5 32± 5 2.59± 0,60 5,21± 0,63 
------·------~------------------------------------------~-------------------------------------------~-·-
*, significantly different (p < 0,05) from the values in normotensive rabbits, 
@, hepatic artery flow. 
In the hypertensive 
of the ca:rdiac output is 
xabbits a significantly larger 
:received by the hea:rt, 
vai: iables. 
pe:rcentage 
and small intestine: a smalle:r fraction is 
b:rain 
fat. :received by the 
the blood the no:rmotensive group, flow Compa:c ed with 
-1 -1 (ml.min .lOOg ) to the kidneys, spleen, skeletal muscles, bones 
and fat was significantly decreased in the hypertensive group. 
Regional vascula:r :resistances -1 -1 (mmHg/mLmin .lOOg were 
significantly higher in the rabbits with bilateral cellophane 
perinephritis in all the organs investigated, with the exception 
of the liver where the increase in vascular resistance was not 
significant. However, this could be attributed to the large 
deviation in the measured values of the vascular resistance in the 
liver. 
In figure l a~e shown the tissue blood flow values in 
hypertensive rabbits expressed as percentage change fi:om the mean 
values in normotensive :rabbits. Despite the lower cardiac output 
% CHANGE IN BLOOD FLOW 
20-
Cl KIDNEYS FAT BONES SKIN MUSCLEHEART GIT 
-2or- I i I i 
-40 '-
BRAIN 
""""" 
~gure l. Mean vaLues of caratac tnaex (CI) and regtonaL bLooa fLo~s tn 
hyper~enstve rabbt~s (n~l5) uere compared ut~h correspondtng vaLues tn 
normo~enstve rabbt~s (n~B). In ~he ftgure are sho~n bLood fLo~s tn hyper~enstve 
rabbt~s expressed as percen~age change from mean vaLues in normozenstve rabbi~s. 
GIT, g~iro-in~7s~inaL ~r~. In hyper~ensive animaLs ~he regtonaL bLood fLo~ 
(mL.mtn .lOOg ) uas signtftcan~Ly decreased tn Zhe ktaneys, fa~, bones ana 
skeLe~aL muscLes (p < 0.05). 
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in hypertensive animals, the blood flow to the brain was 
maintained at a normal level. No change in blood flow could be 
detected in cerebral hemispheres, cerebellum or brainstem of the 
hypertensive rabbits when compared with the values obtained in 
normotensive rabbits. Similarly, the blood flow to the stomach 
and small intestine was normal in hypertensive rabbits. A 
decrease in the blood flow to the large intestine caused the small 
reduction in 
tract. The 
blood flow calculated for the gastro-intestinal 
decrease in blood flow was most pronounced in the 
kidneys where it exceeded the reduction in cardiac index. 
Although there was no significant reduction in blood flow to 
the heart a negative correlation existed between weight of the 
left ventricle and the weight normalized blood flow to left 
LV BLOOO FLO\/ LV BLOOD FLOW/HEART RATE 
-1 -1 (ml.min .100g ) -1 -1 -1 {ml.min .lOOg /beats.min ) 
400 2.0 
.. 
A B 
. .. 
300 1.5 .. 
• 
• • • 
... 
zoo Ill 1.0 
1 ool;---~,-----+--~ 3 4 5 0 -5~---+----t---: 2 3 4 5 
LVIIEIGHT (g) LV WEIGHT (g) 
~gure 2. A nega~tve corre~a~ion exis~ea ~e~~een ~he ~eigh~ (~f of _fhe ~ef~ 
ven~rtc~e (LV) ana ~he b~ood f~o~ ~o ~he ~ef~ ven~ric~e (m~.min .toog ) in ~he 
hypertensive rabbits (r ~o.51, p < 0.05, figure ZA). This corre~a~ion ~ecame 
even more obvious, ~h~n ~he ~ef~ ven~ricLe btooa fto~ ~as atvtaea by ~he hear~ 
ra~e ~o normaLize for ~he momen~ary changes in me~abotic ac~ivi~y of ~he hear~ 
(r5=0.86, p < 0.05, figure 28). 
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vent~icle in the hype~tensive ~abbits (figu~e 2A, ~s=0.5l, 
p < 0.05). This correlation became even more obvious when the 
blood flow to the left ventricle was divided by the heart rate to 
norma~ize for the metabolic activity of the heart (figure 2B, 
r3~0.86, p < 0.05). 
Figu~e 3 shows total pe~ipheral and ~egional vascular 
resistances in hype~tensive ~abbits expressed as percentage change 
from the mean values in normotensive rabbits. The elevation was 
most p~ominent in the kidneys, skeletal muscles, bones, fat and 
skin where the increase in ~esistance was highe~ in compa~ison 
with the inc~ease in total pe~ipheral ~esistance. The elevation 
in vascula~ ~esistance in the brain and gastro-intestinal tract 
was less than the increase in total peripheral resistance. 
% CHANGE IN VASCULAR RESISTANCE 
150-
1 0 0 
I 1' I ~~;~~ 
50 :'!'! :::::: 
- ····· w I I 
····· l~~ ·•·•· ····· :::::: ::::: 
····· 
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·•·•· 
····· ::::: 
::::: 
····· 
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····· ..... 
•·•·•· ::::: 
TPR BRA I N G I T HEART SK I N 
I ~ i ::::: :::: ~t ~~~~; ::::: 
I =~== n~ IIIII ::::: ;t ::::: ::::: ::::: ::::: ::::: 
·:::: ::::: ~;~;; ..... 
·:::: J~; :::;: ==~=: 
FAT BONES MUSCLE KIDNEYS 
~guro 3. Mean vatues of ~o~at peripherat resis~ance (TPR) and regiona~ 
vascu~ar resis~ances in hyper~ensive rabbits uere compared ui~h corresponding 
vatues in normo~enstve rabbi~s. Vascutar resistances are expressed as 
percen~age change from mean va~ues in normotensive animats. G!T, 
gastro-intes~inat tract. rn hypertensive animats vascuLar resis~ances uere 
significan~ty increased in aLL ~he organs investiga~ed (p < 0.05). 
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DISCUSSION 
The ~esults indicate that in the established phase of 
bilate~al cellophane perinephritis hypertension in rabbits the 
increase in blood pressure is due to an elevated total peripheral 
resistance. Cardiac output is decreased as a consequence of a 
reduction in stroke volume. The fall in cardiac output by nearly 
20% with unchanged heart rate has been reported previously in 
rabbits with bilateral cellophane perinephritis (Fletcher et al., 
1976). However, in rabbits with unilateral cellophane 
perinephritis and contralateral nephrectomy a more severe 
reduction in cardiac output (> 35%) has been measured as a result 
of a decrease in both, stroke volume and heart rate (Ichikawa et 
al., 1977; Van Boom and Saxena, 1980). Thus one might conclude 
that in compa~ison with the one-kidney perineph~itis, the cardiac 
function is impaired less in the two-kidney fo~m-
The total peripheral resistance in rabbits with one-kidney 
perinephritis 
1977; Van 
hypertension is more than doubled (Ichikawa et al., 
Boom and Saxena, 1980) whereas, in our present 
experiments, an increase of only 80% was observed. This is in 
agreement with the values reported by Fletcher et al. (1976) and 
it indicates qualitative and/or quantitative differences in 
regional haemodynamics between the two forms of experimental 
hypertension in the same species. A redistribution of the cardiac 
output is observed in the present study in rabbits with bilateral 
cellophane perinephritis hypertension. A larger fraction of the 
cardiac output is received by the brain, heart and small 
intestine, which results in normal blood flow values to the brain 
and gastro-intestinal tract. The finding, that hind limb blood 
flow in rabbits with bilateral cellophane perinephritis 
hypertension is decreased (West et al., 1975; Angus et al., 
1976), is in accordance with our observations of a decreased blood 
flow to skeletal muscles and bones in the hypertensive 
Regional blood flows are also significantly reduced 
rabbits. 
in the 
kidneys, spleen and fat. The same distribution pattern can be 
observed in rabbits with unilateral cellophane perinephritis 
hypertension, except for a significantly reduced blood flow to the 
brain in these animals and, of course, a decrease in percentage 
cardiac output received by the kidneys due to nephrectomy (Van 
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Boom and Saxena, 1980). The reduction in blood supply to the 
brain demonstrates again the more severe consequences of 
unilateral cellophane wrapping with contralateral nephrectomy on 
cardiovascular variables. Although different vascular beds can be 
affected in experimental and clinical forms of hypertension 
(Lund-Johansen, 1980), usually the brain succeeds in maintaining 
blood supply at a normal level, as has been demonstrated in renal 
and spontaneously hypertensive rats (Flohr et al, 1976; Ferrone 
et al., l979) and in salt loading hypertension in the dog (Liard, 
1981). However, Gavras et al. (1980) also noticed a decrease in 
blood flow to the brain after acute renal artery occlusion in the 
dog. 
The increase in percentage of cardiac output received by the 
heart in rabbits with bilateral cellophane perinephritis 
hypertension, as indeed in the unilateral cellophane perinephritis 
hypertension (Van Boom and Saxena, 1980), can be attributed to 
hypertrophy of the heart. In rats with chronic renal hypertension 
a two-fold increase in myocardial hydroxyproline content has been 
found, indicating increased collagen synthesis (Averill et al., 
~976). This increase in non-contractile fibrous tissue in the 
hypertrophied heart may be a potent factor in altering cardiac 
structure leading to a depression in cardiac performance by 
increasing ventricular compliance (Ferrario et al., 1976). 
Usually, it is found that the weight normalized myocardial blood 
flow in animals with left ventricular hypertrophy is within normal 
limits (Mueller et al., 1978; Marcus et al., 1979; Yamori et 
al., 1979; Breisch et al., 1980). This is in accordance with our 
observations in rabbits with bilateral cellophane perinephritis 
hypertension, where cardiac blood flow is not significantly 
reduced. However, there are several indications of an inadequate 
myocardial perfusion in human and experimental hypertension with 
cardiac hypertrophy, usually indicated by a decrease in coronary 
reserve (Marcus et al., 1979; Breisch et al., 1980). Mueller et 
al. (1978) observed a failure of the cross-sectional area of the 
coronary bed to increase commensurate with the degree of 
hypertrophy in dogs with renal hypertension. In young 
spontaneously hypertensive rats an inverse correlation between 
heart weight and the lumen to transectional area ratios of 
coronary arteries has been found (Yamori et al., ~979). These 
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~atter findings are compatib~e with our observation of a negative 
corre~ation between b~ood f~ow to the ~eft ventricle and the 
weight of the left ventric~e in the hypertensive rabbits. This 
corre~ation is even more convincing when the blood flow to ~eft 
ventricle is divided by the heart rate. An increase in myocardial 
b~ood flow, as a result of coronary autoregulation in response to 
e~evated metabolic requirements, can be observed in stress 
situations and during exercise. These temporary changes in 
myocardial blood flow can be predicted by the heart rate. Indeed, 
a close linear relationship between these variab~es has been 
observed during exercise in normal dogs and in dogs with left 
ventricular hypertrophy due to perinephritic hypertension (Bache 
and Vrobel, 1979). Therefore, by using the ratio of blood f~ow to 
the left ventricle and heart rate, a correction is made for 
momentary changes in myocardial blood flow during the experiments. 
A decrease in myocardial blood flow as ventricular weight 
increases may be an indication for inadequate coronary perfusion 
in the pressure overloaded hypertrophied heart. On the other 
hand, it is possible that the non-contractile tissue, becoming a 
more important component in the hypertrophied heart (Averill et 
al., 1976), requires less blood flow. 
In dogs with one-kidney perinephritic hypertension an 
increase in venous compliance has been described (Simonet al., 
1976). The pu~se pressure increased significantly in the rabbits 
with bilateral cellophane perineprhitis hypertension, which may be 
a reflection of a more generalized decrease in vascular compliance 
involving the arterial part of the circulation as well. The 
finding that in cellophane perinephritis hypertension in dogs the 
systolic blood pressure begins to rise earlier than the diastolic 
pressure also indicates lowering of arterial compliance 
(Castro-Tavaras et al., 1981). A decrease in vascu~ar 
distensibility has been postulated to result from an increase in 
the wall to lumen ratio of the blood vessels (Folkow, 1978). 
Besides these structural vascular changes, a decrease in 
vascularity may also contribute to the enhanced peripheral 
resistance (West et al., 1975; Angus et al., 1976). The changes 
in vascular resistance observed in the present study in rabbits 
with bilateral cellophane perinephritis hypertension are most 
prominent in the kidneys, where the increase exceeds the 
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enhancement in total peripheral resistance. A marked elevation of 
the ~enal vascula~ ~esistance, togethe~ with a fall in ~enal blood 
flow, appears to be a common characteristic of many experimental 
and clinical forms of hypertension (Flohr et al., 1976; Ferrone 
et al., 1979; Gavras and Liang, 1980; Lund-Johansen, 1980; Van 
Boom and Saxena, 1980; Liard, 1981; Zandberg, 1984). In the 
skeletal muscles, bones, fat, skin and heart, the increase in 
vascular resistance is more or less equal to the elevation in 
total peripheral resistance, whereas the changes in the brain and 
gastro-intestinal tract are less pronounced but still significant. 
In conclusion, the established phase of hypertension in 
rabbits with bilateral cellophane perinephritis is maintained by 
an increase in total peripheral resistance. Although cardiac 
output is reduced in the hypertensive rabbits, blood flow remains 
unchanged in the brain and gastro-intestinal tract. A significant 
reduction in blood flow is measured in the kidneys, spleen, 
skeletal muscles, bones and fat. In comparison with hypertension 
induced by unilateral cellophane perinephritis (Van Boom and 
Saxena, 1980), the haemodynamic consequences of bilateral 
cellophane perinephritis 
most saliently by a larger 
reduced blood flow to the 
less severe. This is demonstrated 
impairment of cardiac performance, a 
brain and, of course, a more 
reduction in renal blood flow due to nephrectomy in the 
form. 
REf"ERENCES 
pronounced 
one-kidney 
Angus, J.A., West, M.J., Korner, P.I. (1976) Assessment of autonomic and 
non-autonomic components of resting hindlimb vascular resistance and 
reactivity to pressor substances in renal hypertensive rabbits. CJ.in. Sci. 
Mol. Med. 51: 57s-59s. 
Averill, D.B., Ferrario, C.M., Tarazi, R.C., sen, s., Bajbus, R. 
performance in rats with renal hypertension. Circulation Res. 
Bache, R.J., Vrobel, T.R. (1979) Effects of exerci.se on blood 
hypertrophied heart. run. J. cardiol. 44: 1029-1033. 
( 1976) cardiac 
38: 28Q-268. 
flow in the 
Breisch, E.A., Elouser, S.R., carey, R.A., Spann, J.F., Bove, A.A. (1980) 
Myocardial blood flow and capillary density in chronic pressure overload of 
the felic left ventricle. cardiovascular Res. 14: 469-475. 
Bolt, G.R., Saxena, P.R. (1983) Systemic and regional hemodynamic 
characteristics of bilateral cellophane perinephritis hypertension in 
conscious rabbits. Clin. Exp. Hypertension AS: 865-901. 
Bolt, G.R., Saxena, P.R. (1984) Interaction of atenolol with the syste~c and 
regional hemodynamic effects of hydralazine in conscious renal hypertensive 
rabbits. J. Pharmacol. Exp. Ther. 230: 205-213. 
38 
campbell, O.J., Skinner, S.S:., Day, A.J. (~973) cellophane perinephritis 
hypertension and its reversal in rabbits; Effect on plasma renin, renin 
substrate, and renal mass. Circulation Res. 33: 105-112. 
castro-Tavaras, J., Garrett, J., Goncalves, v. (1981) Cellophane perinephritic 
hypertension in the dog; some biochemical, haemodynam1c and pathological 
cha.racteristics. Blood vessels 18: 67-74. 
Ferrario, C.M., Kocoglov, A., 
performance after onset 
51: 14ls-143s. 
Bajbus, 
of renal 
R., Nadzam, 
hypertension. 
G.R. ( 1976) 
Clin. SCi. 
ventricular 
Mol. Med. 
Ferrone, R.A., walsh, G.M., Tsuchi.ya, M., Frohlich, E.D. ( 1979) compari.son 
ha.emodynami.cs in conscious spontaneous and renal hypertensive rats. Am. 
Physiol. 235: Fl74-Fl79. 
of 
J. 
Pletcher, P.J., Korner, P.I., Angus, J.A., Oliver, J.R. 
Cardiac output and total peripheral resistance during 
hypertension in the rabbit; lack of confirmity ~th 
theory. Circulation Res. 39: 633-639. 
( 1976) Changes in 
development of renal 
the autoregulation 
Flohr, H., Brue11, w., Dahners, H.W., Redel, o., COnradi, H., stoepel, 
( 1976) Regional distribution of vascular resistance in two models 
experimental renovascular hypertension. PflUg. Arch. 362: 157-164. 
K. 
of 
Folk.ow, B. ( 1978) cardiovascular structural adaptation; its role in 
initiation and maintenance of primary hypertension. Clin. SCi. Mol. 
55: 3s-22s. 
the 
Med. 
Ga.vras, H., Liang, C.S. (1980) Acute renovascular hypertension in conscious 
dogs. Interaction of the renin-angiotensin system and sympathetic nervous 
system in systemic hemodynamic and regional blood flow responses, Circulation 
Res. 47: 358-365. 
Hales, J.R.S. (1974) Radioactive microsphere techniques for studies of the 
circulation. Clin. Exp. PharmacoL Physiol. 1.5: 31-46. 
Ichikawa, s., Johnson, J.A., stanton, M.W., Payne, e.G., Keitz.er, W.F. (1977) 
Bemodynam1c effects of an angiotensin II antagoniSt in rabbits with 
perinephritis hypertension. Proc. soc. Exp. Biol. Med. 155: 259-263. 
Liard, J. ( 1981) Regional blood flows in salt loading hypertension in the dog. 
Am. J. Physiol. 240: EI361-H367. 
Lund-Johansen, P. (1980) Ha.emod:ynamics in essential hypertension. Cli.n. SCi. 
59: 343S-354S. 
Marcus, M.L., Mueller, T.M., GaScho, J.A, Kerber, R.E. (1979) Effects of 
cardiac hypertrophy secundary to hypertension on the coronary circulation. 
Am. J. Cardiel. 44: 1023-1026. 
Mueller, T.M., Marcus, M.L., Kerber, R.E., Young, J.A., Barnes, R.W., Abboud, 
F .M. ( 1978) Effect of renal hypertension and left ventricular hypertrophy on 
the coronary circulation in dogs. Circulation Res. 42: 543-549. 
Page, I.S:., Salmoiraghi, G.C., McGubbin, J.W. (1955) Observations on the method 
of producing perinephric experimental hypertension. J. Lab. Clin. Med. 
46: 914-916. 
Page, I.E!:. (1939) The Production 
cellophane perinephritis. J. Am. 
of persistant arterial hypertension by 
Med. ASS. 113: 2046-2046. 
Saxena, P.R., scha:rohardt, s:.c., Forsyth, R.P., r.oeve, J. (1960) computer 
programs for the radioactive microsphere technique: Determination of 
regional blood flows and other haemodynaroic variables in different 
experimental circumstances. Computer Programs Biomed. 12: 63-84. 
Siegel, s. ( 1956) Non parametric statistics for the behavioural sciences, 
M<?Graw-Bill Kogakusha, Tokyo. 
Simon, G., Pamnani, M.B., OVerbeck, H.W. (1976) Decreased venous compliance in 
dogs with chronic renal hypertension. Proc. soc. Exp. Biol. Med. 
152: 122-125 . 
39 
van Boom, M, Saxena, P.R. (1980) Systemic 
experimental renal hypertensi.on in 
PharmacoL Physi.oL 7: 627-634. 
and regional haemodynamics i.n 
conscious rabbits. Clin. Exp. 
warren, D.J., Led:ingham, J.G.G. (1972) Chronic left atrial catheteri.zation in 
the rabbit. Pflug. Arch. 335: 167-172. 
West, M.J., .Angus, J.A ... Korner, P.I. (1975) Estimation of 
autonomic components of iliac bed vascular :resistance in 
non-autonomic and 
renal. hypertensive 
rabbits. cardiovascular Res. 9: 697-706. 
Yamo:ri, Y ... Mori, C., Ni.shio .. T ... OOshima, A., Horie .. T ... Ohtaka, M., Soeda, T., 
saito, M., Abe, K., Nara, Y., Nakao, Y., Kihara, M. (1979) cardiac 
hypertrophy :in early hypertension. Am. J. cardi.ol. 44: 964-969. 
'Zandberg .. P. (1984) Anilllal. models in experimental hypertension: Relevance to 
drug testing and discove:ry, in "Handbook of Hypertension", volume 3: 
40 
Pharmacology of .Antihypertensi.ve drugs (Ed. van ZWieten, P .A., Elsevier 
SCience Publishers B. v. , Amsterdam) 6-45. 
CHAPTER 4, 
HAEMOOYNAMIC PROFILE OF CAPTOPRIL IN CONSCIOUS HYPERTENSIVE RABBITS 
The radioactive m:icrosphere technique was used to study the systemi.c and 
regional haemodynamic effects of the converting enzyme inhibitor captopril 
( 0 .1, 0. 3 and 1. 0 mgjk.g) ten minutes after i. v. adminiStration in conscious 
rabbits with bilateral cellophane perinephritis hypertension, an experimental 
model of hypertension associated with normal plasma renin levels. 
captopril lowered the arterial blood pressure as a result of a dose 
dependent decrease in total peripheral resistance. The fall in blood pressure 
was accompanied by an increase in cardiac output after the second and third dose 
of captopri.l; the heart rate was not significantly altered. captopril produced 
a generalized peripheral vasodilatation, the changes in vascular conductance 
being most pronounced in the kidneys, intestines and skin which resulted in a 
significant increase in blood flow to these vascular beds. 
The effective antihypertensive properties of captopril in this "low plasma 
renin.. model of hypertension and the uniform increase in vascular conductances 
produced by captopril1 which antagonizes the generalized increase in vascular 
resistances that characterizes 
indicate the involvement of an 
cellophane perinephritis 
increased activity of the 
hypertension1 may 
renin-angiotensin 
system in tissues such as the vascular wall and brai.n in the maintenance of the 
elevated blood pressure in this hypertensive form. 
Inhibitors of the renin-angiotensin system (RAS} effectively 
lower the arterial blood pressure in clinical and experimental 
forms of hypertension associated with high plasma renin levels 
(Ondetti and cushman, 1981). In addition, converting enzyme 
inhibitors (CEis) are also capable of reducing the blood pressure 
in hypertensive forms with low or normal plasma renin activity, a 
property which is not shared by angiotensin (Ang) II receptor 
antagonists or Ang antibodies (Antonaccio and Cushman, 1981; 
Loyke, 1981). Since the angiotensin converting enzyme is the same 
enzyme as kininase [[, it is possible that accumulation of the 
vasodepressor peptides kallidin and bradykinin serves as an 
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additiona~ mechanism in the hypotensive action of CE!s (Mimran et 
a~-r 1980). However, the evidence presented thus fu denies an 
important contribution of the increase in p~asma kinin ~eve~s in 
the hypotensive mechanism of CE!s (Unger et al., 1983). 
Recent~y it has been demonstrated that a loca~ generation of 
Ang II in tissues such as the vascular wa~l and brain may p~ay an 
importent role in the maintenance of blood pressure in certain 
models of hypertension (SWales, ~979). An increased renin content 
has been found in the arteria~ wall of spontaneously hypertensive 
rats With normal p~asma renin levels (Asaad and Antonaccio, ~982)­
Moreover, an interference of CEis with the local generation of Ang 
has been demonstrated (Cohen and Kurz, 1982; Unger eta~., 1984) 
which has led to the suggestion that the differences in 
hypotensive activity of CEis and Ang II antagonists in certain 
models of hypertension are related to their relative abilities to 
penetrate these local sites (Antonaccio et al., 1980). In order 
to confirm the effectiveness of CEis in lowering blood pressure in 
"low p~asma renin" hypertension (Vo~~er et al., 1981) we studied 
the hypotensive effects of captopri~ in conscious rabbits with 
bilateral ce~lophane perinephritis hypertension. In addition, we 
measured the captopril-induced changes in regional blood flows and 
vasculaz conductances using the radioactive microsphere technique. 
This has been investigated because the rather selective 
vasodilatation after converting enzyme inhibition in "high plasma 
renin" models (Gavras et al., 1978; Gavras and Liang, 1980) and 
the more generalized vasodilatation produced by captopril in 
spontaneously hypertensive rats with normal plasma renin levels 
(Antonaccio and Cushman, 1981; Richer et al., 1983) indicates 
that the regional haemodynamic profile of CEis may differ 
depending on the experimental form of hypertension used. The 
results obtained in this study will be published elsewhere (Bolt 
and Saxena, 1985). 
METHODS 
Animals and surgical procedures 
Experiments were performed on eight male hypertensive New 
zealand White rabbits (3.3 X 0.1 kg). Hypertension was induced by 
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bilateral cellophane wxapping of the kidneys (Page, 1939), six to 
ten weeks before the experiment. Nine to fourteen days before the 
experiment a left-sided thoracotomy was performed in order to 
cannulate the left atrial appendage with a nylon catheter for the 
administration of microspheres (Warren and Ledingham, 1972)-
Subsequently, four to eight days before the experiment the left 
carotid artery was cannulated for the measurement of blood 
pressure and heaxt rate during the experiments and the withdrawal 
of arterial blood samples. The different surgical procedures 
together with the systemic and regional haemodynamic 
characteristics of bilateral cellophane perinephritic hypertension 
in rabbits have been described in detail elsewhere (Bolt and 
Saxena, 1983; Bolt and Saxena, l984a; chapter 2 and 3). 
Measurement of haemodynamic variables 
On the day of the experiment the animals were placed in a 
rabbit restrainer box. A Statham P23Dc pressure transducer was 
connected to the carotid catheter for the recording of the 
arterial blood pressure and the heart rate using a Grass model 7 
polygraph. Mean blood pressure was obtained by electronically 
damping of the blood pressure signals. Cardiac output and 
regional blood flows were measured with the radioactive 
microsphere technique, using the reference blood sample method 
(Hales, 1974; Heymann et al., 1977; Bolt and Saxena, 1984a). 
Nen-Trac microspheres were used with a diameter of 15 ~ and 
labeled with either 141Ce, 1 ~ 3Sn, 103Ru, 95Nb or 46Sc. Cardiac 
output (ml/min) and regional blood flows (ml/min) were calculated 
using a set of computer programs especially designed for the 
radioactive microsphere technique (Saxena et al., 1980). Details 
are given in chapter 2. Peripheral vascular conductances were 
obtained by dividing respective tissue blood flows (ml/min) by 
mean arterial blood pressure (mmHg). 
Experimental protocol 
The marginal ear vein was cannulated under local anaesthesia 
(lidocaine 2%) for the administration of captopril HCl (Squibb 
Inc., Princetown, OSA) 
stabilization period 
dissolved in physiological saline. After a 
of at least 30 min the first batch of 
microspheres was injected to deteLmine baseline values of caLdiac 
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output and regional haemodynamic variables. Heart rate and 
arterial blood pressure values were recorded continuously. After 
measuring baseline values each animal received three cumulative 
doses (0.1, 0.3 and 1.0 mg/kg) of captopril at 15 min intervals. 
A batch of microspheres was injected 10 min after each dose of 
captopril at which time point the maximal fall in blood pressure 
was observed. An arterial blood sample (0.3 ml) was withdrawn 
immediatly after each microsphere injection to measure pH-, 
and P0 -values, using an ABL-2 (Radiometer, Copenhagen). 
2 
Statistical evaluation 
All data have been expressed as mean (±SEM) in the text. Due 
to skewed distribution and lack of homogeneity of variances in 
some variables, non-parametric tests were used for the statistical 
evaluation (Siegel, 1956). Initially, the Friedman's two way 
analysis of variance was used to establish whether the samples 
represented different populations. 
signed ranks test was applied to 
The 
test 
Wilcoxon matched-pairs 
the "significance" 
(p < 0.05, two-tailed) of the changes in haemodynamic variables 
from baseline values. 
RESULTS 
Blood gases 
Values of arterial blood gases and pH were not affected by 
min after the successive doses of captopril. Before and 10 
captopril (0.1, 0.3 and 1.0 mg/kg) the respective values were: 
pH, 7.40 ± O.Ol, 7.36 ± 0.03, 7.38 ± O.OZ and 7.40 ± O.OZ; PCO , 
32 ± 2, 29 ± l, 28 ± 2 and 27 ± l mmHg; and P0 , 95 ± 2, 98 ± l, 
97 ± Z and 97 ± z mrnHg. 2 
Systemic haemodynamic variables 
Table 1 shows the effects of captopril, 0.1, 0.3 and 1.0 
mg/kg, on systemic haemodynamic variables 10 minutes after the 
administration in the conscious rabbits with bilateral cellophane 
perinephritis hypertension. A fall in blood pressure was observed 
after the successive doses of captopril which could be attributed 
to a dose-dependent reduction in total peripheral resistance. 
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Table L Effects o£ captopril, 0.~. 0.3 and 1.0 mg/kg, on systemic haemodynami.c 
variables ~o minutes after i. v. administration in conscious hypertensive rabbits 
(n.-a). 
captopril 
baseline o.~ mg/kg o.3 mgjkg 1.0 mq/kg 
Arterial blood pressure (mmHg), 
• • Systolic • 142 ± 6 126 ± 4, 112 ± 7. 103 ± 9, 
Diastolic 106 ± 6 89 + 5 79 + 6 72 ± •. - . - . Mean 121 ± 6 105 ± 5 91 ± 6 84 ± a 
Heart rate (beats/min) 259 ± 16 264 ± 14 274 ± 11 279 ± a 
cardiac output ( tnl/min) 433 • • ± 31 486 ± 39 549 ± 39 531 ± 41 
Stroke volume ( m1) 1.7 ± 0.1 1.9 ± 0.2 2.0 ± 0.2 1.9 ± 0.2 
Total peripheral _
1 • • • resistance (mmHg/l.min ) 293 ± 33 224 ± 19 171 ± 16 160 ± 15 
*, significantly different from baseline values (p < o.05). 
Although the changes in heart rate and stroke volume were not 
significant, both variables tended to increase which led to a 
moderate but significant rise in cardiac output after the second 
and third dose of captopril. 
Regional haemodynamic variables 
Figure 1 shows the changes 
different organs and tissues 
in regional blood flows to the 
measured ten minutes after the 
successive administrations of captopril (0.1, 0.3 and 1.0 mg/kg) 
in the conscious hypertensive rabbits. 
blood flow to the intestines, kidneys 
The compound increased the 
and skin, but did not 
significantly affect that to the stomach, skeletal muscles, brain, 
heart, bones and "lungs". As the lungs receive 15 ~ microspheres 
via peripheral arteriovenous anastomoses as well as via bronchial 
arteries, the measured blood flow values represent the combination 
of arteriovenous anastomotic and bronchial flows. Though total 
coronary flow did not change, the blood flow to the right 
ventricle increased significantly after the second and third dose 
of captopril (+29 ± 8 and +34 ± 7%, respectively). The converting 
enzyme inhibitor did not affect the weight-normalized left 
ventricular endocardial/epicardial blood flow ratio; the values 
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Figure 1. Effec-ts of capt;.oprt.Z. on regtonaz. bZ.ood ftous. (mZ./Jntn) t.n consctous 
hyper~enstve rabbi~s (n=B). Do~~ed bars, baseZ.ine vaz.ues; open bars, vaz.ues 10 
min af~er ~he t.v. aamtnis~ra~ton of cap~oprit, 0.1, 0.3 ana 1.0 mgjkg, 
respe~iveZ.y; AVA+ BB, ar~ert.ovenous anas~moses + broncht.az. vascuZ.ar bed; ~, 
stgntficant change JTom basettne vatues (p < 0.05). 
being 1.2 ± 0.1, 1.1 ± 0.1, 1.1 ± 0.1 and 1.1 ± 0.1 before and 
after the successive doses of captopxil, respectively, indicating 
a normal regional distribution of blood in the left ventricular 
wall after captopril administration. The compound had also no 
effect on the blood flows to the different regions of the brain 
(cerebral hemispheres, cerebellum, brainstem). 
Figure 2 shows that captopril produced a rather generalized 
vasodilatation (increase in vascular conductance) in the different 
vascular beds. The changes after the successive doses of 
captopril were most pronounced in the intestines, the kidneys, 
skeletal muscles and skin. More moderate changes were observed in 
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the stomach, brain, heart and bones whereas the mean vascular 
conductance of the combination of the arteriovenous anastomoses 
and bronchial vascular bed was not significantly affected. In the 
heart the changes were most pronounced in the right ventricle 
where the vascular conductance increased by 28 ± 10, 74 ± 14 and 
104 ± 22%, respectively, after the three successive doses of 
changes in vascular conductance in the captopril. The respective 
left ventricle were +13 ± 9, 
intra-ventricular 
the atria -4 ± 7, 
septum +16 ± 
+46 .± 21 
+56 .± 13 
10, +46 .± 
and +73 .± 
10 and +71 
and +56 .± 23%. In 
11%, in the 
± 14%, and in 
the cerebral 
vascular bed the vascular conductance increased after the 
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successive doses of captopril in the cerebral hemispheres by 
5 ± 11, 36 ± 15 and 43 ± 18%, in the cerebellum by 10 ± 13, 
48 ± 15 and 55 ± 16% and in the brainstem by 29 ± 19, 49 ± 15 and 
71 ± 23%, respectively. 
DISCUSSION 
This study describes the systemic and regional haemodynamic 
effects of captopril in conscious rabbits with bilateral 
cellophane perinephritis hypertension. The two-kidney 
perinephritis model of hypertension produced in rabbits and dogs 
is associated with normal plasma renin levels (Page, 1939; 
Campbell et al., 1973). In addition, infusion of the Ang II 
antagonist saralasin into rabbits and dogs with cellophane 
perinephritis hypertension fails to lower the arterial blood 
pressure (Ichikawa et al., 1977). Despite these facts which 
suggest that the RAS is not involved in maintaining the elevated 
blood pressure in this hypertensive model (Ichikawa et al., 1977), 
a pronounced fall in blood pressure is observed in the present 
study after captopril administration in conscious perinephritic 
rabbits. The CEI captopril has also been found capable of 
reducing the blood pressure in dogs with cellophane perinephritic 
hypertension, implicating a greater role for the RAS in this 
hypertensive model than suggested in previous investigations using 
other pharmacological blockers of the RAS (Vollmer et al., 1981). 
Recently it has been demonstrated that CEis interfere not only 
with the plasma RAS but also with the local Ang II generation in 
tissues such as the vascular wall and brain (Asaad and Antonaccio, 
1982; Cohen and Kurz, 1982; Unger et al., 1984)- Thus the 
differences in the hypotensive activity of Ang II antagonists and 
CEis may be explained in part by their relative abilities to 
penetrate these local sites (Antonaccio et al., 1980). Further 
support for this contention is provided by the finding that the 
fall in blood pressure produced by CEis is closely correlated with 
the degree of converting enzyme inhibition in tissues whereas the 
antihypertensive potencies of these compounds are neither 
reflected by changes in converting enzyme activity in the plasma 
or lung vascular endothelium, nor by reductions in circulating Ang 
48 
II (Cohen and Kurz, 1982; Unger et al., 1984). 
The decrease in blood pressure after the successive doses of 
captopril in conscious hypertensive rabbits is due to a 
dose-related fall in the total peripheral resistance which 
illustrates the arterial vasodilator properties of the CEI. A 
pronounced reflex tachycardia, which usually accompanies the fall 
in blood pressure after vasodilator treatment in conscious animals 
due to the hypotension induced activation of the baroreceptor 
reflex, (Bolt and Saxena, l984a,b,c) was not observed in the 
present study after captopril administration. This has been 
attributed to the ability of captopril to alter the set point of 
the baroreceptors (Hatton et al., 1981). In addition, because 
endogenous Ang II has a facilitory effect on the autonomic nervous 
activity (Lumbers and Potter, 1982; Heyndrickx et al., 1976), its 
inhibition by captopril may blunt the reflex response secondary to 
the fall in blood pressure. Since a reflex stimulation of the 
heart was not observed in the present study, the elevated cardiac 
output after captopril, 0.3 and 1.0 mgjkg, may be due to the 
pronounced fall in afterload resulting from the reduction in total 
peripheral resistance (Liang et al., 1978). The increase in 
cardiac output also suggests that the CEI predominantly affects 
the arterial site of the circulation since an unchanged or even 
reduced cardiac output is expected after dilatation of venous 
capacitance vessels and the subsequent reduction in venous return 
(Tarazi et al., 1976). Similar changes in cardiac output have 
been reported after captopril administration in spontaneously 
hypertensive rats which also have normal plasma renin levels 
(Antonaccio and Cushman, 1981). 
A rather generalized peripheral vasodilatation is observed 
after the administration of captopril in the conscious rabbits 
with cellophane perinephritis hypertension. This is not expected 
from the differential pattern of vasoconstriction produced by 
exogenous Ang II with the greatest effects on the renal and 
coronary bed and less intense effects on the mesenteric and iliac 
bed (Market al., 1972; Heyndrickx et al., 1976). Compatible 
with the response of exogenous Ang II is the rather selective 
vasodilatation observed after converting enzyme inhibition in 
hypertensive dogs submitted to renal artery occlusion (Gavras and 
Liang, 1980) and in normotensive sodium depleted dogs (Gavras et 
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al., 1978), with significant falls in vascular resistance in the 
heaxt, brain 
However, in 
and kidneys and no effects on muscles and skin. 
contrast to perinephritic hypertension, the models 
mentioned above are both associated with 
A more generalized vasodilatation, 
high plasma renin levels. 
comparable with the 
captopril-induced changes noticed in the present study, has been 
observed after captopril administration in spontaneously 
hypertensive rats (Antonaccio and Cushman, 1981; Richer et al., 
1983), which have normal plasma renin levels but an elevated 
arterial vessel wall renin-content (Asaad and Antonaccio, 1982). 
Thus it is possible that the regional haemodynamic profile of CEis 
varies in different models of hypertension depending on the 
relative contribution of plasma and tissue renin in the 
maintenance of the elevated blood pressure. However, differences 
in the haemodynamic profile of captopril as a result of the use of 
different species cannot be excluded. 
The increase in vascular conductance produced by captopril in 
the present study is less pronounced in the heart and brain, both 
organs known to posses a strong autoregulatory mechanism which 
maintains the arterial blood supply in accordance with the 
respective metabolic demands. The changes in myocardial activity 
can be predicted, at least in part, by the product of heart rate 
and systolic blood pressure (Weber and Janicki, 1979). This 
variable decreased after the successive captopril doses by 9 ± 3, 
15 i 5 and 19 ± 7%, respectively. Nevertheless, the vascular 
conductance increased in the coronary vascular bed and a 
significant increase in blood flow to the right ventricle was 
measured indicating a pronounced direct vasodilator action of 
captopril in this vascular bed. 
A large increase in vascular conductance is observed after 
captopril administration in the kidneys and intestines, which 
resulted in an increased blood supply to these vascular beds. A 
pronounced vasodilatation in the renal and splanchnical bed has 
been reported in previous investigations using low as well as high 
plasma renin models of hypertension (Gavras at al., 1978; Gavras 
and Liang, 1980; Antonaccio and Cushman, 1981; Richer et al., 
1983; Suzuki et al., 1984). The increase in vascular conductance 
in the cutaneous and muscular vascular bed has also been found in 
spontaneously hypertensive rats (Antonaccio and Cushman, 1981). 
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Especia~~y the vasodilatation and inc~ease in b~ood flow in the 
skin is ~ema~kable considexing the xe~ative inactivity of 
vasodilators of diffe~ent types to affect the cutaneous vascu~a~ 
bed (Bolt and Saxena, 1984a,b,c). In view of the known vasoactive 
prope~ties of kinins in the vascu~atuxe of the skin (Rowell, 
1981), a possible cont~ibution of the captop~il-induced inhibition 
of the kinin deg~adation must be conside~ed. 
Finally, the xegional haemodynamic p~ofile obtained with 
captopri~ completely counteracts the gene~alized inc~ease in 
peripheral vascular xesistances with, quantitatively, the most 
pronounced changes in kidneys, muscles and skin and more moderate 
changes in the brain measured in conscious rabbits with bilateral 
cel~ophane perinephritis hypertension (Bolt and Saxena, 1983). 
This may indicate an important role for the RAS in tissues such as 
the vascular wall andjor brain, in the maintenance of the elevated 
blood pressure in this experimental form of hypertension. 
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CHAPTER 5: 
INTERACTION OF ATENOLOL WITH THE HAEMODYNAMIC PROFILE OF 
HYDRALAZINE IN CONSCIOUS HYPERTENSIVE RABBITS 
The radioactive microsphere technique was used to characterize the acute 
haemodynamic profile of hydralazine, alone and in combination with atenolol, in 
conscious hypertensive rabbits. Bydralazine, 0.3 mgjkg, t.v., increased the 
heart rate, stroke volume and cardiac output and decreased total peripheral 
resistance. A fall in arterial blood pressure was observed only at higher doses 
( 1. o and 3. 0 mgjk.g, i.. v. ) due to a further reduction in total peripheral 
resistance. The drug caused vasodilatation in the heart., brain, kidneys, 
diaphragm, chest wall and large intestine. In contrast, a, probably 
reflex-mediated, vasoconstriction was noticed in the skin, stomach and small 
intestine. In the heart hydralazine preferentially increased blood flow to the 
outer layers of the left ventricular wall, which resulted in a significant 
decrease in the cmd(')c:ardialjc~pi<:a"Tdial blood flow ratio. Hydralazine also 
greatly enhanced the percentage of 15 ~ microspheres distributed to the lungs, 
indicating an increased arteriovenous anastomotic flow. 
Atenolol (1 mgjkg, -t.v.) elicited bradycardia and moderately reduced blood 
pressure due to a decrease in cardiac output. In cotl'lbination with atenolol, 
hydralazine o. 3 mgjkg caused a less pronounced cardiac stimulation and.. now, a 
fall in blood pressure was produced by the low dose of hydralazine. In 
contrast, with the high hydralazine dose (3.0 mg/kg) the synergistic effect on 
blood pressure response disappeared due to an increase in cardiac output, 
despite effective ~adrenoceptor bloCkade. In addition, atenolol interfered 
with the vasodilator response of hydralazine in the heart, skeletal muscles and 
the arteriovenous anastomoses. The ~adrenoceptor antagonist increased the 
endocardial/epicardial blood flow ratio and thereby abolished the negative 
effect of hydralazine on this parameter. 
In conclusion, the antihypertensive drugs acted synergistically only at a 
low hydral.azine dose. A better haemodynam:ic profile was obtained after combined 
treatment as atenolol protected against the undesirable changes in regional 
myocardial blood flow distribution observed with hydralazine alone. 
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The use of arterial vasodilators in hypertensive therapy has 
gained renewed interest, now that the reflex tachycardia induced 
by these agents can be blocked effectively by the simultaneous 
administration of a S-adrenoceptor antagonist (Koch-Weser, 1978). 
In addition, vasodilators counteract the increase in vascular 
tone, which is commonly observed after treatment with 
S-adrenoceptor antagonists alone (Man in 't Veld and Schalekamp, 
1982). Although, for the reasons mentioned above, a synergistic 
effect on blood pressure after combined treatment with these 
antihypertensive drugs might be expected, 
have been obtained in clinical (Gutkin 
contradictory results 
et al., 1977) and 
experimental (Provost et al., 1981; Kubo et al., 1981) studies. 
This has led to speculations on an interference of s-adrenoceptor 
antagonists with the peripheral effects of vasodilators, possibly 
by an accentuation of the reflex-mediated vasoconstrictor response 
due to "unopposed" a-adrenoceptor stimulation (Cutkin et al., 
1977). In order to obtain additional information concerning the 
interaction of the direct- and reflex-mediated effects of 
vasodilators and S-adrenoceptor antagonists, we used the 
radioactive microsphere technique to investigate the acute effects 
of hydralazine and atenolol on systemic as well as regional 
haemodynamic variables in conscious rabbits with bilateral 
cellophane perinephritis hypertension. The cardioselective 
s 1 -adrenoceptor antagonist was chosen to minimize the blockade of 
vascular s2 adrenoceptors (Barrett, 1977). The data presented in 
this chapter have been published elsewhere (Bolt and Saxena, 
1984). 
METHODS 
Animals and surgical procedures 
Experiments were performed on conscious male New Zealand 
White rabbits with bilateral cellophane perinephritis hypertension 
(Page, 1939). Nine to fourteen days before the experiment a 
left-sided thoracotomy was performed in order to cannulate the 
left atrial appendage with a nylon catheter for the administration 
of microspheres (Warren and Ledingham, 1972). Subsequently, four 
to eight· days before the experiment the left carotid artery was 
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cannulated for the measurement of blood pressure and heart rate 
during the experiments and the withdrawal of arterial blood 
samples. The different surgical procedures have been described in 
detail elsewhere (Bolt and Saxena, 1983; chapter 2 and 3). 
Measurement of haemodynamic variables 
On the day of the experiment the animals were placed in a 
rabbit restrainer box. A Statham P23Dc pressure transducer was 
connected to the carotid catheter for the recording of the 
arterial blood pressure and heart rate using a Grass model 7 
polygraph. Mean arterial 
electronically damping the 
regional blood flows were 
blood pressure 
pressure signals. 
measured with 
was obtained by 
Cardiac output and 
the radioactive 
microsphere technique, using the reference blood sample method 
(Hales, 1974; Heymann et al., 1977). Nen-Trac microspheres were 
used with a diameter of 15 ~ and labeled with either 141ce, 
113
sn, 
103Ru or 95Nb. Cardiac output (ml/min) and regional blood 
flows (ml/min) were calculated using a set of computer programs, 
especially designed for the radioactive microsphere technique 
(Saxena et al., 1980; details are given in the second chapter of 
this thesis). Peripheral vascular conductances were obtained by 
dividing the respective tissue blood flows (mljmin) by the mean 
arterial blood pressure (rnmHg). 
Experimental protocol 
The effects of hydralazine (Apresoline, Ciba Farmaca bv, 
Arnhem, The Netherlands) and atenolol (Tenormin, ICI Farma bv, 
Rotterdam, The Netherlands) were investigated in two groups of ten 
conscious hypertensive rabbits. The marginal ear vein was 
cannulated under local anaesthesia (Lidocaine 2%) for the 
administration of drugs. After a stabilization period of at least 
30 minutes, the first batch of microspheres was injected to 
determine baseline values of cardiac output and regional 
haemodynamic variables. Subsequently, the first group of rabbits 
(body weight: 3.07 ± 0.06 kg) received 3 cumulative doses of 
hydralazine (0.3, 1.0 and 3.0 mg/kg, i.v.) at 20 minutes intervals 
(figure lA). Fifteen minutes after each hydralazine dose a batch 
of microspheres was injected to measure the hydralazine-induced 
changes in cardiac output and regional haemodynamics. 
t aydralazine 0.3 iaydralazine 1.0 iaydralazine 3.0 • 
Ml. M2 M3 M4 
r r t t 
"' 
I I I i 
t= 0 5 20 25 40 45 GO min 
tAtenolol 1.0 iaydralazine 0.3 iaydralazine 3.0 
• Ml. M2 M3 M4 
r t s, 
t~ 0 5 20 25 40 45 60 min 
Ftgure 1. Schema~ic represen~a~ion of ~he ~ime scedu~es used~ s~uay ~he ef-
fec~s of hydra~azine (0.3, t.O and 3.0 mgjkg) (A) and of a~no~L (1.0 mgjkg) in 
combina~ion ~i~h hydraLazine (0.3 and 3.0 mgjkg) (B). Four successive badges of 
microspheres (M1 to M4) ~ere injec~ed a~ 20 min in~erva1s, 5 min before and 15 
min af~er ~he subsequen~ adminis~ra~ions of ~he drugs. 
In pxeliminaxy experiments it was shown that at about 15 
minutes after each hydralazine administration the maximal change 
in blood pressure was reached after which period the response 
stabilized. Just before each microsphere injection, values of 
heart rate and blood pressure were obtained and an arterial blood 
sample (0.3 ml) was taken to measure pH, Pco and p0 using an 
ABL-2 (Radiometer, Copenhagen). The second grou~ of rab6its (body 
weight: 2~84 ± O~lO kg) received atenolol, l~O mg/kg i.v. and, 
subsequently, hydralazine 0.3 and 3.0 mg/kg (cumulative doses) 
using the same experimental protocol (figure lB)~ The dose of 
atenolol was selected on basis 
which the ..e-adrenoceptor 
of preliminary 
blocking effect 
experiments, 
of atenolol 
in 
was 
ascertained using the heart rate responses to isoprenaline in 2 
conscious rabbits (6 observations). Atenolol, 1 mg/kg, caused a 
shift in the dose-response curve of 1.4 ± 0~04 log unit~ The 
blocking effect remained stable for at least 55 minutes~ The 
interaction of atenolol with only two doses of 
be studied, because of the availability 
microspheres. 
hydralazine could 
of four batches of 
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Statistical evaluation 
All data have been expressed as mean (±SEM) in the text~ Due 
to skewed distribution and lack of homogeneity of variances in 
some variables, non-parametric tests (Siegel, 1956) were used for 
the statistical evaluation. The changes in haemodynamic variables 
from the baseline values were calculated in each experiment 
seperately~ Initially the Friedman's two-way analysis of variance 
was used to establish whether the 
populations. For the comparison 
samples 
of data 
represented 
in one 
different 
the Wilcoxon matched-pairs signed ranks test 
Mann Whitney 0-test was chosen for the 
was 
group of animals 
employed~ The 
comparison of the 
drug-induced changes in the two different groups of animals~ 
Differences were considered significant for p < 0.05 (2-tailed). 
Correlations we~e determined using the Spearman Rank test. 
RESULTS 
Effects of hydralazine 
Significant changes in arterial blood gases were observed 
after the administration of hydralazine, 0.3, 1.0 and 3.0 mg/kg. 
P0 increased from 88 ± 2 to 101 ± 2, 101 ± 2 and 104 ± 3 mmHg and PC~ decreased from 38 ± 2 to 30 ± 2, 30 ± 2 and 28 ± 1 mmHg after 
the2successive hydralazine injections. The pH value increased 
from 7.32 ± 0.02 to 7.50 ± 0.03, 7.52 ± 0.03 and 7.53 ± 0.03. 
svstgmi c bagmodynamj cs 
The effects of hydralazine (0.3, 1.0 and 3.0 mg/kg) on 
systemic 
in table 
haemodynamic variables in hypertensive rabbits are shown 
l. The lowest hydralazine dose significantly increased 
the heart rate, cardiac output and stroke volume and decreased 
total peripheral resistance. These effects were observed in the 
absence of any hypotensive response with this dose. Instead, a 
small but significant rise in systolic and mean blood pressure was 
noticed. Only after hydralazine 1.0 and 3.0 mg/kg blood pressure 
decreased, accompanied by a further increase in heart rate and 
decrease in total peripheral resistance. 
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Tabl.e ~. Effects of hydralazine, o. 3, 1. o and 3. o mg/k:g, on systemi.c 
haemodynam:ic variables :in hypertens:ive rabbits ( n=10). 
Baseline Hydralazine 
0.3 mgfkg 1.0 mg/k:g 3.0 mg/k:g 
ARl"ERRAL BLOOD PRESSURE 
Systolic ( mmHg) 1S1 ±S 1SB ± sa 142 ± 5 124 ± sa 
Diastolic ( mmHg) 121 ± 4 123 ± 4a 109 ± 3a 94 ± 4a 
Mean (mmHg) 134 ± 4 139 ±4 122 ± sa 106 ± sa 
HEART RATE ( beatsjmin) 242 ±B 2BO ± l.4a 307 ± 9a 309 ± Ha 
CARDIAC OUTPUT (ml/min) 483 ± 30 66S ± 46a 641 ± 68a 636 ± 63a 
STROKE VOLUME ( ml) 2.0 ± 0.2 2.4 ± 0.2a 2.~ ± 0.3 2.1 ± 0.3 
TOTAL PERIPHERAL 
-1 17a 20a 19a RESISTANCE ( mmHg/l.min ) 287 ± 23 2~7 ± 207 ± n9± 
a, significantly different from baseline values (p < 0.05). 
Tisane blQ!X'i £Jew 
The effects of hydra~azine, 0.3, ~-0 and 3.0 mg/kg, on the 
tota~ amount of b~ood received by the different organs in 
hypertensive rabbits are shown in figure 2. As can be deduced 
from this figure, an important part of the increase in cardiac 
output after hydra~azine was received by the ~ungs, heart and 
kidneys. The proportion of 15 Am microspheres trapped in the 
lungs increased from 3.6 ± 0.8% to 6.7 ± ~-2%, 9.2 ± 1.3% and 8.2 
.± 1.4%, 
doses. 
respectively, 
Considering the 
after the three successive hydralazine 
sma~~ contribution of the bronchiaL 
vascu~ar bed in the total circu~ation (Warren and Ledingham, 
1974), the ~arge changes in blood supp~y to the lungs observed 
after hydralazine administration probab~y indicated an increased 
shunting of bLood from the arteria~ to the venous side of the 
circu~ation via arteriovenous anastomoses (AVAs). Also in the 
brain, diaphragm and chest wa~l a significant increase in blood 
supply was measured, however, on~y a small amount of the total 
cardiac output is received by these organs. Blood f~owes to 
skeletal muscles and bones were not significantly altered by 
hydra~azine a~though, especia~~y at the lowest dose of the drug, 
the blood supp~y to the muscular bed tended to increase. The 
arterial vasodilator reduced the b~ood flow to the skin, stomach 
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Fi,gure 2: Effects of hydraZ.azine on regionaL bZ.ood fZ.otJ (mt.(mt.n) 
renaL hypertensive rabbits (n~zo). Dottea bars, baseLine vaLues; 
min after hydraLazine, 0.3, 1.0 ana 3.0 mgjkg, respe~tvety; z, 
different from basetine vaLues (p < 0.05). 
tn conscious 
open bars, 15 
stgntticant:."Ly 
and small intestine~ In the large intestine the blood flow was 
significantly raised after the third hydralazine dose. 
Figure 3 shows the effects of hydralazine on the blood supply 
to the different regions of the brain and the left ventricular 
walL In the brain an increase in blood flow was measured in 
cerebellum and brain stem, while in the cerebral hemispheres the 
change in blood supply was not significant. In the left 
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Fi-gure 3: Effec-ts of hydra~azt.ne (0.3, 1.0 and 3.0 mg/kg, t.v.) on tiLooa fLou t:.o 
different:. regions of t;.he brat.n (A) and t:.he Left:. vent:.ricuLar uatL (B) t.n 
percent:.age change from t~asett.ne vatues (n=10). Bet:.~n bracket:.s: basett.ne 
vatues in mLjmt.n; x, st.gnt.ftcant:. change trom baseLt.ne vatues (p < 0.05). 
ventricular wall the increase in blood flow to epicard and 
mesoca~d was larger than in endocard. This resulted in a 
significant reduction in the endocardial/epicardial blood flow 
ratio, which was lowered by the three successive hydralazine doses 
f"om 1.34 i 0.06 to 1.20 i 0.05, 1.10 i 0.04 and 0.99 i 0.05, 
respectively. 
vascular gmdnctance 
Dose dependent increases in vascular conductances were 
obsei:ved after hyd~alazine 0.3, 1.0 and 3.0 mg/kg in the 
combination of AVAs and bronchial bed, in the diaphragm, heart, 
brain, kidneys and chest wall (figu~e 4). In the skeletal muscles 
and bones the vascular conductance tended to increase although 
significant levels were not reached. A vasoconstriction was 
measured in the skin, stomach and small intestine after the 
administration of the 3 successive doses of the vasodilator, while 
in the large intestine a significant increase in 
conductance was noticed after hydralazine 3.0 mg/kg. 
vasculal: 
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Figure 4: Effect-s of hyara~aztne (0.3, 1.0 ana 3.0 mg/k.g, -t.v.) 
conauct.ances in percent-age change from base~ine va~ues (n=lD). 
change from base~ine va~ues (p < 0.05); AVA+BB, art.er-Lovenous 
bronchiaL vascuLar bea. 
Effects of atenolol and hydralazine 
Muscles 
Bones 
Skin 
Stomach 
Small 
intestine 
Large 
intestine 
X 
on vascu~ar 
:r:, Sign"Lficant. 
anast-omoses + 
Atenolol (1.0 mgjkg) had no effects on arterial blood gases 
nor did the drug modify the significant changes in these variables 
produced by hydralazine. When hydralazine, 0.3 and 3.0 mg/kg, was 
given, P0 increased from 90 i 2 and 91 i 2 mmHg (before and after 
ateno1o1, 2respective1y) to 102 i 2 and 103 i 3 mmHg, respectively, 
PCO decreased from 36 i 3 and 35 i 4 mmHg to 27 i 3 and 26 ± 3 
mmHa, and the pH value increased from 7.45 ± 0.01 and 7.45 ± 0.02 
to 7.56 ± 0.02 and 7.56 ± 0.02. 
Systemic hagmgdynami cs 
After the administration of atenolol (1.0 mg/kg) a small 
decrease in blood pressure was measured. Heart rate and cardiac 
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Table z. Effects of atenolol, LO 
hydralazine, 0.3 and 3.0 mgjkg, 
hypertensive rabbits ( n=lO). 
mgjkg, alone and in combination with 
on systemic haemodynami.c variables in 
ARrERIAL BLOOD PRESSURE 
systolic ( mmHg) 
Diastolic ( mmHg) 
Mean (mmHg) 
HEART RATE (beats/min) 
CARDIAC O'C1I'PUT ( mlfmin) 
STROKE VOLUME ( ml) 
TOTAL PERIPHERAL 
RESISTANCE ( mmBg/l.min -l) 
Baseline 
140 ± 6 
111 ± 4 
124 ± 4 
231 ± 16 
482 ± 59 
2.1 ± 0.2 
286 ± 31 
Atenolol 
1.0 mgfkg 
132 ± 6a 
,03 ± 4a 
l16 ± sa 
,90 ± 11a 
405 ± 3Sa 
2.2 ± o.z 
319 ± 44 
Hydralazine 
0.3 mgjkg 3.0 mqjkg 
126 ± 5a,b 113 ±sa 
95 ± 5a,b 86 + sa 
110 ± 5a,b 99 ±sa 
210 ± 11a,b 235 ± lOb 
440 ± 36b 551 ± 63a 
2.2 ± 0.2 2.4 ± 0.2 
273 ± 34 191 ± 17a 
a 1 significantly different from baseline values (p < 0.05); b, combined 
response of atenolol and hydralazine significantly different from response after 
treatment with hydralazine alone (see table l)(p < o.OS). 
output we~e ~educed, while st~oke volume and total 
~esistance did not change significantly (table 
p~et~eatment with atenolol, hydralazine (0.3 and 
peripheral 
2) _ After 
3.0 mg/kg) 
further reduced blood 
baseline values were not 
treatment. Cardiac 
pressure. Heart rate 
exceeded significantly 
increased, but 
after combined 
output increased and total peripheral 
resistance decreased after the administration of hydralazine 0.3 
.1m< and 3.0 mg/kg. The combined ~esponse of atenolol and the 
hydralazine dose on systolic, diastolic and mean blood pressure, 
heart rate and cardiac ouLput (table 2) differed significantly 
from the response of hydralazine, 0.3 mg/kg, alone (table 1). The 
decrease in total peripheral resistance also seemed to be smaller 
after combined treatment, however, the difference with the 
response after single treatment was not significant. The 
synergistic effect on the blood pressure response was not observed 
with the hlgher dose of hydralazine due to the large increase in 
cardiac output after hydralazine, 3.0 mgjkg, despite effective 
e-adrenoceptor blockade. Only the combined response on the heart 
rate was still significaritly different from the response after 
single treatment with hydralazine, 3.0 mg/kg~ 
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Tjssue hlQQd flow 
In figure 5 are shown the effects of atenolol (1.0 mg/kg), 
alone and in combination with hydralazine (0.3 and 3.0 mg/kg), on 
the amount of blood received by the different organs and tissues 
in the hypertensive rabbits. An overall tendency for blood flow 
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~gure 5: Effe~s of a~enoLoL (l.O mgfkg, t.v.) aLone or tn combtna~ion ~i~h 
hydraLazine (0.3 and 3.0 mgjkg, t.v.) on regionaL ~Lood fLo~ (mL/mtn) tn 
consctous renaL hyper-tensive rab~t.:ts (n=ZO). Dcrtt.ed bars, baseLtne vaLues; 
ft.LLea bars, at.enoLoL (1.0 mg/kg); open bars, hydraLaztne, 0.3 and 3.0 mg/kg 
respect-iveLy; x, stgntficant.Ly differen~ from baseLine vaLues; o, co~ined 
response of at.enoLoL and hydraLaztne signtftcant.Ly different. from response of 
hydraLazine atone (p < 0.05). 
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to decrease was noticed after the administration of the 
S-adrenoceptor antagonist. Significant reductions in blood supply 
were measured in the lungs (arteriovenous anastomotic + bronchial 
flow), heart, bones, small intestine and large intestine. After 
atenolol pretreatment, hydralazine increased blood flow to the 
lungs, heart, kidneys, brain and diaphragm, while a decrease in 
blood supply to the skin, stomach and small intestine was 
observed. Atenolo1 decreased the proportion of microspheres 
distributed to the lungs from 4.0 ± 1.4% to 3.7 ± 1.4%, while 
again after hydralazine the percentage increased up to 4.6 ± 1.2% 
and 9.5 ± 1.5%, respectively. However, in combination with 
atenolol, hydralazine, 0.3 mg/kg, caused a significantly smaller 
increase in blood flow to the lungs, when compared with the 
changes induced by hydralazine alone, which indicated an 
inhibition by atenolol of the hydralazine-induced increase in 
arteriovenous anastomotic flow. Together with atenolol, the 
hydralazine-induced increase in blood flow to the heart was 
significantly smaller for both hydralazine doses. In skeletal 
muscles and bones a significant reduction in arterial blood supply 
was measured and also in these vascular beds the combined response 
of atenolol with the low hydralazine dose differed significantly 
from the response of hydralazine, 0.3 mg/kg, alone. Combined 
treatment with atenolol also reduced the hydralazine-induced 
increase in blood flow to the chest wall. 
The S-adrenoceptor antagonist had no effect on the 
supply to the different regions of the brain (figure 6). 
blood 
After 
combined treatment with atenolol, again the changes in blood flow 
induced by hydralazine were most pronounced in cerebellum and 
brain stem, and not significantly different from the effects after 
single treatment with hydralazine. In the left ventricular wall 
atenolol, 1.0 mg/kg, decreased blood flow in epicard by 24 ± 5%, 
in mesocard by 18 ± 6% and in endocard by 15 ± 4% (figure 6). 
Consequently, there was a significant increase in the 
endocardial/epicardial blood flow ratio from 1.51 ± 0.06 to 1.69 ± 
0.07. The favourable blood flow redistribution towards the 
endocard after atenolol compensated for the negative effect of 
hydralazine on the endocardial/epicardial blood flow ratio as is 
shown in figure 6 where the combined effects of atenolol (1.0 
mg/kg) and hydralazine (0.3 and 3.0 mg/kg) on the blood flow to 
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J?t.gure 6: Effects of atenoz..ot ( 1.0 mg/'l<g) atone ana t.n combt.nat:t.on IJ'Lt;h 
hyarataztne (0.3 and 3.0 mgjkg) on btood fZ..oiJ t:o dtfferent; regions of 'the brain 
(A) and 'the tef't vent:rt.cutar IJatt (B) tn percen-tage change from basett.ne vatues 
(n~lO). Bet;IJeen bracket:s: basettne vatues tn mtjmtn; fitted bars, at:enoZ..oZ..; 
open bars, hydTaZ..azi.ne, 0.3 and 3.0 mg/kg respeci;tveZ..y; :c, si.gntft.cant: change 
]'rom basez..t.ne vaz..ues; o, combtnea response of at:enoz..oz.. and hydraZ..aztne 
stgntftcant:Z..y a'Lfferent; from response of hydraZ..~ne atone (p < 0.05). 
epi-, meso- and endocard appeared to be similar. After 
hydralazine, 0.3 and 3.0 mg/kg, the endocardial/epicardial blood 
flow ratio decreased to 1.59 ± 0.07 and 1.57 ± 0.04, respectively, 
but the values were not lower than that at baseline level (1.51 ± 
0. 06) • In addition, only the combination of atenolol with the ~ 
hydralazine dose resulted 
the endocard, while in 
in a smaller increase in blood flow to 
the epicard 
atenolol with bQth hydralazine doses was 
from the response of hydralazine alone. 
vascular CQ!Jductancy 
the combined response of 
significantly different 
Only small changes in regional vascular conductances were 
observed in the hypertensive rabbits after the administration of 
atenolol, 1.0 mg/kg (figure 7). A significant decrease was 
measured in the combination of AVAs and bronchial vascular bed, in 
the heart and in the large intestine. 
atenolol, hydralazine again caused 
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broncht.aL vascuz.ar bed. 
combination of A VAs and bl:onchial bed. Howeve1:, the combined 
1:esponse of atenolol and the 
.1m< hydralazine dose was 
significantly smaller, when compared with the response of 
hydralazine, 0.3 mg/kg, alone. Also in the heart and the skeletal 
muscles the combined effects of atenolol and the low hydralazine 
dose were significantly different from the changes observed after 
single treatment with hydralazine, 0.3 mg/kg. The increase in 
vascular conductance in the heart was reduced, while in the 
skeletal muscles no vasodilatation could be observed after 
combined treatment. Only in the heart a significantly smaller 
increase in vascular conductance was observed after combined 
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treatment with atenolol and the high hydralazine dose. Atenolol 
did not significantly modify the hydralazine-induced 
vasodilatation in diaphragm, brain, kidneys, chest wall and large 
intestine nor did the s1ad~enoceptor antagonist interfere with the 
vasoconstrictor response after hydralazine, 0.3 and 3.0 mg/kg in 
the skin, stomach and small intestine. 
DISCUSSION 
Systemic effects of hydralazine and atenolol 
Using a low dose of hydralazine (0.3 mg/kg) an increase in 
heart rate, stroke volume and cardiac output and a decrease in 
total peripheral resistance was noticed in the conscious renal 
hypertensive ~abbits, while no hypotensive effect co~ld be 
measured. Considerable cardiac stimulation with hydralazine in 
the presence of an unchanged or even elevated arterial blood 
pressure has been reported earlier (Spokas and Wang, 1980; Vidrio 
and Tena, 1980; Lin et al.,l983). Spokas and Wang (1980) have 
suggested that, in addition to baroreceptor activation, the 
augmentation of heart rate and cardiac output after hydralazine 
results from an increase in venous return which activates atrial 
stretch receptors (Bainbridge reflex). In fact, it is generally 
agreed that drugs, which cause arterial vasodilatation without 
affecting venous tone, elicit a greater increase in heart rate and 
cardiac output than vasodilators which dilate both resistance and 
capacitance vessels (Tarazi et al., 1976). When higher doses of 
hydralazine were administered, a reduction in blood pressure was 
observed. 
compensated 
resistance. 
Thus, the increased cardiac 
the further decrease in 
output no longer 
total peripheral 
In the renal hypertensive rabbits atenolol (1.0 mg/kg), like 
propranolol (Van Boom and Saxena, 1983), caused a small reduction 
in blood pressure which was accompanied by a decrease in heart 
rate and cardiac output. After atenolol there was a tendency for 
total peripheral resistance to increase and a clear negative 
correlation existed between the changes in cardiac output and 
total peripheral resistance (rs 0.927, p < 0.05, figure 8). 
This suggests that a large fall in arterial blood pressure after 
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atenolol, as a result of the lowered cardiac output, is prevented 
by reflex-mediated peripheral vasoconstriction (Man in 't Veld and 
Schalekamp, 1982). 
In contrast with the effects of hydralazine alone, the low 
hydralazine dose (0.3 mg/kg) immediately caused a further decrease 
in blood pressure after atenolol pretreatment because of an 
inhibition of the hydralazine-induced cardiac stimulation. In 
agreement with other studies on the interaction of S-adrenoceptor 
antagonists and arterial vasodilators (Gutkin et al., 1977; 
Provost et al., 1981; Kubo et al., 1981; Man in 't Veld et al., 
1978) a synergistic effect on blood pressure was no longer 
observed with the high hydralazine dose (3.0 mg/kg). In part this 
could be explained by the increase in cardiac output after 
hydralazine (3.0 mg/kg) despite s1 -adrenoceptor blockade. In 
addition, a tendency was observed for total peripheral resistance 
to decrease less after atenolol pretreatment, indicating a 
possible interference of atenolol with the peripheral effects of 
hydralazine. Although mean heart rate values after combined 
• 
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~gure 8: A s~gn~f~can~ nega~~ve correLa~~on e~s~ed be~~en ~he a~enoLoL (1.0 
mgjkg)-~nauced changes ~n caratac ou~pu~ (00) ana ~o~aL p&rtpheraL res~s~ance 
(TPR) tn consc~ous renaL hypertenstve rabbtts (r5~0.927, p < 0.05). 
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treatment did not exceed baseline values, the hydralazine-induced 
reflex tachycardia was still present after 8-adrenoceptor 
blockade. Because the blockade of the isoprenaline-induced 
tachycardia by atenolol does nor wear off during the course of 
these experiments (see Methods), it appears that a withdrawal of 
the parasympathetic tone is mainly responsible for the 
vasodilator-induced reflex tachycardia (Man in 't Veld et al., 
1978; Reid, 1979). However, a possible direct myocardial 
stimulatory action of hydralazine cannot be excluded 
(Songkittiguna and Rand, l982). 
Regiona~ effects of hydralazine and atenolo~ 
bed 
considering the 
in the total 
small contribution of the bronchial vascular 
circulation (Warren and Ledingham, 1974), the 
large increase in microsphere content of the lungs after 
hydralazine must be attributed for a major part to an increase in 
the arteriovenous anastomotic blood flow. Similarly, the decrease 
in the amount of microspheres trapped in the lungs after atenolol 
can be explained by a constriction of AVAs due to reflex-mediated 
a-adrenoceptor stimulation. Indeed, Spence et al. (1972) have 
demonstrated that AVAs are under a-adrenergic control. However, 
the apparently very large vasodilatation of AVAs after hydralazine 
without any sign of opposing reflex-mediated vasoconstriction 
suggests that, compared to the adrenergic influence, these 
non-nutritional vessels are more effectively regulated by tissue 
autoregulatory mechanisms. Thus, if the oyerall metabolic need of 
the body remains essentially unchanged and the cardiac output 
increases (as after hydralazine) or decreases (as after atenolol), 
there should be parallel changes in arteriovenous anastomotic 
flow. Accordingly, as atenolol reduces the hydralazine-induced 
increase in cardiac output, a smaller enhancement of the 
arteriovenous anastomotic flow is expected and observed after 
combined treatment. 
An adaptation of the myocardial blood flow to the enhanced 
metabolic demands resulting from the hydralazine-induced cardiac 
stimulation obviously contributed to the large increase in blood 
flow to the heart observed after hydralazine administration. 
Similarly, a reduction in metabolic 
blockade probably determines for 
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activity after £ 1-adrenoceptor 
a major part the coronary 
vasoconstriction observed in the present study after atenolol 
administration. The favourable blood flow redistribution towards 
the endocardium after P-adrenoceptor blockade has been reported 
earlier (Saxena, 1983). An increase in diastolic perfusion time 
and a decrease in myocardial wall stress after atenolol are 
possible explanations for this phenomenon (Thomas et al., 1981; 
Saxena, 1983). Moreover, the increase in the 
endocardial/epicardial blood flow ratio after atenolol completely 
abolished the negative effect of hydralazine on this parameter. 
This important observation indicates that S-adrenoceptor 
antagonists not only oppose the hydralazine-induced cardiac 
stimulation, but may also prevent the potentially injurious 
effects of hydralazine on regional myocardial blood supply which 
has been associated with the precipitation of myocardial ischaemia 
after treatment with arterial vasodilators. 
Pronounced vasodilatation after hydralazine was also observed 
in the brain, kidneys, diaphragm, chest wall and large intestine. 
Because a strong cerebral autoregulation has been demonstrated, it 
is possible that an increase in metabolic activity in certain 
regions of the brain, for instance in the cardio-acceleration 
and/or vasomotor centres in medulla and pons, contributed to the 
large increase in blood flow to cerebellum and 
hydralazine. Autoregulatory mechanisms possibly 
brainstem after 
also participated 
in the hydralazine-induced vasodilatation in diaphragm and chest 
wall, because an increase in ventilation after hydralazine has 
been reported previously (Johnston, 1975) and is also indicated in 
the present study by the rise in P0 and fall in PCO observed 
after hydralazine administration. 2 2 
The complete absence of the vasodilator actions of 
hydralazine in skin, stomach and small intestine may be attributed 
to the activation of cardiovascular reflex mechanisms. 
Reflex-mediated vasoconstrictor responses, due to an enhanced 
sympathetic vascular tone and circulating catecholamines, oppose 
the direct vasodilator actions of hydralazine. In addition, it 
has been shown that even in acute experiments the activation of 
the renin-angiotensin system contributes to the reflex-mediated 
changes in 
blood flow 
observed 
vascular tone (Gutkin et al~, 1977). A decrease in 
to the skin and stomach after hydralazine has also been 
in anaesthetized rabbits (Johnston, 1975) and in 
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conscious spontaneously hypertensive rats (Pegram et al., 1982). 
In contrast, a generalized vasodilator response after hydralazine 
administration which included the femoral and mesenteric vascular 
beds has been reported in studies on blood prefused circulations 
isolated from the autonomic nervous system in rats (Sakai et al., 
l980)-
A tendency for vascular conductance to increase was observed 
after hydralazine administration in the skeletal muscles and 
bones~ spokas and Wang (1980), observing a moderate 
vasodilatation in the femoral vascular bed of conscious dogs only 
at low, non-hypotensive, doses of hydralazine, suggested that with 
hypotension reflex-mediated vasoconstriction might off-set the 
direct femoral vasodilating action of hydralazine. In contrast 
with the effects of hydralazine alone, the low hydralazine dose 
caused an immediate further reduction in blood pressure when given 
after atenolol in the hypertensive rabbits. Hence, a more 
pronounced reflex-mediated vasoconstrictor respons can be expected 
which is compatible with the significantly different response in 
the skeletal muscles after combined treatment with atenolol and 
hydralazine. In addition, although atenolol is known as a s 1 
selective adrenoceptor antagonist, a partial blockade of vascular 
£ 2 receptors in skeletal muscles resulting in an accentuation of 
the -ceflex-mediated vasoconstrictor -response, due to "unopposed" 
a-adrenoceptor stimulation, cannot be excluded (Gutkin et al., 
1977) and may contribute to the complete absence of the 
vasodilator response in the skeletal muscles after combined 
treatment. 
[n conclusion, cardiovascular reflex mechanisms and tissue 
autoregulation play an important role in the observed systemic and 
regional haemodynamic effects of hydralazine and atenolol in 
conscious renal hypertensive rabbits. The cardioselective 
e-adrenoceptor antagonist inhibited the hydralazine-induced 
cardiac stimulation and thereby accentuated the hypotensive effect 
of the arterial vasodilator. With higher hydralazine doses the 
synergistic effect on the blood pressure response disappeared, due 
to an increase in cardiac output, despite effective S-adrenoceptor 
blockade~ Moreover, atenolol indirectly reduced the peripheral 
vasodilator effects of hydralazine in certain vascular beds. 
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Finally, atenolol abolished the potentially injurious effects of 
hydralazine on regional blood flow distribution in the left 
ventricular wall. 
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CHAPTER 6: 
HAEMODYNAMIC PROFILE OF FELODIPINE, A NEW CALCIUM l\NTAGONIST, 
IN CONSCIOUS HYPERTENSIVE RABBITS 
The radioactive m.icrosphere technique was used to study the acute systemic 
and regiona~ ha.emodynamic effects of felodipi.ne {3, 10 and 30 p..gfkg, t..v.) in 
conscious rabbits with bilateral cellophane perinephritis hypertension. A 
dose-dependent decrease in arterl.al blood pressure was observed after felodipine 
administration, accompanied by tachycardia. cardiac output increased 
significantly after the thi.rd felodipine dose. Thus, the hypotensive effect of 
the drug resulted from a reduction in total peripheral resistance. 
Pelodipine increased the blood flow to the heart. However, probably 
secondary to the reduction in diastolic perfusion time, a decrease in the 
endocardial/epicardial blood flow ratio was noticed in the left ventricular 
wall. The drug also enhanced the blood supply to the brain, the 
gastro-intestinal tract and, at higher do!:ies, to the Skeleta1 m.uscl.es while that 
to the kidneys and the bones remained unChanged. After the highest dose of 
felodipine a significant decrease in the blood flow to the Skin was measured. 
With the exception of the cutaneous vascular bed, felodipine caused a rather 
generalized peripheral vasodilatation. 
rn conclusion, felodipine appears to be a very effective antihypertensive 
agent. However, the st~lation of the heart and the unfavourable regional 
blood flow distribution in the left ventricular wall illustrate the negative 
aspects of single treatment with this arterial vasodilator. 
Calcium entry blockers are a heterogeneous group of compounds 
which share the common ability to relax vascular smooth muscle, 
decrease pacemaker activity and reduce cardiac muscle force 
development (Fleckenstein, 1977; Naylor, 1983; Saini, 1984). 
Because the antihypertensive property of calcium entry blockers is 
based upon the decrease in total peripheral resistance induced by 
these agents, efforts have been made to synthesize new compounds, 
which show selectivity for vascular smooth muscle. This has led 
to the development of felodipine, a new dihydropyridine derivative 
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Nifedipine Felodipine 
Ftgu:re I. structu:ra~ fonrru~ae of nf..fed:i.pin.e ana fe~odtpi,ne. 
with a structure resembling that of nifedipine (figure 1). The 
vasodilator potency of the compound appears to be 100 times 
greater than its negative inotropic potency as was shown in a 
comparative study on the isolated rat portal vein and rat 
papillary muscle (Ljung, 1980). Since considerable heterogeneity 
in the affinity of different vascular smooth muscle preparations 
for calcium entry blockers has been demonstrated (Vanhoutte, 1982; 
Naylor, 1983), we have studied the systemic as well as regional 
haemodynamic effects of felodipine in conscious renal hypertensive 
rabbits using the radioactive microsphere technique. The data 
presented in this chapter have been published elsewhere (Bolt and 
Saxena, l983a; Bolt and Saxena, l984a). 
METHODS 
Animals and surgical procedures 
Experiments were performed on 10 male hypertensive New 
zealand White rabbits (2.9 ± 0.1 kg). Hypertension was induced by 
bilateral cellophane wrapping of the kidneys according to the 
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method of Page (1939), 6-10 weeks before the experiment. Nine to 
forteen days before the experiment a left-sided thoracotomy was 
performed in order to cannulate the left atrial appendage with a 
nylon catheter for the administration of microspheres (Warren and 
Ledingham, 1972). Subsequently, 4-8 days before the experiment 
the left carotid artery was cannulated for the measurement of 
blood pressure and heart rate during the experiments and the 
withdrawal of arterial blood samples. The different surgical 
procedures have been described in detail elsewhere (Bolt and 
Saxena, 1983b; Bolt and Saxena, 1984b; chapter 2 and 3). 
Measurement of haemodynamic variables 
On the day of the experiment the animals were placed in a 
rabbit restrainer box. A Statham P23Dc pressure transducer was 
connected to the carotid catheter for the recording of the 
arterial blood pressure and the 
polygraph. Mean blood pressure 
heart rate, using a Grass model 7 
was obtained by electronically 
damping of the blood pressure signals. 
Cardiac output and regional blood flows were measured with 
the radioactive microsphere technique, using the reference blood 
sample method (Hales, 1974; Heymann et al., 1977). Nen-Trac 
microspheres were used with a nominal diameter of 15 ~ and 
labelled with either 141ce, 113sn, 103Ru, 95Nb or 46sc. Cardiac 
output (ml/min) and regional blood flows (ml/min) were calculated 
using a set of computer programs especially designed for the 
radioactive microsphere technique (Saxena et al., 1980; relevant 
information is given in chapter 2). Peripheral vascular 
conductances were obtained by dividing respective tissue blood 
flows (ml(min) by mean arterial blood pressure (mmHg). 
Experimental protocol 
The marginal ear vein was cannulated under local anaesthesia 
(lidocaine 2%) for the administration of felodipine (Astra 
Pharmaceuticals AS, Molndal, sweden). After a stabilization 
period of at least 30 minutes, the first batch of microspheres was 
injected to determine baseline values of cardiac output and 
regional haemodynamic variables. Heart rate and blood pressure 
values were recorded continuously. After measuring baseline 
values each animal received 3 cumulative doses (3, 10 and 30 
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~g/kg) of felodipine dissolved in 10% polyethyleneglycol. Ten 
minutes after each dose a batch of microspheres was injected. An 
at:ter ial blood sample ( 0. 3 ml) was withdrawn just before each 
microsphere injection to measure pH-r 
an ABL-2 (Radiometer; copenhagen). 
Pea - and P0 -values; using 2 2 
Statistical evaluation 
All data have been expressed as mean (XSEM) in the text. Due 
to skewed distribution and lack of homogeneity of variances in 
some variables; we used non-parametric tests (Siegelr 1956). 
Initially, the Friedman's two way analysis of vat:iance was used to 
establish whether the samples represented different populations. 
haemodynamic 
separately 
variables from the baseline values 
in each the 
The changes in 
were calculated 
"significance" (p ( 0.05, two-tailed) 
experiment and 
of these changes was 
determined by using the Wilcoxon matched-pairs signed-ranks test. 
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Figure 2. Effec~s of fe~odtptne (3, 10 and 30 ~g/kg, t.v.) on mean ar~ertat 
btooa pressure (MBP) ana he~ r~e (BR) in conscious renaL hyper~enstve rabbt~s 
(n=10). 
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RESULTS 
Blood gases 
The effects of felodipine, 3, 10 and 30 ~g/kg, on pH-, PCO -
and P0 -values were measured 10 minutes after the i~~· 
administtation of the drug in the conscious renal hypertensive 
rabbits. Mean values were for pH: 7.44 ± 0.04, 7.45 ± 0.03, 7.45 
± 0.04 and 7.45 ± 0.04, for Pco , 43 ± 2, 42 ± 4, 42 ± 3 and 39 ± 
3 mmHg and for P0 ' 83 ± 3, 85
2
± 3, 87 ± 3 and 94 ± 4 mmHg before 
and after the ~ successive doses, respectively. Only the 
P0 -value was significantly increased after the highest felodipine do~e-
Systemic haemodynamic variables 
Figure 2 illustrates that within 2 minutes after the i.v. 
administration of felodipine in conscious renal hypertensive 
rabbits the maximum effect on blood pressure was reached. The 
hypotensive effect remained stable for at least 10 minutes and was 
accompanied by an increase in heart rate. 
Tab~e 1 shows the changes in systolic and diastolic blood 
TABLE 1. Effects of felodip1ne on systemic haemodynam1cs 10 minutes after i.v. 
administration in conscious renal hypertensive rabbits ( n=S). 
ARTERIAL BLOOD PRESSURE 
systol.ic ( tomB:g) 
diastolic ( mmHg) 
HEART RATE 
(beats/min) 
CARDIAC OUTPtrl' 
(ml./min) 
STROKE VOLUME 
(ml) 
Baseline 
139 ± 5 
113 ± 5 
231 ± 14 
477 ± 56 
2.1 ± 0.2 
TOTAL PERIPHE~l RESI&rANCE 
(tmllHgjl.min ) 290 ± 33 
Felodipine ( p.gfkg): 
3 
133 ± 4 
108 ± 6 
277 ± 11 
514 ± 51 
• 
1.8 ± 0.2 
248 ± 25 
10 
• 112 ± 7.,. 
89 + 6 
• 300 ± 13 
590 ± 66 
2.0 ± 0.2 
• 187 ± 26 
30 
• 91 ± 61t" 
66 ± 4 
• 304 ± 14 
• 696 ± 99 
2.2 ± 0.3 
• 128 ± 19 
--------------------------
.,., significantly different from baseline values (p < o.os). 
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pressure, heart rate, cardiac output, stroke volume and total 
peripheral resistance, 10 minutes after the administration of the 
3 successive felodipine doses. The hypotensive effect of the drug 
resulted from a dose-dependent decrease in total peripheral 
resistance. After the highest felodipine dose a significant 
increase in cardiac output was measured; stroke volume did not 
change significantly. 
Regional haemodynamic variables 
Figure 3 shows the effects of felodipine on regional blood 
flows measured ten minutes after the administration of the drug in 
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(ml/min) 
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~gure 3. Effec~s of tetoatptne (3, 10 ana 30 M9/kg, t.v.) on regtonat btooa 
tto~s (mt/mtn) tn conscious renat hyper~enstve rabbt~s (n=8). Do~~ea bars, 
baseLine vatues; open bars, vatues 10 mtnu~es aj~er ~he successive tetoatptne 
aoses; *, stgntttcan~ty differen~ from basettne vatues (p < 0.05); G!T, 
gas~ro-tn~es~tnat ~rae~; AVA+BB, ar~eriovenous anas~omoses + bronchiat vascutar 
bed. 
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the conscious animals- A la~ge increase in blood flow was 
observed in the heart, the gastro-intestinal tract and, after the 
highest dose, in the skeletal muscles. Felodipine also increased 
blood supply to the brain, although this organ received only a 
small part of total cardiac output. Blood flows to the kidneys 
and the bones we~e not effected by the drug. In the skin a 
significant reduction in blood flow was measured after felodipine 
30 p.g/kg. As the lungs receive microspheres via bronchial 
arteries as well as peripheral arteriovenous anastomoses, the 
blood flow values represent a combination of bronchial and 
arteriovenous anastomotic flow. The decrease in this variable 
observed with felodipine did not reach a significant level. 
Figure 4 shows that a redistribution of the myoca~dial blood 
flow was observed after felodipine; the increase in blood flow 
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81 
was most pronounced in the 
wall. This resulted in 
outer layers of the left ventricular 
a reduction of the weight-normalized 
endocardial/epicardial blood flow ratio, which decreased from 1.42 
.± 0.08 to 1.32 .± 0.10 (p > 0.05), 1.15 .± 0.11 (p < 0.05) and 0.91 
± 0.07 (p < 0.05), respectively, after the 3 successive felodipine 
doses. 
A rather generalized vasodilatation (increased vascular 
conductance) was observed after the i.v. administration of 
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felodipine (figure 5). The changes in vascular conductance were 
most pronounced in the heart, brain, gastro-intestinal tract and 
skeletal muscles. A relatively smaller but still significant 
increase was noticed in the kidneys and bones. In the heart and 
brain a significant increase in vascular conductance was already 
measured with felodipine, 
vasodilatation could only 
3 ~g/kg, while in the skeletal muscles 
be observed at higher doses. The 
changes in vascular conductance in the skin and in the combination 
of bronchial bed and arteriovenous anastomoses were also not 
significant. 
DISCUSSION 
Using the radioactive microsphere technique we studied the 
acute systemic and regional haemodynamic effects of felodipine. A 
dose-dependent decrease in arterial blood pressure accompanied by 
an increase in heart rate was measured after the i.v. 
the conscious renal hypertensive administration of the drug in 
rabbits. The latter effect was probably due to an increased 
sympathetic activity and a withdrawal of the vagal tone as a 
result of the hypotension-induced activation of the baroreceptor 
reflex (Nakaya et al., 1983; Saini, 1984). Especially at higher 
doses, felodipine increased the cardiac output. Thus, the 
hypotensive effect of felodipine resulted from a dose-dependent 
decrease in total peripheral resistance. 
A rather 
after the 
hypertensive 
sympathetic 
generalized peripheral vasodilatation was observed 
administration of felodipine in 
rabbits. Because in the intact 
the conscious 
organism the 
nervous system is the most important determinant of 
vascular function (Vanhoutte, 1981) it is remarkable that, despite 
the large reduction in arterial pressure and the resultant 
reflex-mediated increase in sympathetic tone, no compensatory 
vasoconstriction could be observed with felodipine in any of the 
organs selected for flow measurement. This is in contrast to the 
effects of acute administration of the arterial vasodilator 
hydralazine in conscious hypertensive rabbits where, in addition 
to a vasodilator response in most organs and tissues, a 
vasoconstriction was noticed in the skin, stomach and small 
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intestine (Bolt and Saxena, 1984b). Thus, when compaxed with 
hydralazine, felodipine appears to be a more potent vasodilatox. 
In addition, calcium entry blockers inhibit the contractions 
evoked by most natuxally occurring vasoconstrictor substances 
(Vanhoutte, 1982), which possibly explains the absence of a 
reflex-mediated vasoconstrictor response in the present study. 
Apart from a direct effect of felodipine on the coronary 
vasculature, a metabolic autoregulatory vasodilatation, secondary 
to the cardiac stimulation, possibly contributed to the enhanced 
blood supply to the heart. However, on the other hand, a decrease 
in myocardial oxygen consumption is caused by the 
felodipine-induced xeduction in afterload. Moreovex, after 
intracoronary administration of felodipine in anaesthetized pigs, 
Verdouw et al. (1983) noticed a large decrease in myocardial 
o2-extraction despite minimal changes in myocardial o2-demand, 
suggesting that a possible direct effect of the drug on myocardial 
metabolism is involved as well. Felodipine preferentially 
increased blood flow to the outer layers of the left ventricular 
wall, which resulted in a reduction in the endocardial/epicardial 
blood flow ratio. This phenomenon, which has been associated with 
the precipitation of myocardial ischaemia after treatment with 
arterial vasodilators especially in palicnts wlth limited coronary 
reserve, is probably related to the decrease 
perfusion time that results from the increase 
in diastolic 
in heart rate 
(Boudoulais et al., 1979). Indeed, pretreatment with the 
ca~diose~ective beta-adrenoceptor antagonist atenolol not only 
inhibited the reflex tachycardia observed after hydralazine 
administration in conscious hypertensive rabbits, but also 
prevented the negative effect of this arterial vasodilator on the 
endocardial/epicardial blood flow ratio in the left ventricular 
wa~l (Bolt and Saxena, 1984b). 
Because a strong autoregulatory mechanism has also been 
demonstrated in the brain, it is possible that an increase in 
cerebral metabolism contributed to the pronounced increase in 
cerebral blood flow. However, Haws et al. (1983) noticed a 
similar increase in cerebral blood supply with no change in 
cexebral o 2-consumption after the acute administration of 
nimodipine in anaesthetized rabbits, suggesting that the strong 
vasodilator potency of the dihydropyridine was due to a direct 
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effect on vascular muscle rather than to cerebral autoregulation. 
Felodipine did not change renal blood flow and a relatively small 
vasodilatation was observed in the renal vascular bed. Minor 
effects on renal blood flow have also been reported for nifedipine 
and PY 108-068 in anaesthetized cats (Hof et al., 1982), for 
diltiazem in conscious rats (Flaim and Zelis, 1982) and for 
nimodipine in conscious rabbits (Haws et al., 1983). Also in the 
gastro-intestinal tract and the skeletal muscles pronounced 
vasodilatation was observed, however, especially in the skeletal 
muscles higher doses were needed to obtain significant changes. 
This is compatible with the reported differences in affinity of 
smooth muscles of different vascular beds for calcium entry 
blockers (Mullett et al., 1983). 
Felodipine did not significantly change the vascular 
conductance in the skin. Moreover, a decrease in arterial blood 
supply to the skin was measured after the third felodipine dose. 
The relative insensitivity of the cutaneous vascular bed to 
calcium entry blockers has been reported previously (Vanhoutte and 
Rimele, 1982). Similarly, the combined arteriovenous anastomotic 
and bronchial artery flow decreased after felodipine 
administration although significant levels were 
Considering the small contribution of the bronchial 
not reached. 
vascular bed 
in the total circulation (Warren and Ledingham, 1974; Saxena and 
verdouw; 1982) this may indicate a reduction in the arteriovenous 
shunting of blood via arteriovenous anastomoses. Similar effects 
have been reported for nifedipine and PY 108-068 in anaesthetized 
cats (Hof et al., 1982). 
Finally, considering the similarities between the regional 
haemodynamic profiles of felodipine and that of other, 
structurally related (nimodipine, PY 108-068 and nifedipine) and 
unrelated (diltiazem) calcium antagonists, a similar mechanism of 
action is probably involved in the vascular effects of these 
agents. In addition to the blockade of the voltage-dependent 
ca2+ channel (Fleckenstein, 1977), several investigators have 
suggested an intracellular site of action for some of these 
compounds. BostrOm et al. (1980), who demonstrated binding to 
calmodulin by felodipine, have suggested that the dihydropyridine 
may exert its vascular effects by inhibiting calmodulin-dependent 
myosin light chain kinase activity (Herzig, 1984) rather than by a 
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blockade of calcium influx across the sarcolemma. However , the 
necessary to demonstrate this relatively high concentrations 
intracellular action makes its 
doubtful (Sa ida and Van Breemen, 
pharmacological 
1983). Moreover, 
significance 
it has been 
shown that calmodulin binding is not necessarily related to 
inhibition of smooth muscle myosin light chain kinase activity 
(Silver et al., 1984). Thus, an inhibitory effect on ca2+-fluxes 
across the sarcolemma, as proposed by Fleckenstein (1977), is 
still the most likely mechanism responsible for the vascular 
smooth muscle relaxing potency of felodipine as well as other 
calcium antagonists. 
In conclusion, felodipine appears to 
antihypertensive agent. However, the 
accompanied by the preferential increase in 
be an effective 
cardiac stimulation 
blood flow to the 
outer layers of the left ventricular wall illustrated the negative 
aspects of single treatment with this arterial vasodilator. 
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CHAPTER 7, 
HAEMODYNAMIC PROFILE OF PRAZOSIN IN CONSCIOGS HYPERTENSIVE RABBITS 
The radioactive m:icrosphere technique was used to study the acute system.:ic 
and regional haemodynami.c effects of prazosin (O.o~. o.03 and 0.10 mgjkg, t..v.) 
in conscious hypertensive rabbits. The a 1-adrenoceptor antagonist decreased the 
arterial blood pressure dose-dependently and increased the heart rate. A 
reduction in strOke volume was measured which resulted in a moderate but 
significant fall in cardiac output at the highest dose of prazosin. 
Due to the prazosin-'induced. vasodilatation i.n the kidneys, intestines and 
bones, the blood flow to these tissues was not reduced deSJ?ite the decrease in 
cardiac output. In contrast, a reduction in the blood flow to the skeletal 
muscles, skin and, at the highest dose, to the heart, brain and stomach was 
measured after prazosin administration. 
In conclusion, the selective vasodilatation produced by prazosin causes a 
redistribution of the cardiac output at the expense of vital organs such as the 
brai.n, a finding which may possibly explain the symptoms related to the first 
dose phenomenon of prazosin in man. 
Prazosin is an antihypertensive agent that is believed to act 
through a blockade of postsynaptic a 1-adrenoceptors (Cavero and 
Roach, 1980; Stanaszek et al.~ 1983). When compared with a 
nonselective a-adrenoceptor antagonist, such as phentolamine, 
relatively minor changes in heart rate and renin activity are 
observed at hypotensive doses of prazosin (Massingham and Hayden, 
1975; Graham and Pettinger, 1979). This has been associated with 
the failure of prazosin 
thereby leaving unaffected 
to block presynaptic a 2-adrenoceptors 
the negative feedback mechanism by 
which noradrenaline regulates its own release from synaptic nerve 
endings (Cambridge et al.~ 1977). 
Relatively little attention has been paid to the peripheral 
vascular effects of the a1 -adrenoceptor 
obtained from in-vitro studies indicate that 
antagonist. Results 
differences exist in 
the sensitivity of various vascular 
actions of prazosin (Jauernig et al., 
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beds to the sympatholytic 
1978). Moreover, in-vivo 
the effects of the a~-ad~enoceptor antagonist may vary in the 
different organs and tissues depending upon the basal sympathetic 
tone in the respective vascular beds~ The heterogeneity in the 
vascular response which may result in a redistribution of the 
cardiac output has been used as a possible explanation for the 
serious side effects such as dizziness and even loss of 
consciousness observed after the acute administration of prazosin 
in man, often refe~red to as the "first dose phenomenon" (Moulds 
and Jauernig, 1977)~ Therefore, we studied the acute effects of 
prazosin on systemic as well as regional haemodynamic variables in 
conscious rabbits with bilateral cellophane perinephritis 
hypertension using the radioactive microsphere technique~ The 
data presented in this chapter have been published elsewhere (Bolt 
and Saxena, 1984a). 
MATERIALS AND METHODS 
Animals and surgical procedures 
Experiments were performed on ten male hypertensive New 
Zealand White rabbits (3.4 ± 0.1 kg)~ Hypertension was induced by 
bilateral cellophane wrapping of the kidneys, six to ten weeks 
before the experiment, according to the method of Page (~939). 
Nine to fourteen days before the experiment a left-sided 
thoracotomy was 
appendage with 
performed in order to cannulate the left atrial 
a nylon catheter for the administration of 
microspheres (Warren and Ledingham, 1972). subsequently, four to 
eight days before the expe~iment the left carotid artery was 
cannulated for the measurement of blood pressure and heart rate 
during the experiments and the withdrawal of arterial blood 
samples. The different surgical procedures have been described in 
detail elsewhere (Bolt and Saxena, 1983; chapter 2 and 3 of this 
thesis). 
Measurement of haemodynamic variables 
On the day of the experiment the animals were placed in a 
rabbit restrainer box~ A Statham P23Dc pressure transducer was 
connected to the carotid catheter for the recording of the 
arterial blood pressure and the hea~t ~ate using a Grass model 7 
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po]._ygzaph. Mean 
damping of the 
regional blood 
blood pressure was obtained 
blood pressure signals. 
flows were measured with 
by electronically 
cardiac output and 
the radioactive 
microsphere technique, using 
(Hales, 1974; Heymann et al., 
the reference blood sample method 
1977). Nen-Trac microspheres with 
± ]._ (SD) ""' and l,_abel,_ed with eithex 
46sc were used. Cardiac output 
a nominal diameter of 15 
l,_4J._C H3S W3R 95Nb e, n, u, or 
(ml/min) and regional blood flows (ml/min) were calculated using a 
set of computer programs especially designed for the radioactive 
microsphere technique (Saxena et al., 1980; relevant information 
is given in chapter 2). Peripheral vascular conductances were 
obtained by dividing respective tissue blood flows (ml/min) by 
mean arterial blood pressure (mmHg)~ 
Experimental protocol 
The marginal ear vein was cannulated under local anaesthesia 
(lidocaine 2%) for the administ~ation of prazosin HCl (Pfize~ 
B~V~, Rotte~dam)~ The compound was dissolved in distilled water~ 
The concent~ations we~e such that the maximum injection volume was 
less than 0~5 ml~ After a stabilization pe~iod of at least 30 
minutes the first batch of microspheres was injected to determine 
baseline values of cardiac output and ~egional haemodynamic 
variables~ Heart rate and a~terial blood pressure values were 
recorded continuously~ After measuring baseline values each 
animal received three cumulative doses (0~01, 0~03 and 0~10 mg/kg) 
of prazosin at 20 minutes intervals~ Fifteen minutes after each 
dose a batch of microspheres was injected~ An arterial blood 
sample (0~3 ml) was withdrawn immediatly after each microsphere 
injection to measure pH-, PCO - and P0 -values, using an ABL-2 
(Radiometer, Copenhagen)~ 2 2 
statistica~ evaluation 
All data have been expressed as mean (±SEM) in the text~ Due 
to skewed distribution and lack of homogeneity of variances in 
some variables, non-parametric tests were used for the statistical 
evaluation (Siegel, 1956). Initially, the Friedman's two way 
analysis of variance was used to establish whether the samples 
represented different populations~ 
signed ranks test was applied to 
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The 
test 
Wilcoxon matched-pairs 
the nsignificance" 
(P < 0~05, two-tailed) of the changes in haemodynamic variables 
from baseline values~ 
RESULTS 
Blood gases 
Values of arterial blood gases and pH were not affected by 
prazosin~ .Before and 15 minutes after the successive doses of 
prazosin (0~01, 0.03 and 0~10 mg/kg) the respective values were: 
pH, 7.44 ± 0.01. 7.46 ± 0.01, 7.46 ± 0.01 and 7.45 ± 0.01; Pco • 
31 ± 2, 31 ± 2, 34 ± 2 and 33 ± 2 rnmHg; and P0 , 91 ± 2, 91 ± ~. 
89 ± 2 and 90 ± 3 rnmHg _ 2 
beats/min 
340 
260 
mmHg 
160 
prazosin0.01 
0 
0.03 
20 
r 
HR 
0.10 mgjkg 
40 60min 
~gure 1. Ttme course Of hear~ rate (BR), systoLic (SBP) ana dias~oLic (DBP) 
bLood pressure responses after t.v. a.aministration of prazosin, 0.01, 0.03 ana 
0.10 mgjkg, in conscious hypertensive rabbi~s (n=IO). 
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Systemic haemodynamic variab~es 
Figu~e l shows the time cou~se of the prazosin-induced 
changes in hea~t ~ate, systolic and diastolic arterial blood 
pressures. A dose dependent decrease in blood pressure 
accompanied by an increase in heart rate was observed with 
prazosin. The latter effect reached a maximum within the first 
five minutes after each prazosin administration (+19 i 3%, 
+21 ± 3% and +20 ±3% above baseline level, respectively) and then 
gradually declined. Figure 2 shows the changes in systemic 
haemodynamic variables 15 minutes after the successive doses of 
prazosin (0.01, 0.03 and 0.10 mgjkg). Despite the increase in 
heart rate a significant reduction in cardiac output was measured 
at the highest prazosin dose due to a decrease in stroke volume. 
The a 1-adrenoceptor antagonist decreased the total peripheral 
resistance dose-dependently. 
%change 
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Figure 2. Percen-tage change tn sys-temi-c haemodynamt.c vart.cwr..es measured 15 
mtnu-tes af-ter "the i.v. aamint.s"tra"ti.on of prazosi-n, 0.01, 0.03 ana 0.10 mg/kg, 
respec"ttver..y, tn consci-ous hyper-tensi-ve rabbi--ts (n~10). MBP, mean bl-ood 
pressure (132 ± 4 mmBg); ffR, hear-t ra-te (270 ± 11 bea-ts;mt.n); CO, cardi-ac 
ou-tpu-t (556 ± 31 mr..;min); SV, s-troke vor..ume _f2.1 ± 0.2 mr..); TPR, -to-tar. 
pertpherar.. rest.s"tance (24~ ± 25 mmBg/L.mtn ); be"t~een bracke-ts: baseLi-ne 
vaLues; ~, stgnt.ft.cant change from baseLtne vaLues (P < 0.05). 
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Regional haemodynamic variables 
Figu~e 3 shows the changes in regional blood flows to the 
different organs and tissues measu~ed 15 minutes after the 
successive prazosin administrations (0.01, 0.03 and 0.10 mg/kg) in 
the conscious hypertensive rabbits. Despite the decrease in 
cardiac output, the blood supply to the intestines, kidneys and 
bones was not reduced. As the lungs receive 15 ~ microspheres 
via peripheral arte~iovenous anastomoses as well as bronchial 
arteries, the obtained blood flow values represent the combination 
of arteriovenous anastomotic and bronchial flow. No alteration 
was noticed in this variable. After the second and third dose of 
prazosin a significant decrease in blood flow to the skeletal 
muscles (-16 .± 5% and -21 .± 8%, respectively) and the skin 
(-12 .± 4% and -17 .± 7%, respectively) was measured. At the 
highest dose blood flow was also significantly reduced in the 
blood flow 
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Fi.gure 3. Effect;s of prazostn on reg'Lonat btooa f'Lous (m'L/mtn) tn consct.ous 
11ypert.enst:.ve rabbi.t;s (rt-10). .Do'ttea bars, basel.t.ne val.ues; open bars, vatues 
15 mi.nu~s after prazosi.n, 0.01, 0.03 ana 0.10 mgjkg, respectt.vety;- AVA ~ BB, 
ar~r'Lovenous anastomoses ~bronchi-at vascutar bea; ~, si.gnt.f'[.cant; c11ange trom 
basel.t:.ne vatues (P < 0.05). 
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stomach (-22 i 5%), heart (-11 i 5%) and brain (-15±6%). 
Remarkab~y, in the brain on~y the b~ood f~ow to the cerebra~ 
hemispheres was significant~y ~owered by prazosin, 0.~0 mg/kg, 
(-18 i 5%) whereas that to the cerebe~~um and brain stem was not 
significantly changed (-5 i 9% and 
Similar~y, in the heart only the 
ventricu~at: wall (-12 i 5%) and 
+1 .± 10%, respectively). 
blood flows to the left 
intra-ventricu~ar septum 
(-12 _t 4%) were significantly reduced at the 
whereas blood flows to atr ia ( -1 .± 16%) 
(-6 .± 5%) were not significantly affected. 
highest prazosin dose 
and right ventricle 
vascular conductance 
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Figure 4. Effec-t;.s of prazostn on regionaL vascuLar conduc-tances tn percent:.age 
change from baseLine vaLues 15 minu-tes aft;.er t:.he i.v. admtnis'tra'tion of 
prazostn~ 0.01, 0.03 and 0.10 mg/kg, respect:.tvety, tn consctous hypert:.ensive 
rabbit;.s (n~10). AVA+ BB, art:.eriovenous anas-tomoses+ bronchi-at vascuLar bed; 
~,signi-ficant;. change from basettne vaLues (P < 0.05). 
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Figure 4 shows that prazosin produced a significant 
vasodilatation (increase in vascular conductance) in the 
intestines, kidneys and bones. The mean vascular conductance of 
arteriovenous anastomoses + bronchial vascular bed also increased, 
however, the changes were 
significantly affect the 
not significant. Prazosin did not 
vascular conductance in the different 
regions of the brain. In the heart a 
conductance to increase was noticed. 
tendency for the vascular 
A significant vasodilatation 
was measured after the second and third prazosin dose in the right 
ventricle where the vascular conductance increased by 19 ± 6% and 
22 ± 6%, respectively. Prazosin did not significantly alter the 
vascular conductance in the atria, the left ventricle or the 
intra-ventricular septum. 
DISCUSSION 
Using the radioactive microsphere technique we studied the 
acute haemodynamic profile of prazosin in conscious hypertensive 
rabbits. A dose-dependent decrease in arterial blood pressure 
accompanied by an increase in heart rate was measured after the 
acute administration of the a 1-adrenoceptor antagonist. The 
latter effect is probably due to a reflex-mediated increase in 
sympathetic activity and a withdrawal of the vagal tone as a 
result of a decrease in firing frequency of baroreceptors since in 
sinoaortic denervated rabbits the tachycardia produced by prazosin 
was greatly diminished and no longer significant (Hamilton et al., 
1982). The cardiac stimulation observed in the present study 
attained a peak value within a few minutes after each prazosin 
administration. Subsequently, a decline was observed during the 
following 15 minutes despite the persistance of pronounced 
hypotension. A similar response was observed by Cavero (1982) 
after a constant infusion of prazosin in conscious normotensive 
rabbits. As reported previously for normotensive rabbits 
(Hamilton et al., 1982), the maximal increase in heart rate 
produced by prazosin was still less than that observed after the 
acute administration of more selective arterial vasodilators, such 
as hydralazine (Bolt 
Saxena, l984c), 
and Saxena, l984b) 
in rabbits with 
and felodipine (Bolt and 
cellophane perinephritic 
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hypertension. McCall and Humphrey (1981) have reported a central 
action of prazosin in anaesthetized cats where the drug caused a 
reduction in sympathetic nervous discharge. Thus it is possible 
that this central action partly opposes the baroreceptor-induced 
changes in autonomic nervous system activity. In addition, the 
rather moderate reflex tachycardia observed with prazosin may be 
related to dilatation of venous capacitance vessels (Patel, 1981; 
Schultz and Westfall, 1982) which results in a decrease in venous 
return. In contrast, an increase in venous return is usually 
measured with more selective arterial vasodilators which leads to 
an activation of atrial stretch receptors (Bainbridge reflex) and 
thereby contributes to the positive chronotropic effects observed 
with these agents (Cavero and Roach, 1980; spokas and Wang, 
1980). The decrease in cardiac output and stroke volume observed 
in the present study can also be attributed to the 
prazosin-induced dilatation of the venous capacitance vessels and 
the subsequent reduction in venous retut:n. Pt:azosin produced a 
dose-dependent 
illustrates the 
decrease in total peripheral 
vasodilatory action of the 
xesistance which 
a 1-adxenoceptox 
antagonist on arterial resistance vessels. 
The fall in cardiac output observed at the 
doses did not result in a generalized reduction 
higher prazosin 
in blood flow to 
the different organs 
blood received by 
and tissues. The decrease in the amount of 
the skeletal muscles accounted fot: the majot: 
part 
the 
of the deficit. Prazosin also reduced the blood supply to 
skin and, at the highest dose used, to the heart, brain and 
stomach. The vascular conductance was not significantly affected 
by prazosin in the organs and tissues mentioned. Thus, one might 
conclude that the resting 
beds is low. On the 
vasodilatory effects of 
vascular tone due 
a:1 -adrenergic 
other hand, 
prazosin are 
to tissue 
tone 
it is 
in these 
possible 
vascular 
that the 
obscured by 
autoregulation 
changes 
and 
in 
the 
hypotension-induced activation of cardiovascular reflex mechanisms 
(Reid, 1980). Although vascular a:1 -adrenoceptors are blocked, the 
reflex-mediated increase in sympathetic activity after prazosin 
administration (Reid and Hamilton, 1980) can still induce 
peripheral vasoconstriction via the activation of the 
renin-angiotensin system (Graham and Pettinger, 1979) and the 
stimulation of postsynaptic vascular a 2 -adrenoceptors (Drew and 
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Whiting, l979). In this respect, Horn et al. (l982) noticed a 
relative preponderance of postsynaptic a 2 -adrenoceptors in the 
femoral vascular bed which is in accordance with the absence of a 
vasodilator response of prazosin in the skeletal muscle in the 
present study. 
Especially in the heart the changes in blood supply are 
determined for a major part by changes in metabolic demands (Weber 
and Janicki, 1979). The latter can be predicted, at least to some 
extent, from changes 
Despite the 
in the product of 
decrease in the 
heart rate and systolic 
pressure. 
(-16 ± 2 %) at the 
rate/pressure 
highest dose of prazosin a tendency 
product 
for the 
vascular conductance to increase was observed in the present study 
reaching a significant level in the right ventricle. This 
indicates that a resting a 1 -adrenergic tone is probably present in 
the coronary vascular bed. 
be 
The remarkable reduction in the blood supply to 
related to symptoms such as dizziness and 
the brain may 
even loss of 
consciousness observed after the acute administration of a 
relatively large first dose of prazosin in man (Cavero and Roach, 
1980)- The preferential decrease in blood flow to the higher 
regions of the brain observed in the present study is possibly due 
to differences in basal a 1 -adrenergic tone in the different 
regions of the brain. on the other hand, tissue autoregulatory 
responses, reacting upon a possible increase in metabolic demands 
in certain areas of the brain, may contribute to the regional 
differences observed in the present study. 
Despite the decrease in 
kidneys and intestines 
cardiac output, the blood flow to 
remained unchanged due to 
the 
the 
prazosin-induced vasodilatation in these vascular beds. In the 
bones pronounced vasodilatation was already noticed at low doses 
of prazosin which resulted in an increase in blood flow after the 
first dose of the a 1-adrenenoceptor antagonist in the conscious 
hypertensive rabbits. Apparently a significant a 1-adrenergic tone 
is present in the vascular beds of the kidneys, intestines and 
bones. In addition, in-vitro studies show that in comparison wit~ 
the peripheral vascular beds, the visceral vascular beds are 
relatively more sensitive to the sympatholytic action of prazosin 
(Moulds and Jauernig, 1977). 
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In conclusion, our results indicate that dilatation of both 
arterial resistance vessels and venous capacitance 
vessels -leading to a decrease in total peripheral resistance and 
cardiac ouput, respectively- contribute to the acute hypotensive 
effect of prazosin in the conscious hypertensive rabbit. 
a 1-Adrenoceptor blockade leads to selective vasodilatation in 
kidneys, intestines and bones, thereby maintaining the blood 
supply in these vascular beds within normal limits despite the 
decrease in cardiac output. This, however, is at the expense of 
those vascular beds where.the basal a 1 -adrenergic tone appears to 
be low such as the brain. This latter finding may provide an 
explanation for the acute side effects of prazosin in man, often 
referred to as the first dose phenomenon. 
Bolt, G.R., saxena, P.R. {1983) Systemic and regional hemodynamic 
characteristics of bilateral cellophane perinephritis hypertension in 
conscious rabbits. Cl.in. Exp. Hypert. AS: 885-901. 
Bolt, G.R., saxena, P.R. (1984a) Acute systemic and regional haemodynamic 
profile of prazosin in conscious hypertensive rabbits. Eur. J. Pha.rmacol. 
104: 151-157. 
Bolt, G.R., Saxena, P.R. (1984b) 
regional h~ic effects 
rabbits. J. Pha.rma.coL Exp. 
Interaction of atenolol with the systemic and 
of hydralazine in conscious renal hypertensive 
Ther. 230: 205-213. 
Bolt, G.R., saxena, P.R. (1984C) Acute systemic and regional hemodynamic 
effects of felodipine, a new calcium antagonist, in conscious renal 
hypertensive rabbits. J. Cardiovascular. Pha.rmacol. 6: 707-712. 
CaJCbridge D., Davey, M.J., Ma.ssingham, R. (1977) The pharmacology of 
antihypertensive drugs with special reference to vasodilators, 
alpha-adrenergic bloCking agents and prazosin. Med. J. Aust. Specl. 
suppL 2: 2-6. 
cavero, .1.., Roach, A.G. (1980) The pharmacology of prazosin, 
antihypertensive agent. Life Sci. 27: 1525-1540. 
a novel 
cavero, I. (1982) Effects of prazosin on reflex changes in heart rate evoked by 
vasopressor and vasodepressor stilnuli in conscious rabbits. J. Cardiovasc. 
Phannacol. 4: slOS-sll3. 
Drew, G.M., Whiting, S.B. (1979) 
postsynaptic a-adrenoceptors in 
Pharmacol. 67: 207-215. 
Evidence tor two distinct 
vascular smooth muscle in-vivo. 
types 
Brit. 
of 
J. 
Graham, R.M., Pett:lnger, W.A. ( 1979) Effects of prazosin and phentolamine on 
arterial pressure, heart rate, and renin activity: Evidence in the conscious 
rat for the functional significance of the presynaptic alpha-receptor. J. 
Cardiovasc. Pharmacol. 1: 497-502. 
Hales, J.R.S. (1974) Radioactive microsphere technique for studies of the 
circulation. Clin. Exp. Pha.rmacoL Physiol. suppl l: 31-46. 
98 
Hanri.lton, C.A., Reid, J .L. zamboul.is, c. ( 1982) The role of presynaptic 
<x-adrenoceptors in the regulation of blood pressure in the conscious rabbit. 
Sr. J. Pharmacol. 75: 417424. 
Eleymann, M.A., Payne, B.D. Hoffman, J.I.E. Rudolph, A.M. (1977) Blood flow 
measurements with radionuclide-labelled particles. Progr. cardiovasc. Dis. 
20: 55-79. 
Elorn, P.T., Kohli, J.D. Listinski, J.L. Goldberg, L. (1982) Reg:i.onal 
vari.at:i.on in the a-adrenergic receptors in the canine resistance vessels. 
Naunyn-SChmiedeberg's Arch. Pharmacol. 318: 166-172. 
Jauernig, R.A., Moulds, R.F.W. Shaw, J. (1978) The action of prazosin in human 
vascular preparations. Arch. Int. Pharmacodyn. 231: 81-89. 
Massi.ngham, R., Elayden, M. L. ( 1975) A comparison of the effects of prazosin and 
hydrallazine on blood pressure, heart rate and plasma renin activity in 
conscious renal hypertensive dogs. Eur. J. Pharmacol. 30: 121-124. 
McCal.l, R.B., HUm.phrey, S.J. (1981) Evidence £or a central depressor action of 
postsynaptic a.1-adrenergic antagonists. J. Autonom.. Nerv. Syst. 3 : 9-23. Moulds, R.F.W., Jauernig, R.A. (1977) Mechanism of prazosin collapse. Lancet 
1: ZOD--201. 
Page, I.S:. (1939) Production of persistent hypertension by cellophane 
perinephritis. J. Amer. Med. Ass. 113: 2046-2048. 
Patel, P., Bose, D. Greenway, c. (1981} Effects of prazosin and 
phenoxybenzami.ne on alpha- and beta-receptor-mediated responses in intestinal 
resistance and capacitance vessels. J. cardiovasc. Pha.rmacol. 
3 : lOSQ--1059. 
Reid, J.L. (1980) Vasodilators in the management of hypertension. Progr. 
Pharmacol. 3/4: 77-82. 
Reid, J.L., Ram.i.l.ton, c. (1980} catecholamines and blood 
The role of alpha-adrenoceptors, J. cardiovascular. 
pressure regulation: 
3}: S325-S335. 
Saxena, P.R., Schanlhardt, H. C. 
programs for the radioactive 
Biomed. 12: 63-84. 
Forsyth, R.P. 
m.icrosphere 
Loeve, J. 
technique. 
Pha.rmacol. 2( suppl. 
( 1980) 
Computer 
Computer 
Programs 
SChultz, J.c., westfall, D.P. (1982) A pharmacological analysis of the 
a.-adrenoceptor antagonism by prazosin in arteries and veinS. Blood vessels 
19: 79--87. 
Siegel, S. ( 1956} Non-Parametric Statistics for Behavioural Sciences 
(McGraw-Bill Kogakusha, Tokyo) • 
spokaS, E.G., Wang, a. H. ( 1980) Regional blood flow and cardiac response to 
hydralazine. J. PharmacoJ.. Exp. Ther. 212: 294-303. 
stanaszek, w.F., Kellerman, D. Brogden, R.N. Romankiewicz, J.A. (~983) 
Prazosi.n update, a review of its pharmacological properties and therapeutic 
use in hypertension and congestive heart failure. Drugs 25: 339-384. 
warren, D.J., Ledingham, J .G.G. ( 1972) Chronic left atrial catheterization in 
the rabbit. PflUg. Arch. 335: 167-172. 
Weber, K.T., Janicki, J.S. (1979} The metabolic demand and oxygen supply of the 
heart: Physiological and clinical considerations. JUner. J. cardiol. 
44: 772-729. 
99 
CHAPTER g, 
HAEMODYNAMIC PROFILE AND HYPOTENSIVE MECHANISM OF KETANSERIN 
IN CONSCIOUS HYPERTENSIVE RABBITS 
The radioactive microsphere technique was used to study the systemic and 
regional haemodynami.c effects of ketanserin in conscious renal hypertensive 
rabbits. In order to characterize the hypotensive mechaniSm of the compound, we 
evaluated its antagonism towards 5-hydroxytryptami.ne2 {SHT2 ) and a 1-adrenergic 
receptors at hypotensive doses and compared the cardiovascular profile of 
ketanserin with that of the a 1-selective adrenoceptor antagonist prazosin. 
Ketanserin (O.l., o.3 and LO mgjkg, t..v.) produced a biphasic effect on the 
>1rt:P.rial blood pressure. A pronounced fall in blood pressure of short duration 
accompanied by tachycardia preceded a more moderate and longer lasting 
dose-related hypotensive effect. The presence of an adequate autonomic nervous 
system activity seems to be required for the prolonged hypotensive action of 
ketanseri.n since in animals pretreated with hexamethonium ( 30 mgjkg) the blood 
pressure, after an initial decrease, returned to baseline values within a few 
minutes after each ketanserin dose. 
Ketanserin inhibited the pressor responses produced by 5-HT ( ~o, 30 and 100 
~gjkg, ~.v.) and phenylephrine (3, 10 and 30 ~g(kg, t.v.) indicating that, at 
hypotensive doses, the compound antagonized both receptors and 
a 1-adrenoceptors. At doses which caused a comparable degree of a 1-adrenoceptor 
blockade, ketanserin (o.l, 0.3 and l.O mgjkg, t.v.) as well as prazosin (0.01, 
0.03 and 0.10 mg/kg, t.v.) decreased the blood pressure as a result of a 
reduction in total peripheral resistance. However, whereas especially at the 
lower doses of ketanserin the cardiac output increased, a moderate decrease in 
this variable contributed to the hypotensive effect of the highest dose of 
prazosin. Both compounds increased the vascular conductance in the kidneys, 
gastro-intestinal tract and bones, whereas that in the skin and skeletal muscles 
was not significantly altered. In contrast to prazosin, ketanserin also caused 
vasodilatation in the coronary and cerebral vascular beds. 
The results suggest that, in addition to a direct vasodilator effect of 
short duration, ketanserin has a prolonged hypotensive action in conscious 
hypertensive rabbits which is predominantly due to a 1-adrcnoccptor blockade. 
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Ketanserin, a selective 5-HT2 
a 1-adrenoceptor blocking properties 
Nueten et al., 1981; Kalkman et al., 
receptor antagonist with 
(Leysen et al., 1981; Van 
1983), has been shown to 
reduce the blood pressure in animals (Fozard, 1982; Kalkman et 
al., 1982) and humans (De Cree et al., 1981; Wenting et al., 
1984), by a mechanism which is still a matter of debate. In 
hypertensive patients ketanserin can lower the arterial blood 
pressure without causing any attenuation of the pressor response 
to phenylephrine (Wenting et al., 1984; Zabludowski et al., 
1984). This pharmacological evidence has been used to support the 
concept that a blockade of 5-HT2 receptors is responsible for the 
antihypertensive effect of the drug (Janssen, 1983). In contrast, 
studies in spontaneously 
ketanserin lowers the 
blockade of postsynaptic 
et al., 1982; Cohen 
hypertensive rats provide arguments that 
blood pressure merely by a competitive 
a
1
-adrenoceptors (Fozard, 1982; Kalkman 
et al., 1983a). In addition, a central 
action has been suggested to contribute to the hypotensive action 
of the compound (McCall and Schuette, 1984; Mylecharane et al., 
1984). In 
mechanism 
order to provide further information on the hypotensive 
of ketanserin we studied its blood pressure lowering 
effect in conscious hypertensive rabbits and have tried to relate 
this effect to the blockade of SHT2 and a 1 -adrenergic receptors in 
these animals. In addition, the changes in regional blood flows 
and vascular resistances after ketanserin administration were 
determined to characterize the complete haemodynamic profile of 
this new antihypertensive drug. Since we have recently studied 
the effects of the a
1
-selective adrenoceptor anatagonist prazosin 
using the same methodology (Bolt and Saxena, l984a), it enabled us 
to compare the complete haemodynamic profiles of the two compounds 
in conscious hypertensive rabbits. The data presented in this 
chapter have been published elsewhere (Bolt and Saxena, 1984b; 
Bolt and Saxena, 1985). 
METHODS 
Animals and surgical procedures 
All experiments were performed on conscious hypertensive New 
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Zealand White rabbits (2.4- 4.0 kg). Hypertension was induced by 
bilateral cellophane wrapping of the kidneys, six to ten weeks 
before the experiment, according to the method of Page (1939). In 
the animals used for the microsphere experiments a left-sided 
thoracotomy was performed nine to fourteen days before the 
experiment in order to cannulate the left atrial appendage with a 
nylon catheter for the administration of microspheres (Warren and 
Ledingham, 1972). Subsequently, four to eight days before the 
experiment the left carotid artery was cannulated in these animals 
for the measurement of blood pressure and heart rate during the 
experiments and the withdrawal of arterial blood samples. The 
different surgical procedures together with the systemic and 
regional haemodynarnic characteristics of bilateral cellophane 
perinephritis hypertension in rabbits have been described in 
detail elsewhere (Bolt and Saxena, 1983; chapter 2 and 3). 
Measurement of haemodynamic variables 
On the day of the experiment the animals were placed in a 
rabbit restrainer box. The marginal ear vein was cannulated under 
local anaesthesia (lidocaine 2%) for the administration of the 
drugs. Subsequently, a catheter was inserted into the central ear 
artery in the animals used for the 5-HT and phenylephrine 
experiments. A Statham P23Dc pressure transducer was connected to 
either the central ear artery catheter or the carotid catheter 
(microsphere experiments) for the recording of the arterial blood 
pressure and the heart rate using a Grass model 7 polygraph. Mean 
blood pressure was obtained by electronically damping of the blood 
pressure signals. Cardiac output and regional blood flows were 
measured with the radioactive microsphere technique, using the 
reference blood sample method (Hales, 1974; Heymann et al., 
1977). Nen-Trac microspheres with a nominal diameter of 15 i 1 
(SD) #ID and labelled with either 141ce, 113sn, 103Ru, 95Nb or 40sc 
were used. cardiac output (ml/min) and regional blood flows 
(ml/min) were calculated using a set of computer programs 
especially designed for the radioactive microsphere technique 
(Saxena et al., 1980; relevant information is given in chapter 
2). Regional vascular conductances were obtained by dividing 
respective tissue blood flows (mljmin) by mean arterial blood 
pressure (rnmHg). 
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Experimental protocol 
systemic and regjonal baemqdynamJcs 
The effects of ketanserin on systemic and regiona~ 
haemodynamic variables were studied in ten conscious hypertensive 
rabbits using the radioactive microsphere technique. After a 
stabilization period of at ~east 30 minutes the first batch of 
microspheres 
output and 
was injected to determine baseline values of cardiac 
regiona~ haemodynamic variables. Heart rate and 
arterial blood pressure values were recorded continuously. After 
measuring baseline values, each anima~ received three cumulative 
doses (0.1, 0.3 and 1.0 mgjkg, i.v.) of ketanserin. Ten minutes 
after each dose when heart rate and b~ood pressure response had 
stabilized, a batch of microspheres was injected. An arterial 
blood sample (0.3 ml) was withdrawn immediatly after each 
microsphere injection to measure pH-, PCO - and P0 -va~ues, using 
an ABL-2 (Radiometer, Copenhagen). Value~ of artefial blood gases 
and pH were not affected by ketanserin. Before and 10 minutes 
after the successive doses of ketanserin (O.l, 0.3 and l. 0 mgjkg) 
7.41 ± 0.01, 
1, 31 ±. 1 and 
the respective values were: 
7.39 ± 0.02 
30 ± l mmHg; 
a previous 
and 7.40 ±. O.Ol; 
and P 0 , 94 .± 3, 
study tso1t and Saxena, 
measured the effects of prazosin (0.01, 
7.41 ±. 0.01, 
33 ±. 1, 32 ±. 
95 ±. 3 and 95 ±. 4 mmHg. In 
l984a; chapter 7) we have 
0.03 and 0.10 mgjkg, i.v.) 
in conscious hypertensive rabbits using the same experimenta~ 
protoco~, except that the microspheres were 
after the subsequent doses of prazosin when 
b~ood pressure responses were measured. 
5=RT=antagonjstic actlyJty 
injected ~5 minutes 
stable hear:t r:ate and 
The effects of 5-HT on the heart rate and arterial b~ood 
pressure were studied in seven conscious hypertensive rabbits. 
After an appropriate equi~ibration period increasing doses of 5-HT 
(10, 30 and 100 ~g/kg, i.v.) were administered at 5 minutes 
intervals. Hexamethonium (30 mg/kg, i.v.) was administered 30 
minutes after the measurement of the control responses. When 
steady baseline values of heart rate and blood pressure were 
reached the three 5-HT doses were again administered. This was 
repeated three times at 30 minutes intervals in the presence of 
ketanserin, 0.1, 0.3 and 1.0 mg/kg, i.v., respective~y. 
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~1-adrepogeptor blocking properties 
The effects of ketanse~in and prazosin on the p~essor 
response induced by phenylephrine, 3, lO and 30 ~g/kg, i.v., 
administe~ed at 5 minutes intervals were studied in two groups of 
eight rabbits. In the first group the subsequent doses of 
phenylephrine were administered four times at 30 minutes intervals 
in the absence and presence of ketanserin, 0.1, 0.3 and 1.0 mgjkg, 
i.v., respectively. In the second group the effects of p~azosin, 
0.01, 0.03 and 0.10 mgjkg, i.v., on the phenylephrine pressor 
response were measu~ed using the same experimental protocol. 
Statistical evaluation 
All data, expressed as mean (±SEM) in the text, have been 
statistically evaluated with non-parametric tests (Siegel, 1956). 
Initially, the Friedman's two way analysis of variance was used to 
establish whether the samples represented different populations. 
The Wilcoxon matched-pairs signed ranks test was applied to test 
the "significance• (p < 0.05, two-tailed) of the changes in 
haemodynamic variables from baseline values. 
Drugs 
The following drugs were used: 5-hydroxytryptamine 
creatinine sulphate (Merck, Darmstadt, W.Germany), hexamethonium 
bromide (Fluka, Buchs, Switzerland), phenylephrine hydrochloride 
(Sigma Chemical Company, St.Louis, Missouri). Ketanserin tartrate 
and prazosin hydrochloride were generously supplied by 
or. J.M. Van Nueten of Janssen Pharmaceutica (Beerse, Belgium) and 
by Pfizer B.V. (Brussels, Belgium), ~espectively. 5-HT, 
phenylephrine and hexamethonium were dissolved in physiological 
saline. Ketanserin and prazosin were dissolved in distilled 
water. Concentrations were such that a volume less than 0.5 ml 
was injected at a time. 
RESULTS 
Systemic haemodynamic variables 
The cumulative doses of ketanserin (0.1, 0.3 and 1.0 mg/kg) 
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Figure 1. Ttme course of hear~ ra~e (RR), sys~oLtc (SSP) ana atas~tic (DBP) 
bLOOd pressure responses af~er ~he i.V. aamtnts~ra~ton Of ke~ansertn, 0.1, 0.3 
ana 1.0 mg/kg, tn consctous hyper~enstve rabbt~s (n=lO). 
administered at 10 minutes intervals in conscious hypertensive 
rabbits produced transient falls in systolic and diastolic blood 
pressure of about 2 minutes duration which were followed by a more 
moderate and longer lasting dose-related hypotensive effect 
(figure 1). A transient tachycardia accompanied the initial fall 
in blood pressure reaching a maximum within 30 seconds after each 
ketanserin administration. By 2 minutes the changes in heart rate 
were no longer significant. 
rn animals pretreated with hexamethonium, 30 mg/kg, only a 
transient fall in blood pressure was observed after ketanserin, 
0.1, 0.3 and 1.0 mg/kg; baseline values were reached within 4 
minutes after each ketanserin dose (figure 2). 
The effects of ketanserin, 0.1, 0.3 and 1.0 mg/kg, on mean 
arterial blood pressure, cardiac output and total peripheral 
resistance 10 minutes after the administration in conscious 
hypertensive rabbits are shown in figure 3. The hypotensive 
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0 2 4 
min 
Ngu:re z. Effects 
(n=7), 0.3 (n=7) 
t.v. on systoLic 
of ketansertn, 0.1 
ana 1.0 (n=S) mgjkg, 
ana atastoLtc ~Looa 
pressure in conscious hypertensive 
rab~its pretreated ~ith hexamethonium, 
30 mgjkg. 
effect of ketanserin resulted from a reduction in total peripheral 
1:esistance. Especially at the lower doses of ketanserin an 
increase in cardiac output opposed the ketanserin-induced 
reduction in total peripheral resistance. In figu1:e 3 are also 
shown the effects of prazosin (0.01, 0.03 and 0.10 rng/kg, i.v.) on 
mean blood pt:essu"t"e, cardiac output and total ·periphet:al 
resistance measut:ed 15 minutes after the successive 
administt:ations in conscious hypet:tensive rabbits. In contrast to 
ketanse1:in, a moderate fall in cardiac output contributed to the 
hypotensive effects of the highest dose of prazosin. 
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Fi-gure 3. Effects of ke'tanserin and prazosin on mean b~ood pressure (MBP), 
cardiac ou'tput;, (00) ana ~tat peripheraL resistance (TPR) ~ressed as 
percen-tage change from baseLine vaz.ues !0 mt.nut:.es after ke'tanserin, 0. I ::::::::), 
0.3 (::::::::) ana 1.0 (828!!) mg;'kg, respect;,ivety, (n=10) ana 15 m"tnu'tes aft.er 
prazost.n, 0.01 (:::=:=::), 0.03 (:.;:;:;::)and 0.10 ce:> mg/kg, respect.i:ve'Ly, (n=10) t.n 
consc~us hype~ensive rabbits. ~, significant;, change from basetine vatues 
(p < 0.05). Basetine vatues for ke~~erin: MBP, 127 ± 5 mmHg; 00, ~22 ± 77 
mtjmin; TPR, 309 ± 20 mmBg/Z..min . Data for prazosin have been derived from 
Bott;, ana Saxena (1984a, chapter 7). 
Regional haernodynarnic variables 
Figu~e 4 shows the ~egional blood flow values befoLe and 
aftex the successive i.v. administration of ketanserin, 0.1, 0.3 
and l.O mg/kg in conscious renal hypertensive rabbits. The three 
doses of ketanserin increased the blood supply to the kidneys and 
gastro-intestinal tract. After the first and second dose the 
blood flow to the heart, brain and bones was also enhanced, 
whereas that to the skin was not affected. In the skeletal 
muscles the blood flow decreased after ketanserin, 1.0 mgjkg. 
Figure 5 shows the changes in regional vascular conductances 
10 minutes after ketanserin, O.l, 0.3 and 1.0 mg/kg, respectively. 
Ketanserin produced a significant vasodilatation (increase in 
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ngu:re 4. Effects of ke'tanse:rin, 0.1., 0.3 and 1..0 mg/kg, :respect-iveLy, on 
:regionaL ~Lood fLo~s (mL/min) 1.0 minut-es aft.e:r i.v. aaminist.:rat.ion in conscious 
hype:rt.enstve :rat>~tt:s (n=!O). o, ~aseLtne vaLues; :·:·:::: , ::::::;:ana m, vaLues aft.e:r 
ket.anse:rin, 0.1., 0.3 and 1..0 mgjkg, :respec"ttveLy; G!T, gas't:ro-tn'tes'tinaL 't:rac't; 
~,significant; change f:rom ~aseLtne vaLues (p < 0.05). 
conductance) 
and bones. 
in the heart, brain, kidneys, gastro-intestinal tract 
The increase in vascular conductance was most 
pronounced in the 
skeletal muscles 
latter three vascular beds. In the skin and 
the changes 
selective vasodilatation was 
were not significant. A 
observed with prazosin, 0.01, 
more 
0.03 
and 0.10 mg/kg, 15 minutes after i.v. administration in conscious 
hypertensive rabbits. A significant increase in the vascular 
conductance was measured in the kidneys, gastro-intestinal tract 
and bones whereas the changes in the heart, brain, skin and 
skeletal muscles were not significant. 
5-HT- and a
1
-antagonistic properties 
A transient bradycardia accompanied by a fall in blood 
pressure was observed after the i.v. administration of 5-HT (10, 
30 and lOO ~g/kg) in conscious hypertensive rabbits (figure 6). 
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Fi.gure 5. SffeC"ts of ke"tanserin and prazost:.n on regionaL vascuLar condu.c"ta:nces 
t:.n conscious hyper-tensive rabbi'ts, expressed as percent-age change from baseLine 
vaz.ues 1.0 mtnu"tes af'ter ket.ansertn, 0.1 ( ::::::), 0.3 (;;;;~;;) ana: 1.0 (~) mg/kg, 
respect.tvez.y, (n=lO) and. 15 mi.nu"tes af"ter prazost.n, 0.01 c:;::::: ) , 0. 03 ( ::~::;:) and. 
0. !0 ( m:) mg/kg, respec"tt.veLy (n.::=10) • G!T, gas'tro-in'tes'tinaL 'tract.; "", 
st.gnt.ft.can't change from baseLine vaLues (p < 0.05). Dat-a tor prazost.n have been 
adapt-ed from BoL't and Saxena (1984a, chapt-er 7). 
This effect was followed by a more prolonged hypotensive response 
accompanied by tachycardia. Pretreatment with a ganglionic 
blocker (hexamethonium, 30 mgjkg), which led to an increase in 
heart rate and a decrease in blood pressure, antagonized the first 
phase of the 5-HT responses. The amine now caused a moderate 
increase in blood pressure, again followed by a prolonged 
hypotensive effect (figure 6). Pretreatment with hexamethonium 
prevented the alterations in heart rate produced by ketanserin and 
5-HT indicating an effective ganglionic blockade after 
hexamethonium, 30 mgjkg (figure 6). The pressor response produced 
by 5-HT in the ganglion blocked animals 
partly due to the opposing vasodilator 
Nevertheless, ketanset:in, and 
was rather small probably 
response of 5-HT (22). 
0.3 mg/kg, effectively 
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figure 6. Bea:rt rat.o (beat.s,lmin) and art.ert.aL bLood pressure (mmB.g) responses 
foLLoQtng t.njec"ttons of 5-HT (IO, 30 and IOO M9/~g, t.v.) tn a consct.ous 
hype~enstve rabbt.'t before ana af-ter pret.reat.men't Qt.'th hexame'thontum (30 mgjkg, 
t.v.), tn t.ho absence ana presence of ket.ansert.n, 0.1 ana 0.3 mgjkg, t..v. 
Pret.reat.ment. Qt.'th h~ame"thont.um bLockS ~raaycardt.a by 5-BT ana unmas~es a 
moderat-e pressor response Qht.ch can be succesfuLLy ant.agont.zed by ket.ansert.n. 
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~gure 7. Changes ~n mean b~d 
pressure produced by 5-BT, 10, 30 and 
100 ~g/kg, t.v. in conscious 
hyper~ensive rabbi~s (n=7) pre~re~ed 
ui~h hezame~honium (30 mgjkg) in ~he 
absence (open circLes) ana presence 
(c~sed circLes) of ke~anserin 0.1 and 
0.3 mgjkg (from ~P ~o bo~~om, 
respec~iveLy). 
antagonized the increase in blood pressure as is shown by the 
shift in the pressor response curve produced by 5-HT (figure 7). 
The effects of ketanserin and prazosin on the pressor 
response produced by phenylephrine (10, 30 and 100 ~g/kg) in the 
conscious untreated hypertensive rabbits are shown in figure 8. 
Ketanserin (0.1, 0.3 and 1.0 mg/kg) shifted the three points curve 
dose-dependently. A comparable a
1
-adrenoceptor blocking action 
was observed with prazosin, 0.01, 0.03 and 0.10 mg/kg. 
DISCUSSION 
cardiovascular profile of ketanserin 
The fall in blood pressure observed after ketanserin 
administration in conscious hypertensive rabbits was biphasic; an 
initial pronounced but transient decrease in blood pressure 
preceded a more 
hypotensive effect. 
the initial fall 
moderate and longer lasting dose-related 
The transient tachycardia, which accompanied 
in blood pressure, probably resulted from the 
hypotension-induced activation of the baroreceptor reflex and the 
subsequent increase in sympathetic activity and withdrawal of the 
lll 
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Ft.gu.re 8. Changes in mean b~ood pressure produced by phenyz.ephrt.ne, 3, !0 and 
30 IJ,g/k.g, t..v. in consc"tous hyper-tenst.ve raz>bi:t:.s t.n t:.he absence (open circz.es) 
ana presence (cZ.osed circLes) of ke~anserin, 0.!, 0.3 and 1.0 mgjkg (from ~p ~ 
bot:.~m, respect:.ivez.y, n~B) ana prazosin, 0.01, 0.03 and 0.10 mgjkg (from t:.op ~ 
bot:.t:.om respe~ivez.y, n~B). 
vagal tone (Wenting et al., 1984). Indeed, the ketanserin-induced 
changes in heart rate were not observed after ganglionic blockade. 
The absence of reflex tachycardia during the prolonged hypotensive 
action of 
of the drug 
ketanserin may be related to 
with the autonomic nervous 
the reported interference 
system activity (Fozard, 
1982; Mylecharane et al., 1984), where it causes a decrease in 
sympathetic outflow (McCall and Schuette, 1984). Remarkably, a 
similar heart rate response is observed at hypotensive doses of 
the a
1
-selective adrenoceptor antagonist prazosin in conscious 
normotensive (Cavero, 1982) and hypertensive (Bolt and Saxena, 
1984a) rabbits. Pronounced tachycardia is only observed during 
the first few minutes after the acute administration of prazosin 
despite sustained hypotension. 
The prolonged fall in blood pressure observed after 
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ketanserin administration in the conscious hypertensive rabbits 
was due to a decrease in total peripheral resistance which 
illustrated the arterial vasodilator properties of ketanserin. An 
increase in cardiac output, possibly as a result of the reduction 
in afterload secondary to the fall in 
was observed after ketanserin, 0.1 
total peripheral 
and 0.3 mg/kg. 
resistance, 
The less 
pronounced increase in cardiac output after ketanserin, 1.0 mgjkg, 
may be due to a reduction in venous return as a result of 
dilatation of venous capacitance vessels. In comparison, a 
transient increase in cardiac output has been observed after 
ketanserin administration in hypertensive patients despite the 
fact that a reduction in cardiac filling pressure indicated a 
reduced venous return (Wenting et al., 1984). 
Due to the ketanserin-induced vasodilatation in the heart, 
brain, kidneys, gastro-intestinal tract and bones, the increase in 
cardiac output resulted in an enhanced blood supply to these 
vascular beds. An increase in renal blood flow has also been 
observed after ketanserin administration in hypertensive patients 
(Wenting et al., 1984). In the cutaneous vascular bed the 
vascular conductance and blood flow remained unchanged, whereas in 
the skeletal muscles the vascular conductance tended to decrease 
resulting in a reduced blood flow to the muscles at the higher 
ketanserin doses. Apparently, ketanserin has minor effects in the 
two latter vascular beds. However, it is possible that 
reflex-mediated vasoconstriction and tissue autoregulation obscure 
a direct vasodilator activity of ketanserin in certain vascular 
beds in the conscious animals (Bolt and Saxena, 1984c). 
Hypotensive mechanism of ketanserin 
Direct vamdi later action 
The biphasic blood pressure response after ketanserin 
administration in conscious hypertensive rabbits has also been 
observed in anaesthetized rats (Kalkman et al., 1982) where the 
initial fall in blood pressure was ascribed to a possible direct 
vasodilator action of ketanserin. Also in the hindleg of the dog 
a vasodilator effect of ketanserin has been demonstrated which 
could not be blocked by methysergide or sympathetic denervation 
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(Rion et al., 1983) indicating that this effect is 
In the 
not mediated by 
present study eithe~ 5-HT2 nor a 1 -adrenergic receptors. 
the transient decrease in blood pressure 
ganglionic blockade which shows that the 
was still observed afte~ 
initial fall in blood 
pressure does not depend upon an autonomic nervous tone and may be 
due to a direct vasodilator action of ketanse~in which has also 
been shown for other structurally related quinazolinedione 
derivatives (Rion et al, 1983). Although in the present study 
this initial vasodilatation does not play a role in the prolonged 
hypotensive action of ketanserin, it is possible that when higher 
doses are given or when a different route of administration is 
used the direct vasodilator action may contribute in the 
antihypertensive properties of the compound. In this respect, the 
observed hypotensive effect of ketanserin in patients with 
autonomic insufficiency (Wenting et al., 1984) may possibly be 
attributed to a direct vasodilator effect of the drug. 
s 'ifJ' xecept;or N ockaOe 
The pressor response of 5-HT, though only moderate, could be 
visualized after ganglionic blockade which prevents the fall in 
heart rate and blood pressure that result from the changes in 
autonomic nervous activity secondary to activation of the 
eezold-Jarisch reflex (Paintal, 1973). The pressor response of 
5-HT has been attributed to a direct vasoconstriction mediated via 
5-HT2 receptors aided indirectly by an augmentation of 
noradrenaline and angiotensin II responses (Van Nueten et al., 
1981). These effects can be antagonized by ketanserin due to the 
5-HT2 receptor blocking 
an important role in the 
1981; Janssen, 1983; 
properties of the compound which may play 
hypotensive mechanism (Van Nueten et al., 
Wenting et al., 1984). Indeed, at 
hypotensive doses ketanserin effectively antagonized the 
5-HT-induced pressor responses in the conscious hypertensive 
rabbits pretreated with hexamethonium. Although this antagonism 
may facilitate the vasodilator effect of 5-HT mediated via 
"atypical" 5-HT receptors (Saxena and Verdouw, 1982; Saxena and 
Verdouw, 1984; Verdouw et al., 1984), until now, one has not been 
able to demonstrate an important physiological role for 5-HT in 
the maintenance of the arterial blood pressure. In addition, 
hypotensive properties have not been shown for other selective 
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5-HT
2 
receptm::: antagonists (Fozard, 1982; Cohen et al., 1983b; 
~983). Finally, Amery et al. (~984) have shown 
~ongterm t~eatment with ketanser.in reduced the 
KaUanan et a~_ , 
that, although 
blood pressure in hypertensive patients, 5-HT
2 
receptor blockade 
cou~d not be demonstrated when assessed by p~ate~et aggregation. 
Thus, despite the 5-HT-antagonistic properties at hypotensive 
doses of ketanserin, a contribution of 5-HT receptor blockade in 
the hypotensive action of ketanserin remains to be estab~ished. 
Ketanserin also possessed a
1
-adrenoceptor b~ocking properties 
at hypotensive doses as was shown by the shift in the 3-points 
phenylephrine pressor response curve after ketanserin, 0.~, 0.3 
and 1.0 mg/kg, in the conscious hypertensive rabbits. Similar 
results were obtained in studies in pithed rats where the 
inhibitory effects of ketanserin on the pressor responses of the 
a
1 
-selective 
1982) and 
adrenoceptor stimulants methoxamine (KaLkman et 
phenylephrine (Fozard, ~982) were measured. 
al., 
The 
decrease in b~ood pressure p~oduced by the a
1
-selective 
adrenoceptor antagonist prazosin at doses that caused a comparable 
shift in the pheny~ephrine pressor response curves indicates that 
in conscious hypertensive rabbits, as in rats (Fozard, 1982; 
Kalkman et al., 1982; Cohen et al., l983a), the blockade of 
a
1
-adrenoceptors by itself can be held responsible for the 
prolonged hypotensive action of ketanserin. In addition, in the 
animals p~etreated with hexamethonium the blood pressure retu~ned 
to baseline values within a few minutes which indicates the 
requirement of an autonomic nervous tone for the prolonged 
hypotensive action of ketanserin. In cont~ast, in hypertensive 
patients hypotensive doses of ketanserin (10 mg/kg, i.v.) did not 
alter the p~essor effects of phenylephrine, suggesting that 
ketanse~in may lower blood p~essu~e independently of 
a
1
-adrenoceptor blockade (Wenting et al., 1984; Zabludowski et 
al., 1984). 
seems to be 
Nevertheless, a ce~tain degree of a1 -ad~energic tone 
required for the compound to exert its full 
antihypertensive action in man because pretreatment with prazosin 
blunted the antihypertensive effect of ketanserin in hypertensive 
patients (Wenting et al., 1984). In addition, after chronic 
treatment with ketanserin, Fagard et al., (1984) observed a 
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reduction of the pressor response to methoxamine in patients with 
essential hypertension~ However, it may be that after chronic 
oral treatment with ketanserin (120mg/day) plasma levels were 
higher, causing a more pronounced a
1
-adrenoceptor blockade, than 
after a single i~v~ administration of 10 mg ketanserin (Wenting et 
al., 1984; Zab1udowski et a1., 1984). 
In contrast to prazosin, ketanserin moderately increased the 
cardiac output in the present study~ It may be that the direct 
vasodilator action of ketanserin -which is not observed with 
prazosin (Bolt and Saxena, 1984a)- contributed to the relatively 
more pronounced cardiac stimulation 
hypotensive phase of ketanserin. On 
during 
the other 
the prolonged 
hand, both, the 
less pronounced increase in cardiac output after ketanserin, 1~0 
mg/kg and the decrease in this variable after prazosin, 0~1 mg/kg, 
can be explained by a reduction in venous return secundary to 
dilatation of venous capacitance vessels (Patel et al., 1981; 
Bolt and Saxena, 1984; Wenting et al~, 1984), which becomes more 
prominent when higher doses of the drugs are used~ 
The remarkable similarities in the regional haemodynamic 
profile of ketanserin and prazosin also indicate an important role 
for the a
1
-adrenoceptor blocking properties in the hypotensive 
mechanism of ketanserin. It is tempting to attribute the 
additional vasodilatation produced by ketanserin in the coronary 
and cerebral vascular beds to the 5-HT
2 
receptor blocking 
properties of ketanserin that prazosin does not have (Kalkman et 
al, 1983)~ However, other explanations are possible~ Myocardial 
autoregulation plays an important role in the blood flow to the 
heart (Weber and Janicki, 1979). If we consider the decrease in 
the cardiac output and the more pronounced reduction in blood 
pressure observed with prazosin it is possible that the myocardial 
metabolic demands are less than after ketanserin administration. 
This may explain the difference between the effects of the two 
drugs on the coronary vascular bed. In addition, possible 
differences in the pharmacokinetic properties of ketanserin and 
prazosin as well as the direct vasodilator action of ketanserin 
which prazosin does not have, may contribute to the differences in 
the cardiovascular profiles of the two compounds. 
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by a 1 -adrenoceptors or 5-HT receptors, an autonomic nervous tone 
seems to be required for the prolonged hypotensive action of 
ketanserin. In addition, considering the a -adrenoceptor blocking 
l 
activity of ketanserin at hypotensive doses and the similarities 
in the cardiovascular 
of a
1
-adrenoceptors 
hypotensive mechanism 
rabbits. 
profile of ketanserin and prazosin, blockade 
probably plays a predominant role in the 
of ketanserin in conscious hypertensive 
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CHAPTER g, 
VASODILATORS AND REGIONAL BLOOD FLOW 
At present a wide variety of vasodilator drugs has become available for 
ant~ypertensive therapy. In accordance with the differences in mechanism(,£ 
action, each drug produces a heterogeneous pattern of vasodilator responses 
leading to a characteristic redistribution of the regional blood flows. A more 
profound knowledge of the regional haemodynamic profiles of different types of 
vasodilators may contribute to a better and rational application of these drugs 
in antihypertensive therapy tailored to particular needs of a patient. 
The dominant haemodynamic disturbance in the established 
phase of most hypertensive forms is an increase in total 
peripheral resistance. 
rational approach to 
Consequently vasodilators appear to be a 
treatment. Despite this rationale, the 
usefulness of vasodilatoxs in clinical pxactise is xathex limited 
because of pxonounced activation of caxdiovaculax xeflex 
mechanisms that follows the decxease in blood pxessuxe produced by 
vasodilatox dxugs (Reid, 1979), leading to undesixable changes in 
haemodynamic vaxiables (figure 1). Howevex, at pxesent 
vasodilator drugs have gained renewed interest now that the most 
common problems experienced with these drugs, reflex-mediated 
cardiac stimulation and salt and water retention, can be 
counteracted by concurrent administration - of P-adrenoceptor 
antagonists and diuretic agents. ln addition, new compounds, such 
as converting enzyme inhibitors and a 1-selective adrenoceptor 
antagonists, have been developed which indirectly relax vascular 
smooth muscle through interfexence with pressor systems (figure 1) 
and whose blood pressure lowering effects appear to cause a less 
pronounced activation of cardiovascular reflex mechanisms. 
Considering the revival of interest in vasodilator drugs, a 
reconsideration of the haemodynamic profiles of these drugs seems 
to be justified. 
The changes in systemic haemodynamic variables that accompany 
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the fall in blood pressure during antihypertensive treatment with 
vasodilator drugs are rather well studied. However, less 
attention has been paid to the :regional haemodynamic effects of 
these agents. The available information comes mainly from 
in-vitro studies on isolated vascular preparations and from 
in-vivo studies on separate vascular beds. Thus, a comparative 
review of the regional haemodynamic effects of vasodilator drugs 
consists of a tedious assembly of data obtained from different 
studies in various species. In addition, from a therapeutic point 
of view, more relevant information is obtained when studies are 
performed on conscjons hypertensive animals. This guarantees a 
normal functioning of the different cardiovascular 
reflex-mechanisms which play an important role in the haemodynamic 
profile of antihypertensive drugs. Taking these considerations 
into account, we have used the radioactive microsphere technique 
to study the acute systemic as well as regional haemodynamic 
effects of a series of antihypertensive drugs of different types 
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in conscious rabbits with bilatera~ cellophane perinephritis 
hypertension. This experimental form of hypertension is 
characterized by a rather generalized increase in peripheral 
vascular resistances with the most pronounced change in the renal 
vascular bed, the latter resulting in a decrease in blood flow to 
the kidneys. The cardiac output is moderately decreased due to a 
reduction in stroke volume (Bolt and Saxena, 1983). Plasma renin 
activity is normal (Campbell et al., 1973). Similar haemodynamic 
characteristics have been described for late and severe essential 
hypertension in man (Lund-Johansen, 1983) as well as for many 
other experimental mode~s of hypertension (Zandberg, 1984). The 
results obtained with the different drugs have been published 
elsewhere, separately for each drug (Bolt and Saxena, l984a,b,c, 
1985a,b). This paper, which has been accepted for publication 
(Bolt and Saxena, l985c), serves to compare the haemodynamic 
profiles of five "direct" and "indirect" vasodilators and to 
discuss the pharmacological and therapeutic 
this purpose we have selected the 
hydra~azine, the calcium antagonist 
converting-enzyme inhibitor captopril, 
consequences. For 
arterial vasodilator 
felodipine, the 
the 5HT2 receptor 
antagonist ketanserin and the a1 -adrenoceptor antagonist prazosin. 
SYSTEMIC HAEMODYNAMIC VARIABLES 
The hypotensive action of vasodilator drugs results from 
di~atation of arterial resistance vessels and the consequent 
reduction in total periphera~ resistance. However, the degree by 
which the total periphera~ resistance is reduced in order to 
produce a certain fall in blood pressure varies considerably 
amongst different vasodilators depending upon the concomittant 
changes in cardiac output which either oppose (when cardiac output 
increases) or contribute to (when cardiac output decreases) the 
hypotensive action of the drug. This is illustrated in figure 2 
by the acute effects of hydralazine, 0.3, 1.0 and 3.0 mg/kg, 
felodipine, 0.003, 0.01 and 0.03 mg/kg, captopril, 0.1, 0.3 and 
1.0 mg/kg, ketanserin, 0.1, 0.3 and 1.0 mgjkg, and prazosin, 0.01, 
0.03 and 0.10 mgjkg, on systemic haemodynarnic variables in 
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conscious rabbits with bilateral cellophane perinephritis 
hypertension. To decrease the blood pressure, a relatively large 
fall in total peripheral resistance is necessary to overcome the 
increase in cardiac output produced by hydralazine, felodipine, 
captopril and ketanserin, whereas a reduction in cardiac output 
partly contributes to the 
The cardiac function 
acute hypotensive action of prazosin. 
depends on four major determinants: 
preload, afterload, contractile state of the heart and heart rate 
(Ribner et al., 1982). The fall in afterload, secondary to the 
reduction in total peripheral resistance, is a common mechanism by 
which vasodilator drugs tend to increase cardiac output, 
especially when myocardial function is depressed. The contractile 
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state of the heart and the heart rate are, amongst other factors, 
influenced by changes in antonomic nervous activity. Secondary to 
the fall in blood pressure, the baroreceptor reflex becomes 
activated which results in cardiac stimulation via an increase in 
sympathetic activity and a reduction in vagal tone. In the 
present study a pronounced increase in heart rate (> 30 %) was 
observed with hydralazine and felodipine. A marked but transient 
tachycardia was also noticed immediatly after each ketanserin and 
prazosin administration but the heart rate response returned to 
baseline values within a few minutes after each dose of 
ketanserin, and stabilized at about 10 % above baseline values 
within 15 minutes after each prazosin administration. Captopril 
did not significantly alter the heart rate. The absence of a 
pronounced reflex-tachycardia during the prolonged hypotensive 
action of captopril, ketanserin and prazosin may be due to the 
reported inhibitory effects of these compounds on the autonomic 
nervous system activity and the consequent interference with the 
baroreceptor reflex (Cavero and Roach, 1980; Unger et al., 1983; 
McCall and Schuette, 1984)-
The cardiac stimulation together with the fall in afterload 
is, however, not sufficient for the cardiac output to increase. 
An enhanced venous return of blood to the heart is necessary in 
order to keep up with an increased pumping capacity. Because the 
venous return is determined by the sum of local blood flows 
through peripheral tissues (Guyton, 1981), the arterial dilatation 
produced by vasodilator drugs and the consequent enhanced tissue 
perfusion can lead to an increase in venous return, particularly 
when venous capacitance vessels are not or only slightly dilated 
by the drug. In addition, the reflex-mediated increase in 
sympathetic tone due to the activation of the baroreceptor reflex 
may even lead to a-receptor mediated constriction of venous 
capacitance vessels thereby further enhancing venous return 
(Ribner et al., 1982). On the other hand, a dilatation of venous 
capacitance vessels will reduce the venous return and, 
consequently, decrease the cardiac output in the normal 
functioning heart (Ribner et al., 1982)- Apart from dilatation of 
arterial resistance vessels, prazosin has been shown to affect 
venous capacitance vessels as well (Cavero and Roach, 1980), which 
explains the moderate fall in cardiac output observed after the 
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administ~ation of p~azosin, 0.1 mg/kg, in conscious hype~tensive 
Iabbits (figuie 2)-
An increase in venous return has also been suggested to 
pa~ticipate in the caxdiac stimulation obse~ved with arterial 
vasodilators via the stimulation of atrial •stretch• recepto~s, 
thereby activating the Bainb~idge reflex (Spokas and Wang, 1980). 
This may explain the positive chronot~opic effects and the 
pronounced increase in ca~diac output observed in the present 
study after hydralazine administration at doses which do not 
decrease the blood pressure despite the fall in total peripheral 
~esistance (Spokas and Wang, 1980). 
In conclusion, the changes in systemic haemodynamic variables 
that accompany the fall in blood pressure produced by vasodilators 
of different types va~y considerably depending upon the respective 
site of action (arterial and/o~ venous vessels) and the more or 
less p~onounced activation of cardiovascular reflex mechanisms. 
REGIONAL HAEMODYNAMIC VARIABLES 
Vascular resistance 
The fall in total peripheral resistance produced by 
vasodilator drugs is in gene~al not uniformly distributed over the 
various organs and tissues. Figure 3 shows the acute changes in 
regional vascular resistances in 7 peripheral vascular beds after 
the administration of increasing doses of hydralazine, felodipine, 
captopril, ketanserin and prazosin in conscious hypertensive 
rabbits. Hydralazine preferentially decreased the vascular 
resistance in the cerebral, coronary and renal vascular beds 
whereas the muscular bed was not significantly affected by the 
drug and a remarkable vasoconstriction was observed in the 
gastro-intestinal tract and skin. 
cutaneous vascular bed, a 
vasodilatation 
quantitatively, 
was 
marked 
produced 
regional 
With the exception of the 
rather generalized peripheral 
by felodipine 
differences were 
although, 
noticed. A 
uniform fall in peripheral vascular resistances was measured after 
captopril administration. Both, ketanserin and prazosin, dilated 
the renal and gastro-intestinal circulation and did not 
significantly change the vascular resistance in the muscles and 
skin. In contrast to prazosin, ketanserin also caused a moderate 
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decrease in the vascular resistance in the brain and heart_ 
Ofcourse, the heterogeneous pattern of vasodilator responses 
observed with each drug is mainly determined by the differences in 
potency to dilate the blood vessels in various vascular beds_ The 
effectiveness of hydralazine to decrease the vascular resistance 
in the cerebral, coronary and renal circulation has been 
frequently reported in studies performed on isolated vascular beds 
(Ribner et al., 1982; Sakai et al., 1980)_ The profile observed 
with the dihydropiridine, felodipine, is in agreement with the 
findings obtained with other ca-antagonists of the dihydropyridine 
group (Hof, 1984)- Even the relatively higher doses of the drug 
necessary to dilate the muscular vascular bed is compatible with 
the reported higher potency of Ca-antagonists in the coronary 
vessels when compared with femoral arteries (Mullett et al-, 
l983)- The cutaneous circulation has been shown to be relatively 
insensitive for the vasodilator action of Ca-antagonists 
(Vanhoutte and Rimele, 1982)- The uniform vasodilatation produced 
by the converting-enzyme inhibitor, captopril, is remarkable 
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considering the low plasma renin levels in this "low renin" model 
of hypertension (Campbell et al., 1973). This may indicate a more 
prominant role of the renin angiotensin system, possibly of 
vascular origin, in the maintenance of the increased blood 
pressure in cellophane perinephritis hypertension than previously 
suggested (Campbell et al., 1983). 
The similarities in the regional haemodynamic profiles of the 
5HT2-receptor antagonist, ketanserin, and 
antagonist, prazosin, are compatible with the a 1-adrenolytic 
properties that have also been reported for ketanserin (Kalkman et 
al., 1982). 
blockade 
hypotensive 
(Bolt and 
Indeed, in addition to SHT2 antagonistic activity, a 
of a 1 -adrenoceptors could be demonstrated at the 
doses of ketanserin in conscious hypertensive rabbits 
Saxena, 1985b). Although it is tempting to attribute 
the additional vasodilator properties of ketanserin to the 
antagonism of 5HT2 receptors (Janssen, 
(direct vasodilator action of ketanserin, 
differences 
1983), other explanations 
tissue autoregulation, 
etc) are possible (Bolt in pharmacokinetic properties 
and Saxena, l985b). 
As outlined in figure l, cardiovascular reflex mechanisms 
also play an important role in the regional haemodynamic profiles 
of vasodilators by opposing the direct vasodilator action via an 
increase in sympathetic activity and the activation of the renin 
angiotensin system (Reid, 1979). Because several "indirect" 
vasodilators act through interference with these pressor systems 
(a-adrenoceptor antagonists, converting enzyme inhibitors), the 
contribution of the reflex-mediated vasoconstrictor responses in 
the haemodynamic profile also varies amongst the different drugs 
the 
after 
used. The increase in vascular resistance in 
gastro-intestinal circulation and the skin observed 
hydralazine administration (figure 3) is apparently reflex 
mediated, because a generalized vasodilator response which 
included the femoral and mesenteric vascular beds has been 
reported in studies in blood perfused circulations isolated from 
the autonomic nervous system (Ribner et al., 1982; Sakai et al., 
1980). These data also show that cardiovascular reflex mechanisms 
can still operate in the presence of hydralazine, which indicates 
that the mechanism of action of the drug does not involve a basic 
cellular pathway. In this respect, it has been demonstrated that 
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the vasodilator action of hydralazine depends for a large part on 
the presence of an intact endothelium, whereas angiotensin !I and 
catecholamines mediate their pressor responses via receptors on 
the vascular smooth muscle cell (Spokas et al., 1984). 
Reflex mediated vasoconstriction was not observed after the 
administration of felodipine. This is in agreement with data 
showing that Ca-antagonists of the dihydropyxidine group attenuate 
the vasoconstrictor effects of a-adrenergic stimulants and 
angiotensin !I (Hof, 1984). The generalized vasodilatation 
observed after converting-enzyme inhibition without any sign of 
reflex-mediated vasoconstriction suggests that the renin 
angiotensin system plays an important role in the acute regulation 
of the blood pressure. 
Due to the a 1-adrenolytic activity of ketanserin and 
prazosin, vasoconstrictor responses, mediated via a 1 receptors, 
are blocked. However, it is possible that a vasodilator action of 
these compounds, for instance in the muscular and cutaneous 
vascular beds, is counteracted by the stimulation of vascular a2 
receptors and angiotensin II. In this respect, an increased 
activity of the renin-angiotensin system has been measured after 
the acute administration of ketanserin and prazosin in animal and 
clinical studies (Cavero and Roach, 1980; Janssen, 1983). In 
addition, in a comparitive study on the renal and femoral vascular 
bed a preponderance of a2 receptors has been demonstrated in the 
femoral bed whereas vascular a 1 receptors dominated in the renal 
circulation (Hornet al., 1982), which is compatible with the 
dilator response of prazosin in the renal bed and the unchanged 
resistance in the muscular bed observed in the present study. 
Finally, especially in the brain and heart, tissue 
autoregulation may participate in the observed haemodynamic 
profiles by maintaining the blood flows to these essential organs 
in accordance with the metabolic demands. Consequently, the 
observed changes in vascular resistance must be considered in view 
of the changes in blood flow to these organs and will therefore be 
discussed in the following section of this paper. 
Regional blood flows 
The peripheral dilatation 
cardiac output will greatly 
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blood flows (figure 4). Apart from a qualitative description of 
the changes in regional blood flows, one has to consider the 
contribution of each vascular bed in the total circulation. Large 
amounts of blood are received 
tract and skeletal muscles. In 
by the kidneys, gastro-intestinal 
conscious hypertensive rabbits 
these circulations receive about 13, 27 and 21 % of the cardiac 
output, respectively (Bolt and Saxena, 1983). A relatively small 
but selective dilatation in one of these vascular beds will 
therefore have 
and may lead 
not dilated by 
unchanged or 
illust1:ated by 
impo1:tant consequences for the total circulation 
to unde1:pe1:fusion of other vascular beds which are 
the drug, especially when cardiac output remains 
decreases. This "steal" effect 
the changes in regional blood flow 
is for instance 
observed after 
prazosin administration in conscious hypertensive rabbits (figure 
4). The selective dilatation in the kidneys and gastro-intestinal 
tract produced by the a 1-adrenoceptor antagonist results in 
unchanged blood flows to these vascular beds despite the fall in 
cardiac output after prazosin, 0.1 mgjkg. However, this is at the 
expense of the blood supply to other organs and tissues, amongst 
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which essential oLgans such as the heart and brain. The 
remarkable fall in ceLebral peLfusion observed in the present 
study may be related to the serious side effects such as dizziness 
and even loss of consciousness observed after the acute 
administration of a relatively large first dose of 
hypertensive patients, often refered to as "the 
phenomenon of pLazosin" (Cavero and Roach, 1982). 
pLazosin in 
first dose 
Because of the strong autoregulatory mechanism in the brain 
which under normal circumstances maintains the cerebLal blood flow 
at a constant level over a wide blood pressure range, vasodilator 
drugs are generally consideLed as relatively ineffective in 
changing the blood flow to the brain. HoweveL, it has been 
demonstrated that in hypertension the lower limit to 
autoregulation is shifted to a higher blood pressure level, which 
indicates that hypertensive patients are more susceptible to 
cerebLal underperfusion after an abrupt fall in blood pressure 
(Graham et al., 1983). This may play a role in the effects of 
prazosin on the blood flow to the brain. On the other hand, a 
pronounced vasodilatation and an increase in blood flow to the 
brain was observed after hydralazine and felodipine administration 
in the conscious hypeLtensive rabbits (figure 4). Considering the 
strong cerebral autoregulatory mechanism, it is possible that an 
increase in metabolic activity, for instance in the 
cardio-acceleration andjor vasomotor centres located in medulla 
and pons contribute to the increase in blood flow in the cerebral 
vascular bed. This is supported by the finding that the changes 
observed with hydralazine are completely due to an enhanced blood 
supply to brainstem and cerebellum whereas the blood flow to the 
cortex is not altered by the drug (Bolt and Saxena, l984b). 
Similarly, the changes produced by felodipine were most pLonounced 
in the "lower" regions of the brain. 
Autoregulatory responses also play a role in the observed 
changes in the coronary vasculaL bed. The product of heart rate 
and systolic pressure is generally considered as a determinant of 
the metabolic activity of the heart. An increase in this vaLiable 
is observed at the lower doses of hydralazine and felodipine, 
whereas the 
ketanserin and 
rate/pressure product decreased with 
prazosin (figure 5). Thus an increased 
captopril, 
metabolic 
activity probably partly determined the increase in blood flow to 
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the heart with the fiist two drugs at the lower doses used. On 
the other hand, the moderate fall in coronary blood flow after 
prazosin, 0.1 mg/kg, is not necessarily a negative aspect of the 
drug in view of the lowered metabolic activity (figure 5). 
Despite the observed increase in coronary blood flow, single 
treatment with arterial vasodilators has been reported to induce 
angina pectoris in hypertensive patients (Ribner et al., 1982). 
Apart from the possible involvement of a coronary "steal" effect 
in patients with coronary stenosis (Ribner et al., 1982), an 
additional explanation is offered by the finding that in the 
present study both, hydralazine and felodipine, preferentially 
dilated and increased the blood flow to the outer layers of the 
left ventricular wall (Bolt and Saxena, l984a,b)- A decrease in 
the weight-normalized endocardial/epicardial blood flow ratio was 
measured with 
significantly 
these drugs whereas this variable was not 
altered by captopril, ketanserin or prazosin (table 
1). This is probably due to the decrease in diastolic perfusion 
increase in heart rate observed with time, secondary to the 
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hydralazine and felodipine, and the changes in myocardial wall 
stress (Boudoulais et al., 1979). Indeed, pretreatment with the 
s 1-adrenoceptor antagonist atenolol not only opposed the 
hydralazine-induced cardiac stimulation in conscious hypertensive 
regional 
(Bolt and 
rabbits, but also protected against 
blood flow distribution 
the 
in 
undesirable changes in 
the left ventricular wall 
Saxena, 
single treatment 
1984b). Thus, it seems posssible that 
with arterial vasodilators the relatively 
after 
small 
increase in blood flow to the endocardial layer of the left 
ventricular wall is insufficient to keep up with the increased 
metabolic demands especially in patients with limited coronary 
reserve. 
Each drug reduced the vascular resistance in the renal 
vascular bed (figure 3). However, an increase in blood flow to 
the kidneys was only observed after hydralazine, captopril and 
ketanserin (figure 4), which is in agreement with the reported 
effects of these drugs 
patients (Ribner et 
on the renal circulation in hypertensive 
al., 1982; Mullett et al., 1983; Unger et 
al., 1983). Due to the moderate fall in cardiac output, prazosin 
did not significantly increase the blood flow to the kidneys. A 
relatively less pronounced effect on the renal vascular bed with, 
consequently, minor changes in renal blood flow, seemes to be a 
common characteristic of Ca-antagonists of the dihydropyridine 
group (Hof, 1984)- Because the blood flow to the kidneys is known 
to be reduced in most forms of experimental and clinical 
hypertension, an improved blood supply to these organs may be 
considered as a favourable aspect of the haemodynamic profile of 
vasodilator drugs. 
The gastro-intestinal, muscular and cutaneous circulations 
appear to be relatively more sensitive to reflexly initiated 
vasoconstrictor responses mediated via the autonomic nervous 
system and the renin-angiotensin system (Ribner et al., 1982). 
Indeed, with the exception of captopril, all drugs reduced the 
blood flow to one or more of these three vascular beds (figure 4). 
Although for clarity reasons these vascular beds are considered in 
their entirety, regional differences can be observed in each bed. 
For instance, the fall in blood supply to the gastro-intestinal 
tract observed with hydralazine, appears to be completely due to a 
reduced blood flow to the stomach and small intestine; the blood 
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flow to the large intestine increased after hydralazine, 3.0 mg/kg 
(Bolt and Saxena, 1984b). Similar differences can be expected in 
various regions of the skin and skeletal muscles. Although in 
case of underperfusion, serious side effects may result, these 
vascular beds are generally not considered as "essential"-
Nevertheless, they may play an important role in the circulation, 
because of the large amounts of blood received by these beds. 
This is for instance illustrated by the effects of the highest 
dose of felodipine (0.03 mg/kg) which markedly dilated the 
muscular vascular bed and increased the blood flow to the skeletal 
muscles thereby "stealing" blood from other areas such as the 
cerebral bed which exhibits maximal vasodilatation already at 
lower doses of the drug. 
TABLE L ACute effects of hydralazine, felodipi.ne, captopri.l, ketanserin and 
prazosin on systemic and regional haemodynami.c variables and the 
endocard~l/epicard~l blood flow rati.o in the left ventricular wall. 
hydralazine 
Dose (mg.kg -l) 3.0 
Mean blood pressure 
(% change) -21 ± 4 
seart rate + + + 
Cardiac OUtput 
Total peripheral 
resistance 
Resistance 
brai.n 
heart 
kidneys 
Blood flow 
brai.n 
heart 
kidneys 
Endofepi ratio 
+++ 
+ 
+ + + + 
+ 
felodipine captopril ketanserin 
O.Ol 
-2l ± 4 
+ + + 
+ + 
+ + + 
+ + 
0 
0.3 
-zs ± 3 
0 
+ + 
0 
0 
+ 
0 
LO 
-13 ± z 
0 
+ 
0 
0 
+ 
0 
prazosin 
O.> 
-23 ± 2 
+ 
0 
0 
0 
0 
-,o,+, indicate relative magnitude of responses with - - - - and + + + + as the 
largest decrease and increase, respectively; endojepi ratio, 
endocardialfepicardial blood flow ratio in the left ventricular wall. 
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SUMMARY 
A summary of the data is given in table 1 which compares the 
acute changes in systemic haemodynamic variables and regional 
vascular resistances and blood flows to essential organs in 
conscious hypertensive rabbits at equal hypotensive doses (with 
the exception of ketanserin). Although immediatly after the 
administration of ketanserin, 1.0 mg/kg, a very pronounced fall in 
blood pressure (> -25 %) was observed, by 10 minutes the blood 
pressure response had stabilized at only 13 % below baseline 
level. Because of this initial fall in blood pressure we have 
avoided the use of ketanserin in doses higher than 1.0 mg/kg. As 
outlined in table 1, each drug produces a characteristic pattern 
of vasodilator responses which results in a marked redistribution 
of the cardiac output. The effects of the vasodilator drugs vary 
due to differences in dilator potency in the various vascular 
beds. rn addition, cardiovascular reflex mechanisms and tissue 
autoregulation contribute to a different extent to the observed 
changes in vascular resistances and regional blood flows. 
POSSIBLE CLINICAL RELEVANCE 
Clinicians treating hypertensive patients, ought to take into 
account the haemodynamic characteristics of hypertension and the 
changes in systemic and regional haemodynamic variables that 
accompany the fall in blood pressure produced by antihypertensive 
drugs. A prerequisite for an antihypertensive drug is that it 
should not reduce the blood flow to essential organs, such as the 
brain, heart and kidneys. Moreover, when a hypertensive patient 
suffers from an impaired blood supply to certain vascular beds, an 
improved blood flow to these areas may be required. The important 
differences between the haemodynamic profiles of the various 
vasodilators demonstrated in the present study should help 
clinicians in making optimal use of the drugs and may therefore 
contribute to a more adequate application of these compounds in 
antihypertensive therapy. 
It goes without saying that extreme caution is necessary when 
extrapolating the findings obtained in animal studies to man. 
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Mo~eove~. it is possible that the haemodynamic profiles of 
antihype~tensive drugs vary depending upon the experimental form 
of hypertension used. Finally, although the acute effects of 
drugs are certainly important, these effects may differ from those 
after chronic administration due to factors such as the possible 
adaptation of cardiovascular reflex mechanisms, the involvement of 
volume factors and the tolerance towards drugs. It shall be of 
considerable importance to investigate the changes in systemic and 
regional haemodynamic variables during chronic administration of 
antihypertensive drugs of different types. 
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SUMMARY 
At present many different antihypertensive drugs are available which lower 
the blood pressure through various mechanisms of action (chapter 1). 
Accordingly, it is expected that the haemodynaroic changes that accompany the 
fall in blood pressure during antihypertensive treatment ~th different drugs 
vary considerably. The aim of the studies described in thi.s thesis :i.s to 
characterize and compare the haemodynami.c profiles of various types of 
antihypertensive drugs with special emphasis on the drug-induced changes in 
reqional blood flows. For this purpose the radioactive mi.crosphere technique 
was used to study the acute effects of a series of "direct" and "~irect" 
vasodilators in conscious hypertensive rabbits. 
In order to test the suitability of the radioactive microsphere technique 
for successive measurements of systemic and regional haemodynamic variables in 
conscious animals, a control study was performed in which the effects of three 
subsequent injections of physiological saline (0.1 mlfkg, i.v.) on baseline 
values of cardiac output and regional blood flows were determined in conscious 
normotensive rabbits using microspheres with a diameter of 15 p.m. and labeled 
with different isotopes (chapter 2). No consistent changes were produced by the 
successive saline administrations in any of haemodynami.c variables measured. It 
was therefore concluded that at least four different measurements can be made 
reliably in a period of one hour. 
The effects of the drugs were studied in conscious rabbits with bilateral 
cellophane perinephritis hypertension. In chapter 3 a comparison is made 
between the values of systemic and regional haemodynamic variables in 
normotensive rabbits and in hypertensive rabbits 6 weeks after encapsulation of 
the kidneys with cellophane. Bilateral cellophane perinephritis hypertension 
was characterized by a rather generalized increase in peripheral vascular 
resistances with the most pronounced changes in the renal vascular bed, the 
latter resulti.ng in a marked decrease in blood flow to the kidneys. The cardiac 
output was moderately reduced in the hypertensive rabbits due to a fall in 
stroke volume. A negative correlation was observed between the weight of the 
left ventricular wall and the weight-normalized blood flow to this area 
suggesting inadequate coronary perfusion as myocardial hypertrophy becomes more 
pronounced. 
Chapter 4 describes the acute haemodynamic profile of the converting enzyme 
i.rihibi.tor captopril (0.1, 0.3 and 1.0 mg/kg, i.v.) in conscious hypertensive 
rabbits. '!'he drug effectively reduced the blood pressure in this ''low plasma 
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renin" model of hypertension. A moderate increase in cardiac output was 
observed at the higher doses of the drug. The rather generalized peripheral 
vasodilatation ( increase in vascular conductance ) produced by captopril suggests 
that an increased activity of the renin-angiotensin system in tissues such as 
the vascular wall and the brain may be involved in the maintenance of the 
increased blood pressure in rabbits with cellophane perinephritis. 
The effects of the arterial vasodilator hydralazine (0.3, 1.0 and 3.0 
mgjkg, i.v.), alone and in combination with the selective ~1-adrenoceptor 
antagonist atenoJ.ol (1.0 mg/kg, t.v.), are described in chapter 5. The fall in 
blood pressure produced by hydralazine was accompanied by an increase in heart 
rate and cardiac output. The drug caused vasodilatation and increased the blood 
flow in the heart, brain and kidneys, whereas a, probably reflex-mediated, 
vasoconstriction was measured in the skin, stomach and small intestine resulting 
in a reduced blood supply to these vascular beds. In addition, hydralazine 
.increased the arteriovenous anastomotic flow. Atenolol inhibited the cardiac 
stimulation and thereby accentuated the hypotensive action of hydralazine, 0.3 
mglkg. The synergistic effect on the blood pressure response was not obserbed 
after hydralazine, 3.0 mgjkg, due to the increase in cardiac output at this 
hydralazine dose despite effective ~-adrenoceptor blockade. Mo~over, atenolol 
interfered with the vasodilator response of hydralazine in the heart, skeletal 
muscles and arteriovenous anastomoses. Probably secundary to the changes in 
diastolic perfusion time and myocardial wall stress, the ~-adrenoceptor 
antagonist increased the weight-normalized endocardial/epicardial blood flow 
ratio in the lert ventricular wall and thereby abolished the decrease in this 
variable produced by hydralazine. This finding may be related to the protection 
offered by $-adrenoceptor antagonists against the vasodilator-induced attacks of 
angina pectoris in patients with limited coronary reserve. 
A characterization of the acute haemodynamic profile of the calcium 
antagonist felodipine (3, ~0 and 30 ~gjkg, t.v.) is given in chapter 6. 
Felodipine effectively reduced the blood pressure and increased the heart rate 
and cardiac output. With the exception of the cutaneous vascular bed, a rather 
generalized peripheral vasodilatation was produced by the drug although, 
quantitatively, marked regional differences were noticed. This resulted in an 
increased blood supply to the heart, brain, intestines and, at the higher doses 
used, skeletal muscles. AS observed with hydralazine, the calcium antagonist 
reduced the endocardial/epicardial blood £low ratio, which illustrated the 
negative aspects of single treatment with this arterial vasodilator. 
The acute effects of the 
(0.01, 0.03 and 0.10 mgjkg, 
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selective a 1-adrenoceptor 
i-. v. ) are described in 
antagonist 
chapter 7. 
prazosin 
Prazosin 
decreased the blood pressure by reducing total peripheral resistance. A 
moderate fall in cardiac output contributed to the hypotensive effect of the 
highest dose of prazosin used. only a slight increase in heart rate was 
observed l5 minutes after the successive prazosin administrations. The drug 
produced a rather selective vasodilatation in the kidneys, intestines and bones 
which resulted in unchanged blood flows to these vascular beds despite the fall 
in cardiac output after prazosin, 0 .10 mg/k.g. However, this was at the expense 
of the blood supply to the heart, brai.n, skeletal muscles and skin. The 
remarkable decrease in cerebral perfusion may be related to the "first dose 
phenomenon.. of prazosin in man characterized by side-effects such as dizziness 
and even loss of consciousnes. 
A characterization of the acute haemodynamic profile and the hypotensive 
mechanism o£ 
o:1-adrenoceptor 
pronounced fall 
ketanserin, a selective antagonist with 
blocking properties, i.s given in chapter 8. An initial 
in blood pressure, possibly due to a direct vasodilator action 
of ketanserin, accompanied by tachycardia preceded a more moderate but longer 
lasting hypotensive effect of the drug (O.l, 0.3 and 1.0 mgf):.g, t.v.). 
Espec~lly at the lower doses used, the cardiac output increased. considering 
i} the o:.1-adrenoceptor blocking properties at hypotensive doses of ketanserin in 
conscious hypertensive rabbits shown by the inhibition of the pressor response 
to phenylephrine, 'l i) the decrease in blood pressure produced by prazosin at 
doses which caused a comparable degree of c\-adrenoceptor blockade, iii) the 
absence of a prolonged hypotensive effect of ketanserin after ganglionic 
blOCkade, it was concluded that a
1
-adrenoceptor 
hypotensive effects 
blockade probably plays a 
predominant role in the of ketanserin in conscious 
hypertensive rabbits. In addition, as obServed with the a 1-adrenoceptor 
antagonist prazosin, ketanserin caused vasodilatation in the kidneys, 
gastro-intestinal tract and bones. In contrast to prazosin, ketanserin also 
produced a moderate vasodilatation in the heart and brain. Although it is 
attractive to attribute the differences in the regional haemodynamic profiles to 
the 5-HT2-receptor blocking properties of ketanserin, other explanations are 
possible, e.g. the direct vasodilator action of ketanserin, differences in 
pharmacokinetic properties and tissue autoregulatory responses. 
Chapter 9 summarizes and compares the haemodynamic profiles of hydralazine, 
felodipine, captopril, prazosin and ketanserin in conscious hypertensive 
rabbits. The changes in systemic haemodynamic variables that accompany the fall 
in blood pressure produced by the different drugs vary considerably depending 
upon the respective site of action (arterial and/or venous vessels) and the more 
or less pronounced activation of cardiovascular reflex mecha."l.isms. Each drug 
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produced a characteristis pattern of vasodilator responses which resulted in a 
redistribution of the cardiac output. The regional haeroodynamic profile is 
determined by the potency of the drug to dilate the various vascular beds. In 
addition, the reflex-mediated increase in sympathetic vasomotor tone and 
activation of the renin-angiotensin system, and tissue autoregulatory responses 
contribute to a different extend to the observed changes in vascular resistances 
and regional blood flows. The studies presented in this thesis should alert 
clinicians that important differences exist in the haemodynamic profiles of 
"direct" and "indirect" vasodilator drugs. This may ultimately lead to a more 
rational approach to antihypertensive treatment. 
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SAMENVATl'ING 
Bij de behandeling van hypertensie heeft men de besch1kking over een groot 
aantal antihypertensieve farmaca met diverse werkingsmechanismen. Men mag dan 
ook verwachten, dat de hemodynamische veranderingen, die gepaard gaan met de 
daling in bloeddruk tijdens behandeling met antihypertensieve farmaca, sterk 
uiteenlopen (hoofdstuk 1). Bet doel van het, in dit proefschrift beschreven, 
onderzoek is het hemodynamische profiel van een aantal antihypertensieve farmaca 
te karakteriseren en te vergelijken, waarbij met name aandacht is besteed aan de 
veranderingen in de bloeddoorstroming van peritere vaatgebieden. Hiertoe zijn 
de acute effecten een van vijftal "direkte" en .. indirekte.. vaatverwijders 
bestudeerd in niet-genarcotiseerde hypertensieve konijnen. 
Om zowel de systemische als de regionale hemodynamische variabelen te 
kunnen meten, is gebruik. gemaakt van de radioactieve microsfeer techniek. Een 
serie controle experimenten zijn uitgevoerd om de bruLKbaarheid van deze methode 
voor ons onderzoek te toetsen. Biertoe zijn de acute veranderingen in 
systemische en regionale variabelen bestudeerd na drie opeenvolgende 
toedieningen van een fysiologischc zoutoplossing (0.1 ml/kg, ~.v.) in 
normotensieve niet-genarcotiseerde konijnen, waarbij het hartminuutvolume en de 
perifere bloeddoorstroming in diverse regionale vaatgebieden zijn gemeten met 
behulp van microsferen met een diameter van 15 ~ en gernerkt met verschillende 
radioactieve isotopen. Daar er in geen van de hemodynamische variabelen 
significante veranderingen werden waargenomen, kon worden geconcludeerd, dat het 
mogelijk is om tenminste vier verschillende metingen te verrichten in een 
tijdsbestek van een uur. 
De effecten van de farmaca zijn bestudeerd in niet-genarootiseerde konijnen 
met bilaterale cellofaan perinephritis hypertensie. In hoofdstuk 3 zijn de 
hernodynamische variabelen in normotensieve en hypertensieve konijnen met elkaar 
vergeleken. Bilaterale cellofaan perinephritis hypertensie in konijnen werd 
gekenmerkt door een nagenoeg algemene toename in vaatweerstand in alle organen 
en weefsels. De toename in vasculaire weerstand was het meest uitgesproken in 
het renale vaatgebied hetgeen resulteerde in een vermindering van de 
bloeddoorstroming van de nieren. Bet hartminuutvolume was enigzins verlaagd in 
de hypertensieve konijnen als gevolg van een daling in het slagvolume. Een 
negatieve correlatie werd waargenomen tussen het gewicht en de bloeddoorstroming 
per gewichtseenheid van de linkerventrikelwand. Deze waarneming suggereert, dat 
de coronaire perfusie minder adequaat wordt naarmate de hy~rtrofie van het 
myocard toeneemt. 
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In hoofdstuk 4 staat het acute hemodyn~che profiel besdhreven van de 
remmer van het converting enzyme, captopril (0.~, 0.3 en 1.0 xngjkg), t..v.) in 
niet-genarcotiseerde konijnen met cellofaan perinephritis hypertensie. Deze 
experimentele vorm van hypertensie wordt gekenmerkt door een normale plasma 
renine activiteit. Desondanks werd een sterke daling in bloeddruk waargenomen 
na captopril toediening. De bogere doseringen veroorzaakten een geringe toename 
in het ha.rt:m.inuutvolume. De algemene vasodilatatie in de perifere vaatgebieden, 
welke werd waargenoroen na captopril toediening, suggereert, dat een verhoogde 
activiteit van bet renine-angiotensine systeem in de wand van bloedvaten enjof 
in hersenweefsel mogelijk een rol speelt bij bet instandhouden van de verhoogde 
bloeddrtik in konijnen met cellofaan perinephritis. 
De acute effecten van de arteriele vaatverwijder hydralazine (0.3, 1.0 en 
3.0 mgjkg, t..v. ), alsmede de combinatie van atenolol (1 mgjkg, t.v.) en 
hydral.azine (0.3 en 3.0 mgjkg, t..v. ), worden behandeld in hoofdstl.lk 5. De 
daling in bloeddrtik veroorzaakt door hydralazine ging gepaard met een toename in 
hartslagfrequentie en hartminuutvolume. Vasodilatatie en een toename in 
bloeddoorstroming werden waargenomen in het hart, de hersenen en de nieren, 
terwijl een, waarschijnlijk reflex-gemed.ieerde, vasoconstrictie werd gemeten in 
de huid, de maag en de dunne darm. oit laatste resulteerde in een verminderde 
doorbloeding van deze vaatgebieden. oaarnaast veroorzaakte hydralazine een 
toename in de bloeddoorstroming van arterioveneuze anastomoses. De selectieve 
e1-adrenoceptor antagonist, atenolol, verminderde de stimulatie van het hart, 
hetgeen resulteerde in een accentuering van het bloeddrUkverlagende effect van 
hydralazine, 0.3 mgjkg. Het synergistische effect op de bloeddruk werd niet 
waargenomen na hydralazine, 3.0 mgjkg, als gevolg van een sterke stijging in het 
hartminuutvolume na deze hydralazine dosis, ondanks een effectieve blOkkade van 
$-adrenerge receptoren. Bovendien verminderde atenolol het vasodilatoire effect 
van hydralazine in het hart, de skeletspieren en op de arterioveneuze 
anastomoses. Atenolol veroorzaakte een toe name in de ratio van de 
bloeddoorstroming van endocard en epicard in de lirikerventrikelwand, 
waarschijnlijk als gevolg van een verlenging van de diastolische perfusietijd en 
een verminderde druk op de ventrikelwand in het hart tijdens behandeling met de 
~adrenerge blokker. Rierdoor werd het negatieve effect van hydralazine op deze 
variabele teniet gedaan. Deze waarneming houdt mogelijk verband met de 
bescherming, die wordt geboden door ,6-·adrenerge antagonisten, tegen de door 
vaatverwijders geinduceerde aanvallen van angina pectoris in patienten met een 
beperkte coronai~~ reserve. 
Een karakterisering va~ het acute hemodynamische profiel van de calcium 
antagonist felodipine (3, 10 en 30pg/kg, t..v.) wordt gegeven in hoofdstuk 6. 
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Felodipine veroorzaakte een sterke daling in bloeddruk, welke gepaa:rd ging met 
een stijging in hartslagfr~entie en hartminuutvolume. Met uitzondering van de 
huid, werd een nagenoeg algemene vasodilatatie waargenomen in de verschillende 
organen en weefsels, hoewel kwantitatief duidelijke verschillen werden gemeten. 
Dit resulteerde in een toename in bloeddoorstroming in bet hart, de hersenen, 
bet maagdarrokanaal en, bij de hogere doseringen, in de skeletspieren, terwijl 
een verminderde doorbloeding van de huid werd geconstateerd na de hoogste 
felodipine dosis. Net als hydralazine, verlaagde felodipine de ratio van de 
doorbloeding van endocard en epicard in de litikerventrikelwand. Deze laatste 
waarneming illustreert bet negatieve aspect van behandeling met deze arteriele 
vaatverwijder. 
De acute effecten van de selectieve a~-adrenoceptor antagonist prazosine 
(O.Ol, 0.03 and 0.10 mg/}::g, f...v.) in niet-genarcotiseerde hypertensieve konijnen 
staan besehreven in hoofdstuk 7. Naast een verlaging in de totale perifere 
weerstand, droeg een da1ing in het hartminuutvolume bij tot het hypotensieve 
effect van prazosine, 0.10 mg/}::g. Slechts een geringe stijging in de 
hartslagfrequentie werd waargenomen 15 ~nuten na de opeenvolgende toedieningen 
van het farmacon. Prazosine veroorzaakte een tamelijk selektieve vasodilatatie 
in de nieren, de da.nnen en het botweefsel, hetgeen resulteerde in een 
onveranderde bloeddoorstroming in deze vaatgebieden, onda.nk:s de daling in het 
hartminuutvolume na de hoogste prazosine dosis. Echter, dit ging ten koste van 
de bloedtoevoer naar ondermeer hart, hersenen, skeletspieren en huid. De 
opmerkelijke daling in de cerebrale bloeddoorstroming verklaart bet zogenaamde 
-first dose phenomenon'' van prazosine in mensen, dat wordt gekenmerkt door 
veschijnselen zoals duizeligheid en bewustzijnsverlies. 
Hoofdstuk s geeft een karakterisering van het cardiovasculaire profiel en 
bet bypotensieve mechanisme van ketanserine, een selectieve 5-BT2-receptor 
antagonist met a1-adrenoceptor blokkerende eigenschappen. Een initiele daling 
in bloeddruk van korte duur, rnogelijk veroorzaakt door een direkte vasodilatoire 
werking, welke gepaard ging met tachycardie, werd waargenomen na iedere 
ketanserine toediening. Dit effect werd gevolgd door een geringer hypotensief 
effect van langere duur. Met name na toediening van de lagere doseringen werd 
een toename in het hartminuutvolume geconstateerd. Op grond van i) de 
a 1-adrenolytische eigenschappen van ketanserine in de hypotensieve doseringen, 
aangetoond door een remming van de door fenylefrine geinduceerde stijging in 
bloeddruk, ii) de daling in bloeddruk veroorzaakt door prazosine in doseringen 
met een vergelijkbare a~-adrenolytische activiteit, en iii) de afwezigheid van 
een langdurig hypotensief effect van ketanserine in konijnen na ganglion 
blokkade met hexamethonium, is de conclusie getrokken, dat de hypotensieve 
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werking van ketanserine in de hypertensieve konijnen met name berust op blOkkade 
van vasculaire a~-adrenerge receptoren. Daarnaast veroorzaakte ketanserine, net 
als prazosine, vasodilatatie in de nieren, het maagda.rmkanaal en het botweefsel. 
Echter in tegenstelling tot prazosine, werd na ketanserine toediening tevens een 
geringe vasodilatatie ~genomen in bet hart en de hersenen. Hoewel het 
aantrekkelijk is om de verschillen in het regionale hemodynamische profiel van 
prazosine en ketanserine toe te schrijven aan de blokkerende 
eigenschappen van ketanserine, zijn andere verklaringen mogelijk zoals een 
direkte vasodilatoire werking van ketanserine, versehillen in farmacokinetische 
eigenschappen tussen prazosine en ketanserine en de bijdrage van autoregulatie 
van de bloedtoevoer naar hart en hersenen na prazosine- en ketanserine 
toediening. 
In hoofdstuk 9 zijn de hemodynamische effecten van hydralazine, felodipine, 
captopril, prazosine en ketanserine saroengevat en met elkaar vergeleken. De 
veranderingen in de systemische hemodynamische variabelen, die gepaard gaan met 
de daling in bloeddruk na toediening van de diverse "direkte" en "indirek.te" 
vaatverwijders in niet-genarcotiseerde hypertensieve konijnen lopen sterk uiteen 
afha.nlcelijk van bet aangrijpingspunt van het betreffende farmacon ( arterieel 
en/of veneus) en 
cardiovasculaire 
de door het 
reflex mechanismen. 
farmacon geinduceerde activatie van 
Tevens produceert elk farmacon een 
karak.teristiek patroon van vasodilatoire effecten, hetgeen resulteert in een 
herverdeling van het h~nuutvolume over de verschillende weefsels en organen. 
Het regionale hemodynamische profiel wordt bepaald door de vasodilatoire 
eigenschappen van het betreffende farmacon in de diverse vaatgebieden. 
Bovendien spelen de reflectoire verhoging van de sympatische vaattonus, de 
activatie van het renine-angiotensine systeem en autoregulatie van de 
bloeddoorstroming in diverse weefsels in verschillende mate een rol bij de acute 
veranderingen in vasculaire weerstand en bloeddoorstroming van de perifere 
vaatgebieden. Bet onderzoek, omschreven in dit proefschrift, zou clinici attent 
moeten maken op de belangrijke verschillen in het hemodynamische profiel van 
verschillende "directe" en "indirecte" vaatverwijders, hetgeen z.ou kunnen 
bijdragen tot een meer rationale benadering van de behandeling van hypertensie. 
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